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This thesis is concerned with the nature of biomaterial interactions with compromised 
host tissue sites. Both ocular and dermal tissues can be wounded, following injury, 
disease or surgery, and consequently require the use of a biomaterial. Clear analogies 
exist between the cornea/tear film/contact lens and the dermal wound bed/wound 
fluid/skin adhesive wound dressing. The work described in this thesis builds upon 
established biochemistry to examine specific aspects of the interaction of biomaterials 
with compromised ocular and dermal tissue sites, with a particular focus on the role of 
vitronectin.  
 
Vitronectin is a prominent cell adhesion glycoprotein present in both tear fluid and 
wound fluid, and has a role in the regulation and upregulation of plasmin. The 
interaction of contact lenses with the cornea was assessed by a novel on-lens cell-based 
vitronectin assay technique. Vitronectin mapping showed that vitronectin-mediated cell 
adhesion to contact lens surfaces was due to the contact lens-corneal mechanical 
interaction rather than deposition out of the tear film. This deposition is associated 
predominantly with the peripheral region of the posterior contact lens surface. The 
locus of vitronectin deposition on the contact lens surface, which is affected by material 
modulus, is potentially an important factor in the generation of plasmin in the posterior 
tear film. 
 
Use of the vitronectin mapping technique on ex vivo bandage contact lenses revealed 
greater vitronectin-mediated cell adhesion to the contact lens surfaces in comparison to 
lenses worn in the healthy eye. The results suggest that vitronectin is more readily 
deposited from the impaired corneal tissue bed than the intact healthy tissue bed. 
Significantly, subjects with a deficient tear film were found to deposit high vitronectin-
mediated cell adhesion levels to the BCL surface, thus highlighting the influence of the 
contact lens-tissue interaction upon deposition.  
 
Biomimetic principles imply that adhesive materials for wound applications, including 
hydrogels and hydrocolloids, should closely match the surface energy parameters of 
skin. The surface properties of hydrocolloid adhesives were found to be easily modified 
by contact with siliconised plastic release liners. In contrast, paper release liners did not 
significantly affect the adhesive surface properties. In order to characterise such 
materials in the actual wound environment, which is an extremely challenging task, 
preliminary considerations for the design of an artificial wound fluid model from an 
animal serum base were addressed.     
 
 
Key phrases: bandage contact lens; hydrocolloid; hydrogel; skin adhesive wound 
dressings; vitronectin; wound healing. 
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ABBREVIATIONS AND NOTATIONS 
 
Anti-Fn anti-fibronectin 
 
PIB poly(isobutylene) 
Anti-Vn anti-vitronectin 
 
PMCs post mitotic cells 
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BCL bandage contact lens 
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BK bullous keratopathy 
 
PTK phototherapeutic 
keratectomy 
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RL1 release liner 1 
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RL2 release liner 2 
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cells 
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beta 
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activator 
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UV ultraviolet 
LASIK laser-assisted in situ 
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VEGF vascular endothelial growth 
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MMPs matrix metalloproteinases 
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WR working reagent 
PBS phosphate buffered saline 
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% percent 
 
mg/ml milligram per millilitre 
° degree 
 
mm millimetre  
°C degrees Celcius 
 
mM millimolar 
bn billion 
 
mm/minute millimetre per minute 
cm centimetre 
 
mmol/l millimoles per litre 
cm
2 centimetre 
squared  
mNm
-1
 milliNewtons per metre 
cm³ centimetre cubed 
 
mOsm/kg milliosmoles per kg  
g gram 
 
MPa megaPascal 
g/l grams per litre 
 
N Newton 
Hz Hertz 
 
N/25mm Newtons per 25 
millimetres 
kDa kiloDalton 
 
N/m² Newton per metre 
squared  
 
kg 
 
kilogram  
nm 
pg/ml 
nanometre 
pictogram per millilitre  
m metre 
 
rpm rotations per minute 
m/min metre per minute 
 
μg/ml microgram per millilitre 
mEq/l milliequivalent 
per litre  
μl microlitre 
mg/l milligram per litre 
 
μm micrometre 
 
 
 
eΦ spectrometer work function 
G' elastic modulus 
G'' viscous modulus 
h Planck's constant 
pI isoelectric point 
pH power of the concentration of hydrogen 
ions 
tan δ tan δ 
v photon frequency 
w/e weight equivalent 
 
 
 
Please refer to Section 2.1.1 for the following monomers:  
DMA, HEMA, MA, NCVE, NVP, PBVC, TPVC, TRIS 
   
and Section 2.2.1 for the following chemicals and immunochemicals: 
DMEM, EDTA, HBS, IgG, L-glu, MgCl2 
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1.1 Introduction  
 
The aim of this work is to investigate the nature of biomaterial interactions with 
compromised ocular and dermal tissue sites.  
 
Both the cornea and skin can become wounded, following injury, disease or surgery. It 
is desirable for these compromised tissue sites to return to a ‘normal’ healthy state by a 
natural sequence of events. This is typical of acute wounds which heal in a stepwise 
process of partially overlapping phases. The healing cascade does not, however, always 
occur in an orderly process. Wounds may become trapped in a phase of non-healing, 
otherwise identified as chronic wounds. Synthetic biomaterial devices serve many 
important purposes and protection of the tissue is a primary function; both the wounded 
cornea and wounded skin require protection from the external environment. 
Biomaterials are designed to replace some natural function of the compromised tissue 
site. The presence of a material, however, creates a new interface at the wound surface 
and consequently new interfacial events can occur. The work described in this thesis 
builds upon established biochemistry to examine the consequences of specific aspects 
of the interaction of biomaterials with compromised ocular and dermal tissue sites. 
 
Ocular wounds, including rapidly healing superficial injuries and more severe chronic 
conditions, are often managed by the use of therapeutic bandage contact lenses. 
Hydrogels, which are water-swollen polymer networks, are used to produce 
conventional soft contact lenses and silicone hydrogel contact lenses (SiHy lenses). 
Similarly, hydrogels are also used for skin adhesive wound dressing materials to 
manage acute and chronic dermal wounds. Another important material type of wound 
dressings is hydrocolloids; these do not contain water as the name suggests, but are 
capable of absorbing water to form a hydrophilic gel. The interaction of a biomaterial, 
whether it is a hydrogel bandage contact lens or a hydrogel/hydrocolloid skin adhesive 
wound dressing, with the compromised tissue site brings about physicochemical and 
biochemical changes in the wound environment.  
 
This first area of study in this thesis is concerned with the investigation of contact lens 
interactions with the cornea by the use of a novel on-lens cell-based assay technique. 
Vitronectin is a multifunctional adhesion molecule present in both tear fluid and wound 
fluid. As a pro-healing glycoprotein that promotes cell adhesion and spreading, 
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vitronectin possesses a high affinity for surface interaction. Consequently, vitronectin 
was chosen as an important biomarker for interfacial biomaterial studies in order to 
investigate tissue-material interactions. The second main area of study was the 
investigation of the influence of surface and mechanical properties of skin adhesive 
hydrogel and hydrocolloid biomaterials at the skin-biomaterial interface.  
 
This introduction discusses the unusual similarities between the ocular and dermal 
tissue sites. A background to dermal wound healing is provided. This includes a 
description of the anatomy of skin and the aging skin, the stages of the dermal healing 
process, the role of cell adhesion proteins in the healing process and a comparison of 
acute and chronic wounds. Similarly, background information for ocular wound healing 
is provided with a discussion of the anatomy of the eye and ocular wound healing 
process. Lastly, an overview of key biomaterials relevant to this work for the use in 
both dermal and ocular applications is presented.  
 
1.2 The Ocular/Dermal Wound Healing Analogy  
 
The central theme of this thesis lies in the similarities between ocular and dermal 
wound sites. More specifically, both corneal and skin surfaces act to protect the body 
from the external environment. However, both surfaces can become wounded and it is 
the comparison of these two compromised surfaces which are of particular interest in 
this work. Firstly, the healthy intact cornea with the overlying tear film is comparable to 
the chronic dermal wound; both are surfaces with a rapid cell turnover. The tear film of 
the eye coats the cornea with optical, lubricant and protective functions [1]. Should, 
however, the tear film begin to fail, as in the severe case of chronic dry eye, the cornea 
keratinises to give a dry skin-like structure. It is this damaged corneal surface which is 
physically similar to healthy unbreached skin. Secondly, when considering the 
biointeractions of materials with their respective host site, a contact lens over the 
surface of the cornea may be likened to a wound dressing protecting an injury. 
Comparisons may also be drawn between tear fluid and wound exudate, with the two 
fluids containing many of the same proteins, lipids and mucins.  
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1.3 Dermal Wound Healing 
 
Dermal wound healing is a dynamic biological process involving the repair of 
disruptions or breaches in the structure of skin. Ordinarily the body is capable of 
achieving closure of acute wounds without major complications. However, patients who 
suffer with conditions, such as poor blood circulation and diabetes mellitus for example, 
often experience impaired healing resulting in the formation of chronic wounds [2]. 
There is no set definition for a chronic wound, but it is generally accepted that a wound 
falls under this category if it fails to heal within 3-4 months. In the UK it is estimated 
that around 200,000 patients have a chronic wound, such as foot ulcers, pressure ulcers 
and venous leg ulcers, with a cost to the National Health Service of between £2.3bn-
3.1bn per annum [3]. The occurrence of foot ulcerations alone has been reported at 
64,000 cases per annum, with 2,600 amputations taking place annually [4]. 
 
1.3.1 Anatomy of Skin   
 
Skin is the largest organ of the body, accounting for over 10% of the total body mass 
[5]. Knowledge of the physiology of skin is essential in order to understand wound 
healing. The broad functions of skin are threefold [6]. Firstly, it acts to provide a 
protective permeable barrier against exposure to water and fluids, microorganisms, 
electrolytes, ultraviolet radiation, and mechanical and thermal insults. Secondly, skin is 
involved in the regulation of body temperature and vitamin D synthesis. Finally, skin 
acts as a sensory organ. It contains nerve receptors that detect changes or pain 
encountered in the external environment, such as changes in temperature and pressure 
to skin. Superficial, acute or chronic wounding affects all three functions of skin. The 
structural arrangement of skin consists of three layers; the innermost hypodermis, the 
overlying dermis, and the uppermost epidermis, as shown in Figure 1.1. 
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Figure 1.1 Cross section of skin morphology - the hypodermis, dermis and epidermis. 
1.3.1.1 The Hypodermis  
The hypodermis, also referred to as subcutaneous tissue or the subcutis, is the innermost 
thickest layer of skin. In addition to a network of blood vessels, lymphatics and nerves, 
this layer is abundant in adipose tissue and loose connective tissue. Round adipocyte 
cells are arranged in lobules separated by bands of fibrous connective tissue, which 
compose the interlobular space. Functions of the hypodermis include heat insulation, 
energy store and release, shock absorption, in addition to visually and cosmetically 
contouring the body. It also anchors the skin to underlying tissue and muscles, allowing 
moderate mobility of the skin. Distribution of the hypoderrmis across the body is not 
uniform, with low abundance at the eyelids for example, in comparison to greater tissue 
at the hips and buttocks [7]. Appendages of skin, including hair follicles and sweat 
glands, extend into the hypodermis layer.    
1.3.1.2 The Dermis 
Immediately above the hypodermis lies the dermis; the two layers are connected by 
interconnecting collagen and elastin fibres. The thickness of the dermis layer varies 
with anatomic location, ranging from 0.3 mm at the eyelids to 3 mm at the palms and 
soles [8], and contains blood vessels, lymphatic vessels, hair follicles, eccrine glands, 
aprocine glands and small quantities of striated muscles. The dermis is itself divided 
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into two subcategories; the upper papillary layer, which anchors to the epidermis, and 
the deeper reticular layer, which connects to the underlying hypodermis. The two layers 
are separated by the subpapillary plexus boundary. Loosely organised collagen fibres 
and elastin fibres constitute the thin superficial papillary layer in a perpendicular 
arrangement to the dermal-epidermal junction. Coarser bundles of collagen fibres and 
elastin fibres form the thicker reticular layer to give the bulk of the dermal tissue.       
Fibroblasts are the primary cell type of the dermis, which synthesise collagen, elastin, 
ground substance, proteoglycans and glycosaminoglycans (GAGs). Collagen is a major 
structural protein which accounts for approximately 75% of the dry weight of skin [9] 
and is, therefore, responsible for tensile strength and mechanical resistance. Elastin 
makes up approximately 4% of the dermis [9] and provides elasticity in order to recoil 
the skin to its normal configuration following any disorder. Intracellular ground 
substance consists of water, electrolytes, GAGs and plasma proteins such as fibronectin 
and vitronectin. The transdifferentiation of fibroblast cells to myofibroblast cells is 
central to the wound healing process, as myofibroblasts possess contractile properties, 
thereby allowing wound closure. 
1.3.1.3 The Epidermis 
The epidermis, a stratified squamous epithelium, is the continually renewing uppermost 
layer of skin. It functions to provide a physical barrier, maintain skin integrity and 
hydration, and prevent excessive loss of internal bodily fluids. Keratinocytes are the 
fundamental cells of the epidermis, which synthesise the fibrous keratin protein. The 
epidermis is divided into four further layers; 
 The stratum basale layer consists of a single cell layer of keratinocytes. 
Langerhans cells, Merkel cells and melanocytes form approximately 5-10% of 
this layer. The keratinocyte cells may be categorised as two types. Firstly, 
keratinocytic stem cells undergo mitotic divisions to produce daughter cells, 
which become flatter and lose their nuclei as they migrate towards the 
uppermost layer of skin. The second type of keratinocytic cells connect to the 
basement membrane, thus anchoring the epidermis to the papillary layer of the 
dermis. 
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 The stratus spinosum, also referred to as the spinous or prickle layer, contains 
keratinocytes that are larger and flatter than cells found in the basale layer. 
These prickly-shaped cells, with intact nuclei, are connected by an intracellular 
network of desmosomes. 
 
 The stratus granulosum, or the granular layer, is so-called as the keratinocyte 
cells continue to flatten as they mature and migrate further. The nuclei 
disappear to leave the cytoplasm containing granular lamella.  
 
 The stratus corneum is the uppermost layer of the epidermis, more commonly 
referred to as the horny layer. All nuclei and cell organelles are lost at this 
stage of the cell maturation, and the now hexagonal shaped cells are closely 
packed and adhere together by intracellular lipids and desmosomes. This layer 
undergoes continuous desquamation.  
Additionally, a fifth layer of the epidermis, identified as the stratus lucidum, is often 
only present in regions of thick skin, such as the soles and palms, and is absent from 
thinner skin. This narrow layer of closely packed cells is found between the granulosum 
and corneum.                            
1.3.2 Aging Skin  
A large proportion of individuals suffering with non-healing chronic wounds, such as 
pressure ulcers and venous leg ulcers, are elderly patients [10-12]. The continuing 
growth of the elderly population means that the prevalence of chronic wounds is 
escalating. The elderly population is more susceptible to developing chronic wounds 
because of underlying chronic medical conditions, such as diabetes mellitus, and 
because of mobility issues. It is estimated by the NHS that 1 in 50 people aged over 80 
in the UK suffer with a venous leg ulcer [13].     
As skin ages over time, structural changes result in a decrease of maximal function and 
resiliency, increased vulnerability to the external environment, in addition to reduced 
vascular and glandular response [14, 15]. Intrinsic changes occur due to chronological 
aging, which are independent of environmental effects. Conversely, extrinsic changes 
are a result of long term exposure to the environment, predominantly UV radiation 
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exposure [14]. Collectively, both types of aging may cause skin to appear atrophic, 
wrinkled, sagged, dehydrated, pale and with altered pigmentation [14, 16]. Loss of 
elasticity means that skin is less able to respond to natural stress [16]. A summary of the 
changes that take place with aging in human skin is provided in Table 1.1.   
Table 1.1  A summary of the changes that occur with aging in human skin (adapted 
from Gosain and DiPietro [14]). 
 
Clinical Changes Histological Changes 
Atrophy Flattening of the dermal-epidermal junction 
Drying Increased turnover time 
Roughness Decreased fibroblasts, mast cells and macrophages 
Alterations in pigmentation 
Decreased collagen content 
Disorganised collagen and elastin 
Impaired microcirculation 
Sagging 
Wrinkling 
Benign and malignant 
tumours 
 
 
Although the cell turnover rate of the epidermis decreases as skin ages, little change is 
seen within its structure. The epidermal thickness tends to remain fairly consistent with 
age [17]. The dermis layer, however, is largely affected by aging, particularly at the 
dermal-epidermal junction. The cells here flatten to give decreased contact between the 
dermis and the epidermis. Collagen and elastin depletion occurs due to decreased 
synthesis coinciding with increased degradation, leading to thinning of skin. In the 
hypodermis, migration of the keratinocyte daughter cells decreases by about 50% in 
aged skin, thereby diminishing the volume of subcutaneous fat tissue, and resulting in 
atrophy. As a result, the fragility of aged skin increases and it is more susceptible to 
trauma caused by tearing, which can lead to chronic wounding.   
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1.3.3 The Dermal Wound Healing Process    
The complicated yet dynamic process of wound healing is divided into the four 
overlapping phases of haemostasis and inflammation, tissue granulation or cell 
proliferation, and tissue remodelling, as demonstrated in Figure 1.2. 
The first phase of inflammation occurs immediately after injury and rupturing of blood 
vessels, with the primary vascular response inducing vasoconstriction [18]. The 
proceeding inflammatory response involves platelet adhesion and blood coagulation to 
facilitate the formation of a thrombus. This haemostatic plug consists of a matrix of 
platelets, fibrin, fibronectin and vitronectin. As the principal means of protecting the 
wound from bacterial exposure, the plug also functions as a scaffold for the recruitment 
and migration of many various cell types. Inflammatory host cells, including 
neutrophils and monocytes, rapidly infiltrate the wounded tissue. Neutrophils debride 
the area of bacteria and pathogenic microorganisms by phagocytosis, whilst monocytes 
metamorphosise to macrophages. The debriding macrophages scavenge tissue debris, 
but serve a dual purpose to the healing process by stimulating various growth factors 
and chemotactic mediators; these are essential for the initiation of the subsequent repair 
steps.     
Cell proliferation occurs approximately one day after the initial wounding and may last 
up to several weeks. Macrophages migrate to the open wounded tissue site to provide 
growth factors essential for fibroplasia. Additionally, macrophages and platelets 
stimulate the migration of fibroblasts to the wound. The fibroblasts synthesise and 
deposit a provisional extracellular matrix, thereby providing a platform for cell 
migration. The complex matrix, which initially consists of type III collagen, fibrin, 
fibronectin, vitronectin, tenascin and hyaluronic acid, resembles pebbled granules of 
red/pink tissue. Although the immature collagen is greatly unorganised at this stage, it 
forms a major component of the matrix, and synthesis by fibroblasts is only stopped 
when a sufficient collagenous matrix is developed. Angiogenesis, the process of 
forming new blood vessels from existing vessels, then occurs. These new vessels 
function to sustain cell metabolism by supplying oxygen and nutrients. Fibroblasts then 
undergo a phenotypic change to myofibroblasts, which are responsible for wound 
contraction.   
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The final phase of tissue remodelling aims to recover the normal tissue structure of the 
affected area. As the matrix undergoes maturation, the composition of the granulation 
tissue changes – a decrease in the amount of fibronectin and hyaluronic acid is seen, 
whereas there is an increase in collagen fibres. Type III collagen is eventually replaced 
with type 1 collagen in a careful process of new collagen synthesis and old collagen 
degradation. This degradation is controlled by the action of matrix metalloproteinases 
(MMPs) and tissue inhibitors of metalloproteinases (TIMPs). The newly remodelled 
scar tissue gradually increases in strength due to the reorganisation and realignment of 
the collagen fibres, in a process that can take up to two years. This healed tissue, 
however, loses approximately 20% of its original strength [19] and is consequently at 
greater risk of breach than ordinary tissue.  
 
 
Figure 1.2 Phases of dermal wound healing. 
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1.3.4 Wound Chronicity  
Whilst the healing mechanism for acute wounds occurs in a linear progression of 
overlapping events, the process for chronic wounds is highly disordered and non-linear, 
with some areas of the wound in different stages of healing to others. As stated in 
section 1.3 there is no agreed definition for chronic wounds, but they may be described 
as “wounds which have failed to proceed through an orderly and timely reparative 
process to produce anatomic and functional integrity over a period of 3 months” [20]. 
Chronic wounds are primarily characterised as foot ulcers, venous leg ulcers and 
pressure ulcers, where patients often suffer from an additional underlying condition or 
disease [2]. Low oxygen pressure, tissue hypoxia, nutritional deficiencies or 
malnutrition, infection and repetitive trauma can contribute towards wound chronicity 
[21]. Ischemia results in tissue necrosis and greater susceptibility to bacterial 
colonisation, which therefore increases the risk of serious infection. It is now well 
recognised that the chronic wound microenvironment exhibits increased matrix 
metalloproteinase expression coinciding with decreased tissue inhibitors of 
metalloproteinases expression, in addition to an imbalance between levels of growth 
factors, proteases and cytokines [22]. Together, these factors lead to a state of persistent 
inflammation, whereby the wound is prevented from re-epithelialisation and 
progression onto the proliferation phase of healing. Chronic wounds are, therefore, 
identified by the decrease or complete absence of granulation tissue.    
Many theories regarding the causes of wound chronicity have been formed. Two 
principal theories for the cause of venous ulcers in the lower extremities were proposed. 
Firstly, in 1917 Homans [23] postulated that venous stasis leading to anoxia was a 
cause of tissue necrosis, findings which were later criticised due to the experimental 
technique implemented. Secondly, in 1947 Pratt [24] suggested that the raised oxygen 
tension of blood in legs with venous insufficiency was due to arteriovenous shunts, 
findings which were also later challenged. In 1982, Browse and Burnard [25] then 
proposed a series of events termed the ‘fibrin-cuff’ hypothesis for the cause of venous 
ulceration, suggesting that high venous pressure results in the widening of endothelial 
pores. It was suggested that this may allow the escape of large molecules, in particular 
fibrinogen with an approximate molecular weight of 340 kDa, which form around the 
capillaries in a ‘cuff.’ The cuff prevents the diffusion of oxygen and essential nutrients, 
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leading to tissue death and ulceration. Falanga and Eaglstein [26] expanded this theory 
in 1993 by proposing the ‘trap’ hypothesis. Macromolecules, including albumin, α-2-
macroglobulin and fibrinogen, may leak into the dermis where they trap growth factors 
and matrix proteins. The impedance of normal metabolic activity then results in 
ulceration. Furthermore, the ‘white cell trapping’ hypothesis describes a theory by 
which a reduction in venous blood flow results in the margination of white blood cells 
[27]. This can lead to tissue necrosis by two means; firstly capillary plugging may give 
areas of localised ischaemia, and secondly activation of the cells may release free 
radicals, cytokines and proteolytic enzymes. A study by Bjarnsholt [28] suggested that 
the presence of Pseudomonas aeruginosa in biofilms, together with the lack of 
elimination by polymorphoneclear neutrophils, contribute towards chronicity. Despite 
the numerous hypotheses, there is no single theory that can be attributed to impaired 
wound healing and the development of chronic wounds.  
1.3.5 Cell Adhesion Molecules in Wound Healing   
 
1.3.5.1 The Importance of Cell Adhesion Molecules  
 
Cell adhesion is important in many different phases of the wound healing process and 
cell adhesion molecules are an integral component of this process. Adhesion molecules 
may be categorised into several classes. Integrins are a large family of adhesion 
receptors consisting of α and β sub-units. Integrins may be further classified as 
molecules that mediate cell-cell interactions or molecules that are involved in adhesion 
to the extracellular matrix (ECM).  
 
Additionally, glycoproteins play an important role in cell adhesion to ECM 
components. Glycoproteins are essential to many phases of wound healing such as the 
regulation of haemostasis, cell adhesion, migration and proliferation. One such protein 
is vitronectin, which is a multifunctional protein present in the ECM, plasma and other 
bodily fluids such as the amniotic fluid and urine. Vitronectin is involved in numerous 
physiological processes crucial to successful wound healing. It has been shown that its 
absence from the provisional ECM leads to increased fibrinolysis, which consequently 
delays the healing process [29]. Vitronectin is a key component of the wound healing 
process and thus its structure and functions are discussed in greater detail.  
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1.3.5.2 Vitronectin – Structure, Roles and Functions 
 
Vitronectin, also known previously as ‘S-protein’ or ‘epibolin’, was first discovered in 
1967 [30]. The protein is present in plasma under normal conditions at 200 to 400 
µg/ml, which constitutes approximately 0.2–0.5% of the total protein in plasma [31, 
32]. Vitronectin is a relatively small glycoprotein of 459 amino acid residues [33] and is 
commonly detected in two forms; a single 75 kDa polypeptide chain and a 65 kDa 
subunit linked to a 10 kDa fragment by a disulfide bond [34]. This glycoprotein is 
involved in many physiological processes, a number of which are summarised in Table 
1.2. Its role and functions are dependent on its binding to various matrix and cellular 
components, which in turn stabilises or activates a variety of biological 
macromolecules.  
 
Table 1.2 A summary of the diverse functions of vitronectin. 
 
Process Description Consequences 
Fibrinolysis Stabilises PAI-1 Anti-proteolytic activity 
Complement 
regulation 
Inhibition of MAC (C5b-9) Protection of bystander cells 
T-cell cytolysis Inhibition of cell lysis by 
perforin 
Protection of bystander cells 
Cellular adhesion Integrin binding Migration, attachment and 
aids healing 
Thrombosis Binds thrombin-
antithrombin III 
Inhibits thrombin 
inactivation, regulating blood 
coagulation 
Inflammation Binds β-endorphin Pain suppressor 
Binds structural 
macromolecules 
Heparin, collagen, heparin 
sulphate 
For activation or adhesion to 
surfaces. Healing? 
Growth factor 
interaction 
Vitronectin-GF complexes Promote wounding healing 
and cell regulation 
Anti-bacterial Binds to various strains of 
bacteria 
Inhibition in the initial phase 
of bacterial infections 
 
One of the primary functions of vitronectin is to regulate the spreading and attachment 
of a wide variety and range of cells [35, 36]. An Arg-Gly-Asp (RGD; residues 45-47) 
cell binding sequence enables vitronectin to bind integrins. The integrin family of 
heterodimeric proteins recognise the RGD sequence on many extracellular components, 
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including vitronectin, fibronectin and fibrinogen [37]. This cell-matrix interaction - 
which directly regulates cellular differentiation, proliferation, and migration - can 
influence processes such as wound healing and inflammation. Vitronectin also 
minimises the unnecessary lysis of host cells [38], protecting these nearby bystander 
cells. Regulation of the complement system through the inhibition of the action of 
membrane attack complex is controlled by a number of regulating proteins including 
vitronectin. By binding to the hydrophobic domains of the C5b-7 protein complex to 
form SC5b-7,[39] the SC5b-7 complex is prevented from penetrating into cell 
membranes.   
 
1.3.5.3 The Interaction of Vitronectin with Synthetic Materials  
 
Vitronectin is an adhesive protein which is recognised for its adhesion to synthetic 
biomaterials. The affinity of vitronectin for various polymeric biomaterials has been 
noted by many workers including: commercial and laboratory synthesised materials 
[40, 41], cell culture substrates such as tissue culture polystyrene [42] and Primaria™ 
[43], poly(methyl methacrylate) (PMMA) intraocular lenses [44], silicone [44, 45] and 
conventional hydrogel contact lenses [46]. Due to the fact that vitronectin is such an 
adhesive protein, it is highly likely to interact with biomaterials at the wound interface, 
which includes both dermal and ocular tissue sites.  
 
One important role of vitronectin is the regulation of fibrinolysis, as highlighted in 
Table 1.2. The conversion of plasminogen to plasmin is kept in equilibrium by the 
antagonistic actions of plasminogen activator inhibitor-1 (PAI-1) and tissue 
plasminogen activator (tPA). Vitronectin binds PAI-1 and thus modulates the 
conversion of plasminogen to plasmin. If vitronectin is adhered to a synthetic 
biomaterial at a compromised tissue site, it may bind PAI-1 to create an imbalance of 
plasminogen activator and thus resulting in the upregulation of active plasmin.      
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1.4 Dermal Wound Dressings 
 
1.4.1 The Ideal Wound Dressing  
The history of wound dressings originates from the earliest known record of dressings 
in the form of a clay tablet around 2100/3000 BC. This tablet is considered to be the 
first medical manuscript of ancient medical practice, with concepts of washing the 
wound, applying dressings and bandaging the wound being conveyed. The Egyptians in 
1550BC produced the Ebers Papyrusa - a 20 m papyrus stating that the basic 
constituents of a dressing should include lint to absorb exudates, grease to act as a 
barrier to contamination from external sources, and honey as an anti-bacterial 
component. It was not until the 19
th
 century, however, that a breakthrough in the use of 
antiseptics for wound healing and surgical practice to reduce infections was made. 
James Lister in 1865 observed that soaking dressings in carbolic acid (phenol) prior to 
wound application successfully reduced the rate of wound infection. Following from 
this discovery, Robert Johnson in the 1870s began producing gauze dressings pre-
treated with iodine for its anti-microbial properties. However, it was the concept of 
moist wound healing, demonstrated by George Winter in 1962, that revolutionised the 
field of wound healing. Winter demonstrated that the epithelialisation of porcine 
wounds occurred at a faster rate under occlusive dressings that promoted a moist wound 
environment, rather than wounds which were exposed to air and allowed to dry out 
[47]. This finding led to an evolution of materials used for wound dressing purposes, 
and thus the requirements of materials also expanded.   
The current perception of an ideal biocompatible wound dressing is based upon a 
combination of various functions and properties: 
 Biocompatibility: The primary requirement of a dressing material is that it must 
be biocompatible with the host tissue site. It must be non-toxic, non-allergenic 
and non-sensitising, and ideally interact with the wound without causing any 
adverse reactions.   
 
 Fluid/exudate absorption: A dressing must be able to absorb excess exudate 
without leakage to the surface of the dressing. Suitable fluid handling 
capabilities, whilst maintaining a moist wound environment, are essential.  
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 Humidity: Due to the fact that chronic wounds benefit from a moist 
environment, a high stable humidity prevents scar formation which thereby 
accelerates wound healing. It has been reported, however, that exudate trapped 
within the wound bed increases the wound humidity beyond acceptable levels, 
causing other complications such as an imbalance of the wound pH [48].   
 
 pH maintenance: Although the pH of chronic wound exudate varies from wound 
to wound, the fluid is relatively highly alkaline and has been recorded within the 
range of 7.5-8.9 [49]. The absorbency property of a dressing should remove 
surplus exudates to maintain a natural wound bed pH.         
 
 Impermeability: The dressing must act as an effective “barrier” against all 
external contaminants, including water and bacteria, to protect from secondary 
infections. Occlusive dressings must, however, allow for moisture vapour and 
gaseous exchange between the wound and the external environment.     
 
 Thermal insulation: Wounds heal effectively at body temperature. It has been 
suggested that a wound bed temperature of 36-38°C is optimal for a reduction of 
the wound surface area, whereas temperatures below 35°C and above 42°C may 
hinder healing [50]. A dressing which can provide thermal insulation to the 
wound site, such as foam dressings, or provide a cooling effect, such as 
hydrogel dressings, are suitable for different wound types.        
 
 Structural integrity: The structural integrity of a dressing has the potential to 
cause an inflammatory response, infection and damage to newly re-
epithelialised tissue. Fibres from the dressing may become incorporated into the 
wound itself. This is a downfall of traditional fabric dressings, such as the cotton 
gauze. In order to prevent an inflammatory response, a dressing must not leave 
foreign particles in the wound. 
 
 Adherence: Many wound dressing materials have an adhesive system to keep 
them secure at the wound site. The adhesive may either be separate to the 
dressing, such as adhesive tapes/strips and supplementary adhesives, or the 
adhesive may be a component of the wound dressing. Pressure sensitive 
adhesive (PSA) materials form a large element of biomaterials for wound 
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healing management. PSA materials are designed to provide instantaneous 
adhesion to a substrate upon the application of slight pressure. In this case the 
substrate is skin.  
 
Numerous types of dressings are available which vary in absorptive and adhesive 
capacities, including hydrogels, hydrocolloids, alginates, foam dressings, collagen 
dressings and amorphous gels. Although individual manufacturers undoubtedly use 
testing techniques for quality control of dressing materials within their own industries, 
the academic literature is lacking in the assessment of the biophysical properties of skin 
and the corresponding properties of wound dressing materials. Little is known regarding 
suitable characterisation techniques that may attempt to match or relate the properties of 
materials to the behaviour of the natural tissue. This is in great contrast to the ocular 
area where the clinical relevance of physicochemical properties, such as wetting, 
modulus and permeability behaviour, is well-advanced in both industrial and academic 
settings. One aspect of the work described in this thesis involves the examination of the 
surface and mechanical properties of materials in relation to the biophysics of skin. This 
work is concerned with skin adhesive wound dressing materials and, therefore, skin 
adhesive hydrogels and hydrocolloids shall be discussed in further depth.  
1.4.2 Skin Adhesive Hydrogels 
 
Hydrogels may be described as cross-linked, water-swollen polymer networks [51]. 
They are able to swell due to their hydrophilic nature, without dissolving in water. The 
water content on a fully hydrated hydrogel may range from 20-98% and is expressed as 
the equilibrium water content (EWC): 
 
Equation 1 EWC = [Weight of water in gel / Weight of gel] * 100 
 
Hydrogel wound dressings are generally available as either sheet or amorphous 
formulations. Sheet hydrogels are firm sheets that uphold their structural integrity when 
swollen, whereas amorphous hydrogels are soft shapeless gels that decrease in viscosity 
with increasing fluid absorption.  
 
A distinct advantage of hydrogel dressings is the ability to donate moisture to 
dehydrated tissue and, therefore, maintain a moist wound healing environment. This 
property allows hydrogels to promote autolytic debridement of slough and wound 
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debris. Additionally, hydrogel dressings are able to absorb fluid from an exuding 
wound; the rate of which is dependent upon the EWC. This can, however, lead to over-
hydration of the wound and peri-wound area, particularly for highly exuding wounds. 
Hydrogels have also been reported to relieve pain by providing a cooling effect for 
wounds producing a burning sensation [52]. Amorphous hydrogels have been shown to 
reduce the temperature of a wound by up to 5°C [53]. In general, these properties 
indicate that hydrogel dressings are best suited for dry painful wounds exuding low 
levels of fluid.  
 
Hydrogel dressings are typically non-adherent materials and thus minimise localised 
trauma caused by removal – this is important for cases where frequent dressing changes 
of every 1-3 days are required. A secondary dressing may be necessary to hold the 
hydrogel in place, although many hydrogel dressings are available with an adhesive 
border or entire adhesive surface.  
 
1.4.3 Skin Adhesive Hydrocolloids 
 
1.4.3.1 Hydrocolloids for Wound Dressings  
 
A hydrocolloid forms a colloid system as a result of interaction with water. 
Hydrocolloids may be classified as either natural (formed from natural proteins and 
carbohydrates), semi-synthetic (modification of natural hydrocolloids) or synthetic 
(synthesised from petroleum-based materials). The name “hydrocolloid” is somewhat 
inaccurate, as the material does not contain any water in its formulation. Rather, the 
distinctive feature of hydrocolloid materials is the ability to form a hydrophilic gel 
when in the presence of water, through hydrogen bonding.       
Hydrocolloid dressings are absorptive, occlusive and generally adhesive dressings. 
They are typically formulated of: sodium carboxymethyl cellulose (NaCMC) for 
absorption and exudate management; poly(isobutylene) (PIB) for the provision of an 
adhesive matrix; and gelatine and pectin which act as ‘gum-like’ gel forming agents 
[54]. The structures for each component are provided in Figure 1.3. Hydrocolloids are 
able to absorb low to moderate levels of exudate by undergoing a phase inversion to 
form a hydrophilic gel. This yellow/brown gel, which is responsible for maintaining a 
moist wound healing environment, remains on the wound tissue after dressing removal, 
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and may be aspirated or irrigated off. Hydrocolloids are also available as pastes which 
can be applied directly to the wound cavity in order to improve absorption. As with 
hydrogel dressings, hydrocolloids are generally unsuitable for highly exuding wounds 
due to the risk of peri-wound maceration. In addition, high moisture can cause the 
detachment of the dressing from the wound tissue. Hydrocolloid dressings also provide 
an impermeable, occlusive barrier to bacteria, water vapour and atmospheric gases 
including oxygen. They are often backed with a waterproof layer, therefore providing 
overlying water resistance. This is a functional advantage to patients as they are able to 
bathe with the dressing in place. In contrast to most hydrogel dressings, hydrocolloids 
are highly adherent to dry and moist surfaces, and generally require infrequent dressing 
changes.   
 
 
Figure 1.3 Structures of hydrocolloid components: A) poly(isobutylene),  
B) carboxymethyl cellulose, C) gelatine, D) pectin. 
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A) 1-piece system B) 2-piece system 
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1.4.3.2 Hydrocolloids for Ostomy Devices 
In addition to wound dressings, hydrocolloid technology has been applied to medical 
ostomy devices. It is estimated that 13,500 people per annum undergo stoma formation 
in the UK following colostomy, ileostomy or urostomy surgery [55]. Ostomy devices 
are designed to collect waste products through a surgically created ostomy. The device 
consists of a discharge collecting pouch or bag attached to an adhesive component (also 
referred to as a skin barrier or wafer). Devices are available as either a one-piece 
appliance where the pouch is attached to the adhesive (Figure 1.4A), or as a two-piece 
appliance where the pouch is a separate component to the adhesive and does not come 
into direct contact with skin (Figure 1.4B). The adhesive forms an integral element of 
an ostomy device and is generally formed of a hydrocolloid adhesive. For ostomy 
devices, the hydrocolloid adhesive must not only provide a protective seal around the 
stoma in order to prevent leakage of stomal effluent, it must also absorb moisture to 
avoid maceration of the peristomal skin. It is not uncommon for ostomy devices to be 
changed up to three times a day. Therefore, the adhesive must adhere easily to skin, 
without causing any trauma, irritation, soreness or residue deposition upon removal.  
 
 
 
 
 
Figure 1.4 Ostomy devices with hydrocolloid adhesives are available as: A) a one-piece 
system, B) a two-piece system.    
Adhesion is a central component of skin adhesive hydrogels and hydrocolloids studied 
within this thesis and therefore the mechanism of adhesion and properties of the 
adhesive itself must be considered.       
- Chapter One - 
 
43 
 
1.4.4 Adhesion in Relation to Skin Adhesive Hydrogels and Hydrocolloids 
 
1.4.4.1 Adhesion Mechanism 
  
Adhesion may be defined as the state in which two surfaces are held together by 
interfacial forces. The mechanisms of adhesion may be classified as four theories; 
 
 Chemical adhesion refers to formation of covalent, ionic or hydrogen bonds 
between the adhesive-substrate interface.  
 
 Mechanical adhesion first described by McBain [56] in 1925 refers to the 
adhesive material interlocking into the pores of the solid surface.  
 
 Diffusive adhesion describes the interdiffusion of one component across the 
interface to create an interphase. This theory of adhesion requires sufficient 
mobility of one component in order for interfacial penetration to occur.  
 
 Electrostatic adhesion creates an electrostatic force of attraction between two 
components. This theory was originally described for metal materials, and thus 
is difficult to apply to polymeric wound dressings.  
 
Additionally, in order for measurable tack, the Dahlquist criterion states that the elastic 
modulus of the material must be below 10
5 
N/m
2
.  
 
Bioadhesion is defined as the adhesion of two surfaces, of which at least one has a 
biological nature. Three types of bioadhesion have been identified. Firstly, type I 
describes the adhesion between biological substrates, such as cell-to-cell adhesion 
within wound healing. Secondly, type II describes the adhesion of a biological substrate 
to an artificial substrate, such as cells to cell culture flasks or proteins from the tear film 
to contact lenses. Thirdly, the adhesion of an artificial component to a biological 
substrate is known as type III, for example a synthetic wound dressing to skin tissue or 
dental sealant to tooth enamel. The locus of adhesive failure within any of these 
systems may be categorised as follows: 
 
 Adhesive failure refers to interfacial bond failure between the adhesive and 
substrate.  
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 Cohesive failure of the adhesive arises from the failure of the adhesive to 
maintain the bond between the substrate due to insufficient cohesive strength.  
 
 Cohesive failure of the substrate involves failure within the substrate, 
independent of the bond with the adhesive.   
 
1.4.4.2 Properties of Adhesives  
 
The properties of an ‘ideal’ wound dressing were discussed in section 1.4.1. The 
adhesive system itself, however, has separate functions and requirements, firstly in 
terms of adhesion and then secondly for removal.  
 
For successful and safe adherence to skin, the primary requirement for any adhesive is 
to meet appropriate toxicological standards. It must also secure the dressing at the 
wound site for the intended wear duration, and should not cause maceration to peri-
wound skin. Adhesives are generally required to have good tack, peel and cohesive 
strength at room temperature. Tack describes the measure of initial adhesion or grab to 
the substrate. The force required to remove the adhesive from the substrate under 
defined conditions is termed the peel adhesion; an adhesive that is easily removed with 
a light peel force is desirable. Cohesive strength is the force of attraction between 
molecules of the same substance, the adhesive, which is indicative of the internal 
strength. This is evaluated by the measure of shear strength. It is desirable for an 
adhesive material to retain sufficient cohesive strength throughout its wear duration.    
 
The adhesive should also allow safe removal from the wound, with minimal risk of 
trauma inflicted to the tissue. Traumatic removal of adhesives can have damaging 
consequences for the wound, such as increased wound size and increased healing time, 
in addition to undue pain and trauma to the patient [57]. Furthermore, the adhesive 
should not leave any residue upon removal and should ideally be repositionable if 
necessary. Quite often a dressing may be improperly placed on the first attempt and 
must be reapplied. Therefore, removal and reapplication must not cause any further 
trauma, transfer any adhesive residue upon removal or cause loss of adhesion once 
reapplied.  
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1.5 Ocular Wound Healing   
 
1.5.1 Anatomy of the Eye 
The eyeball consists of an inner globe encased by an outer globe (Figure 1.5). Vitreous 
humour forms more than two-thirds of the volume of the eye to provide structural 
support [58], and largely fills the inner globe which consists of three concentric layers; 
the retina, choroid, and sclera [59]. The innermost retina contains photoreceptor 
neurons, namely rods and cones, and is supported by the nutrient supplying choroid 
layer. The outer sclera is tough, opaque, fibrous tissue which protects the inner layers. 
The inner globe also houses the pupil, crystalline lens and gelatinous vitreous humour, 
whilst the outer globe consists of the conjunctiva, cornea and tear film.  
 
Figure 1.5 Cross section of the human eye. 
1.5.1.1 The Cornea  
 
The cornea is a transparent avascular tissue that forms part of the outermost layer of the 
eye (Figure 1.6). The typical human anterior corneal radius is 7.5 mm [60] with the 
thickness across the structure varying from 0.5 mm at the centre to 0.69 mm at the 
periphery [61]. Corneal thickness has also been shown to change throughout the course 
of the day, and is at its thickest upon wakening [62]. The cornea consists of five layers; 
the underlying endothelium, Descemet’s membrane, the stroma, Bowman’s membrane 
and the epithelium [63]. A sixth layer termed the Dua’s layer has recently been reported 
to lie sandwiched between the Descemet’s membrane and the stroma [64]. The structure 
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of the cornea bears similarity to that of skin because cells in both tissue sites are 
generated at the base and migrate towards the surface of the tissue. Acting as a 
transparent window, the cornea enables refracted light to be transmitted further towards 
the lens. Because of the fact that the cornea is an avascular tissue, the presence of blood 
vessels due to irritation or infection would interfere with this process [65].  
 
Figure 1.6 Five layers of the cornea with the recently discovered sixth layer, and the 
pre-corneal tear film. 
The endothelium is a monolayer of cells that lies between the aqueous humor and 
stroma. It functions to maintain corneal hydration and transparency. Damage to the 
endothelium can result in oedema and, therefore, visual impairment. Fuch’s dystrophy 
and bullous keratopathy are the two most common causes of endothelial disruption. The 
endothelium underlies the basement membrane, termed the Descemet’s membrane, 
which connects to the stroma. Consisting largely of collagen, the membrane coils upon 
injury, but is unable to readily regenerate.  
The stroma forms 90% of the cornea [61]. Collagen fibrils are organised in highly 
ordered parallel sheets of lamellae, with keratocytes forming an interlinking network 
between the sheets. This provides the cornea with high tensile resistance and 
mechanical strength. The anterior portion of the stroma is separated from the overlying 
epithelium by Bowman’s membrane; this membrane is a layer of closely packed 
Dua’s layer [64] 
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collagen fibres without the presence of keratocytes. Although highly resistant, 
Bowman’s membrane is wholly unable to regenerate following injury and heals by 
scarring [66].  
The epithelium connects to Bowman’s membrane via the basement membrane. The 
epithelium is a stratified squamous epithelium bathed in the tear film, and is dependent 
upon the tear film and aqueous humor for nutrition. As a layer of 5-7 cells thick, they 
progress to basal, wing and squamous cells at different stages. The epithelium provides 
a barrier to fluid loss and pathogen exposure. Additionally, the epithelium prevents the 
tear film from diffusing into the stroma.    
1.5.1.2 The Tear Film 
The pre-corneal tear film coats the anterior surface of the eye (Figure 1.6). The tear film 
is a multi-functional liquid layer that is responsible for spreading over and maintaining 
the health of the cornea and conjunctiva. Firstly, the tear film establishes a smooth 
optical surface over the eye, and increases the optical resolution as it fills any 
irregularities of the corneal surface. Secondly, it has a largely lubricious role as it 
sustains a moist surface. This lubricity provides comfort and ease of blinking. Thirdly, 
the tear film has a protective barrier role, which not only is fulfilled by protecting the 
eye from ocular surface infection, but also by removing cellular debris and foreign 
material which are moved by the blinking mechanism. Fourthly, the tear film has an 
antibacterial role and contains antibacterial tear proteins such as lysozyme. Lastly, the 
tear film acts as a transport medium, providing oxygen from the external environment 
and nutritional elements to the underlying cornea, and removing waste products.  
The configuration of the tear film consists of three layers; the overlying lipid layer (0.1-
0.2 µm), the intermediate aqueous layer (6.5-7.5 µm) and the underlying mucous layer 
(0.2-1 µm) [67]. Although the thinnest component of the tear film, the lipid layer has an 
important role in preventing or retarding evaporation of the aqueous layer, in addition to 
preventing overflow of tears. It has been shown that the rate of tear evaporation 
increases by a factor of four when the lipid layer is absent from the tear film [68]. The 
aqueous layer forms 98% of the tear film composition, and contains proteins and 
growth factors, electrolytes, and metabolites. Electrolytes provide osmolarity to the 
fluid, whilst growth factors are essential for cell proliferation during healing. The 
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mucous layer predominantly consists of mucin glycoproteins and adheres to the 
underlying epithelial cells. This layer is responsible for anchoring the tear film to the 
cornea.  
1.5.2 Wounding of Ocular Tissue 
The ocular tissue may become wounded by three means. Firstly, the eye may suffer 
injury due to accidental trauma. The robust ocular surface has the propensity to heal 
rapidly following superficial injuries or abrasions [69]. A minor scratch to the corneal 
surface is normally self-healing with epithelial cells undergoing complete regeneration 
within a few days of the trauma. However, deeper wounds that penetrate the cornea can 
result in corneal scarring, therefore inflicting severe pain and affecting normal visual 
acuity.  
Secondly, surgery to correct common medical conditions, such as cataracts and 
glaucoma, require an incision to be made. Such incisional wounds tend to heal 
successfully. However, underlying and undetected causes often prevent an ocular 
wound from healing successfully. These include disorders of the corneal epithelium, 
conjunctival epithelium and of the tear film. Recurrent corneal erosions, for example, 
may initially occur as a result of corneal trauma, but then persist due to underlying 
corneal epithelial dystrophy. In severe cases of irreversible corneal damage, corneal 
grafts may be necessary; it is estimated that over 52,000 grafts have taken place since 
the UK Corneal Transplant Service was founded in 1983 [70]. 
Thirdly, the ocular surface can be wounded following elective surgery to correct vision. 
The relatively new phenomena of vision correction procedures, such as laser in situ 
keratomileusis (LASIK), have become increasingly popular. Approximately 100,000 
cases of LASIK are performed per year in the UK [71]. This type of surgery has opened 
up a new area of ocular healing. The procedure involves creating a hinged corneal flap 
using a blade or laser in order to expose the underlying corneal tissue. An excimer laser 
is then used to reshape the cornea. At the end of the procedure, the flap is repositioned 
over the cornea without the use of sutures, where it adheres to the corneal stroma.  
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1.5.3 The Corneal Wound Healing Process 
As is the case with dermal wound healing, the objective for healing in the ocular 
environment is the successful repair and restoration of damaged tissue to the previous 
unwounded structure. The formation of scar tissue in dermal sites is the target for 
successful healing. However, the corneal healing process must restore visual clarity and 
corneal transparency. The formation of scar tissue must be minimised to prevent 
impaired vision.  
Wounds that disrupt the corneal epithelium, but do not penetrate the basement 
membrane, tend to heal fairly rapidly due to the self-renewing capacity of the 
epithelium. Conversely, wounds that do penetrate the basement membrane and extend 
into the corneal stroma require a lengthier healing time [72]. Both corneal epithelium 
and corneal stromal healing processes shall be discussed in further detail.  
It should be noted that considerable information regarding corneal wound healing is 
resultant from studies involving animal models such as rabbits and monkeys. 
Anatomical differences, however, exist between species. For instance, Bowman’s layer 
is absent from rabbit corneas. Therefore, consideration should be given when extending 
animal studies to human findings [73]. 
1.5.3.1 Corneal Epithelium Wound Healing    
Corneal wound healing normally begins immediately after an injury or an incision. The 
process includes three overlapping phases as part of a continuous process: the lag/latent 
phase, the cellular migration phase and the proliferation phase. Figure 1.7 provides an 
overview of the three phases.   
The initial lag phase involves the movement of basal epithelial cells at the corneal 
wound margin. Within an hour of injury for smaller wounds, or 4-6 hours for larger 
wounds, polymorphonuclear leukocyte white blood cells are released from the disrupted 
epithelium. These remove necrotic cells and cellular debris by phagocytosis, which 
initially causes an enlargement of the epithelial wound. This action by the 
polymorphonuclear cells is stopped once a monolayer of epithelial cells has formed 
over the wound site. Newly synthesised desmosomes anchor the epithelial monolayer to 
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the basement membrane. Finally, cell membrane extensions, such as lamellipodia, 
filopodia, and ruffles, develop at the wound margin. This increased mitotic activity 
begins the next phase of cell migration.   
The subsequent cell migration phase occurs approximately 24 hours after an injury for 
small to medium wounds or as long as 96 hours for larger severe wounds. This phase, 
whereby epithelial cells migrate across the wound area to cover the defect before 
mitosis ensues, may last up to 2-3 days. The cell migration phase begins with the 
formation of actin filaments, which accumulate at the edges of the developed 
lamellipodial and filopodial cell extensions. This accumulation of actin filaments 
provides the epithelial cells with cytoskeletal support. It is thought that the lamellipodia 
and filopodia create temporary anchors in order to enable the epithelial cells to migrate 
across the wound in a cyclical process [73].  Fibronectin, which is an important cell 
adhesion protein, stimulates the epithelial cells to produce plasminogen activator. The 
action of plasminogen activator converts plasminogen to plasmin, which functions to 
break adhesions between the epithelial cells and the underlying sub-epithelial matrix. 
Thus, the lamellipodia and filopodia bind and cleave from the underlying sub-epithelial 
matrix during the cyclical process, enabling cells to advance over the wound area to 
form an epithelial monolayer. At this stage fibronectin is no longer required in the 
healing process and disappears. The synthesis of new hemidesmosomes and anchoring 
complexes enables firm attachment of the epithelial monolayer to the underlying 
Bowman’s membrane. Anchoring fibrils consisting of collagen spread into the stroma 
to create strong attachment of the epithelium to the stroma.   
The final phase of cell proliferation aims to restore normal epithelial thickness. Stem 
cells located near the limbus produce rapidly dividing transient amplifying cells. The 
transient amplifying cells (TACs) of the basal layer divide to produce post mitotic cells 
(PMCs). In turn, the post mitotic cells fully differentiate into terminally differentiated 
cells (TDCs), which are the final corneal epithelial cells. At this final stage of healing, 
the epithelium is permanently anchored to the underlying stroma by fully developed 
desmosomes. The corneal epithelium is restored to a regular smooth surface.  
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Figure 1.7 The corneal epithelium wound healing process. 
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1.5.3.2 Corneal Stromal Epithelium Wound Healing    
 
Stromal wound healing progresses only once a new epithelium has formed over the 
corneal wound. The process commences with the apoptosis of disrupted keratocytes at 
the wound site. Remaining peripheral keratocytes to this newly created acelleular zone 
differentiate into stromal repair fibroblasts, which then migrate towards the wound. 
These stromal repair fibroblasts are stimulated by transforming growth factor-beta 
(TGF-β) to undergo further differentiation to myofibroblasts. Similarly to dermal 
healing, the myofibroblasts are responsible for wound contraction by re-approximating 
the wound margins and ‘pulling’ or contracting the wound to close. Both stromal 
fibroblasts and myofibroblasts deposit collagens, glycoproteins and proteoglycans to 
initially form a rather disorganised stromal extracellular matrix (ECM). Remodelling of 
the stromal ECM is regulated by the fine balance between matrix metalloproteinases 
(MMPs) and the inhibitory action of tissue inhibitors of metalloproteinases (TIMPs). 
An overview of the stromal wound healing process is provided in Figure 1.8.  
 
Figure 1.8 The corneal stromal wound healing process. 
Remodelling of the ECM 
Stromal fibroblasts and myofibroblasts deposit the 
disorganised extracellular matrix (ECM) 
Myofibroblasts migrate further into the wound 
Differentiation of stromal repair fibroblasts into stromal 
myofibroblasts 
Migration of stromal repair fibroblasts towards the wound  
Differentiation of keratocytes peripheral to the wound margin 
into stromal repair fibroblasts 
Apoptosis of disturbed keratocytes 
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1.6 Ocular Wound Dressings  
 
1.6.1 The Role of Bandage Contact Lenses 
 
In the anterior healing eye a bandage contact lens (BCL) can be used to protect the 
cornea following injury, disease or surgery, thereby relieving pain and improving the 
ability of the corneal epithelium to heal. The roles of a BCL include; mechanical 
protection of the cornea from eyelid movement; protection from atmospheric exposure 
and further ocular insult; improving the ability of the corneal epithelium to heal; corneal 
hydration; and if required drug delivery [74, 75].
 
One of the principal indications of 
BCL use is for the relief of pain and to provide comfort. A study by Jackson et al [74] 
investigating the use of bandage lenses for the management of corneal pathologies 
found that 87% of cases fitted with a BCL were for the primary or secondary indication 
of pain relief. BCLs have been shown to successfully facilitate healing for different 
pathological treatments such as;  
 
 bullous keratopathy [76]  
 dry eye syndrome [77]  
 laser-assisted in situ keratomileusis (LASIK) [78]  
 persistant epithelial defects [79]  
 photorefractive keratectomy/ phototherapeutic keratectomy (PRK/PTK) [80] 
 recurrent corneal erosions [81]  
 
1.6.2 Advances in Contact Lens Materials for Therapeutic Use  
 
The origin of applying a bandage to the ocular surface is thought to date back to the 
first century A.D., when a honey-soaked linen dressing was applied to the eye. This was 
in an attempt to prevent symblepharon formation, a condition whereby the eyelid 
adheres to the bulbar conjunctiva [82]. It was not until the 1950s, however, that Ridley 
[83] fitted poly(methyl methacrylate) (PMMA) scleral contact lenses for the 
management of various ophthalmic disorders. Following Wichterle’s [84] development 
of hydroxyethyl methacrylate (HEMA), Gasset and Kauffman [85] reported the use of 
hydrophilic contact lenses for therapeutic purposes in the 1970s.  Conventional daily 
disposable hydrogel materials, such as etafilcon A, were then typically recommended 
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for therapeutic use [86-88] until the advent of silicone hydrogel (SiHy) contact lenses in 
1998.  
 
Although conventional hydrogel contact lenses are typically low modulus materials, 
which allow for a more uniform draping of the contact lens over the cornea, advances in 
SiHy contact lenses since the introduction of the first generation mean that SiHy lenses 
are no longer constrained by high moduli. The use of conventional hydrogels for 
continuous wear is restricted due to their inability to provide adequate oxygen 
permeability (Dk), therefore potentially resulting in hypoxia-related complications and 
corneal swelling [89]. For this reason conventional hydrogels are poorly suited for 
bandage lens use. Conversely, SiHy contact lenses with higher Dk values generally 
allow for greater oxygen transport over extended wear [90]. Accordingly, many SiHy 
lenses are accepted as a safe material choice for extended wear and bandage lens use, 
with wear times ranging from one day to four weeks of continuous wear. Advances in 
SiHy materials have since resulted in the availability of a wider range of BCLs that are 
able to successfully manage a variety of ocular conditions.  
 
It is extremely important to note that the vast majority of contact lenses currently 
available for therapeutic use are designed for the correction of refractive error and for 
comfortable wear in the non-compromised healthy eye, rather than for purposely 
designed bandage lens use. SiHy contact lenses with Food and Drug Administration 
(FDA) approval for bandage lens usage are shown in Table 1.3. 
 
The risks of inserting a foreign material into an eye which is already compromised 
should be considered. Therefore, the efficacy of various SiHy contact lenses for 
successful therapeutic use has been studied by different authors. Ambrosiak et al [91] 
evaluated the use of lotrafilcon A contact lenses (Air Optix Night & Day Aqua) in 70 
patients with bullous keratophathy, dry eye syndrome or postoperative 
keratoepitheliopathy. Therapeutic improvement was reported in 91% of patients in their 
respective corneal defect following contact lens wear and 94% rated contact lens 
comfort highly. In a similar study, Arora et al [75] investigated balafilcon A contact 
lenses (PureVision) in 30 eyes of 28 patients. The contact lens was found to 
successfully provide pain relief in all cases. Complications occurred in 6 eyes due to 
predispositions to infection.    
 
- Chapter One - 
 
55 
 
Table 1.3 FDA approved silicone hydrogel contact lenses for bandage lens use. 
Commercial 
Contact Lens 
Material Manufacturer 
Water 
Content 
(%) 
Oxygen 
Permeability 
(Dk) 
Modulus 
(MPa) 
PremiO 
Asmofilcon 
A 
Menicon 40 129 0.9 
PureVision 
Balafilcon 
A 
Bausch & 
Lomb 
36 91 1.1 
Biofinity 
Comfilcon 
A 
CooperVision 48 128 0.75 
 
Avaira 
 
Enfilcon A CooperVision 46 100 0.5 
Acuvue 
Advance 
Galyfilcon 
A 
Vistakon 47 60 0.43 
Air Optix 
Night & Day 
Aqua 
Lotrafilcon 
A 
Ciba Vision 24 140 1.5 
Air Optix 
Aqua 
Lotrafilcon 
B 
Ciba Vision 33 110 1.0 
Acuvue 
Oasys 
Senofilcon 
A 
Vistakon 38 103 0.72 
 
1.6.3 Protein Adsorption  
 
When a biomaterial is brought into contact with a biological fluid, the first event that 
occurs is the adsorption of proteins onto the surface. This process of protein adsorption 
may be defined as ‘‘adsorption (that is, adhesion or sticking) of protein(s) on a variety 
of surfaces’’ [92]. In order to consider protein adsorption to contact lenses in both the 
non-compromised and compromised eye, it is useful to consider, firstly, general protein 
structure and, secondly, the fundamentals of protein adsorption to biomaterials.  
 
1.6.3.1 General Structure of Proteins     
 
Amino acids are the organic monomers of proteins; fundamentally peptide bonds 
between the amino acid monomers form the basic structure of a protein. Amino acids 
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contain an amino group (-NH2) and a carboxyl group (-COOH) in addition to a side 
chain (R-group) that provides the amino acid with unique properties. The nature of the 
side chain determines the class of amino acid which may be classified as; non-polar and 
neutral; polar and neutral; polar and acidic; and polar and basic. Figure 1.9 illustrates 
the general structure of an amino acid monomer.  
   
N C C
R
H
H
H OH
O
 
 Figure 1.9 The general structure of an amino acid monomer.  
Protein structure may be designated by four levels: primary, secondary, tertiary and 
quaternary. Firstly, the primary structure of a protein describes the linear sequence of 
amino acid monomers bonded by peptide bonds to give a polypeptide. Secondly, the 
secondary structure describes the conformational shape of the protein from hydrogen 
bonding between the side chains of the amino acids. Three common shapes exist which 
include the α-helix, β-helix and triple helix. The third level of protein structure, tertiary, 
describes the complex three-dimensional folding of the protein. Molecular interactions 
occur between the side chains which include; hydrogen bonds between polar R-groups; 
hydrophobic interactions between non-polar R-groups; ionic bonds between charged R-
groups; and disulphide bonds between sulphur atoms on R-groups. Lastly, the 
quaternary structure of proteins describes the bonding between two or more 
polypeptides.  
1.6.3.2 Principles of Protein Adsorption to Biomaterial Substrates     
 
The affinity of a protein for a substrate surface and the overall protein adsorption to a 
biomaterial is influenced by the nature of the protein, substrate and fluid components of 
the system: 
 
 Protein properties 
 
The properties of an individual protein molecule influence its adsorption to a foreign 
substrate surface. Upon arrival at the substrate, the protein can interact and bind through 
hydrophobic interactions, ionic bonds and charge transfer interactions. These 
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interactions are dependent on the size, charge, and stability of the protein. Firstly, the 
size of the protein molecule governs the rate of diffusion through the solution; smaller 
molecular weight proteins are generally able to diffuse at a faster rate than larger 
proteins and, therefore, primarily adsorb to the substrate surface.  
 
The net charge of a protein is governed by the amino acid monomers of the protein 
structure. Charged hydrophilic amino acids, which are polar in nature, are exposed at 
the outer parts of the protein and are able to preferentially interact with polar regions of 
the substrate surface. It is hypothesised that adsorption is maximised when a protein is 
at its isoelectric point (pI), this is the pH at which a protein does not carry a net charge. 
At the isoelectric point, electrostatic repulsions between other adsorbing proteins are 
reduced, which may favour adsorption to the substrate.  
 
Stability of a protein is also influential upon protein adsorption. Proteins may undergo 
partial or substantial conformational changes during or after adsorption to a substrate. 
Conformational changes are determined to some extent by protein stability. When 
discussing protein stability, proteins are often classed as either ‘soft proteins’ that have 
a low internal stability or ‘hard proteins’ that have a high internal stability. Unfolding of 
‘soft proteins’ during conformational changes may expose greater numbers of domains 
that are able to interact and bind to the substrate. These proteins are therefore able to 
interact with both hydrophilic and hydrophobic domains. Conversely, ‘hard proteins,’ 
with high thermodynamic stability, are governed by hydrophobic interactions with the 
substrate and will essentially adsorb to hydrophobic surfaces. Adsorption of ‘hard 
proteins’ to hydrophilic surfaces occurs when favourable electrostatic interactions exist 
within the system.     
  
 Substrate properties 
 
In addition to protein properties, the chemical properties of the substrate material can 
influence adsorption of proteins to its surface. Four selected surface functional groups 
(methyl -CH3, hydroxyl -OH, amine -NH2 and carboxyl -COOH) of substrates and their 
influence on protein adsorption has been studied by Thevenot et al [93]. Methyl (neutral 
and hydrophobic) functional groups were found to bind fibrinogen and IgG strongly, 
whereas hydroxyl groups (neutral and hydrophilic) were found to decrease the overall 
affinity for plasma proteins. Both amine (positive and hydrophilic) and carboxyl 
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(negative and hydrophilic) groups were found to increase the affinity for fibronectin. 
The negatively charged carboxyl functional groups were found to interact with plasma 
proteins over the positively charged amine groups. Table 1.4 summarises the effect of 
four surface functional groups on preferential protein adsorption.      
 
Table 1.4 The effect of substrate surface functional group on preferential protein 
adsorption (adapted from Thevenot et al [93]). 
 
Surface Functional 
Group 
Effect on Protein Interaction 
Methyl (-CH3) 
neutral, hydrophobic 
 
Strongly binds fibrinogen. 
Binds IgG more effectively than other surface 
functional groups. 
Hydroxyl (-OH) 
neutral, hydrophilic 
Decreased affinity for plasma proteins. 
Amine (-NH2) 
positive, hydrophilic High affinity for fibronectin. 
Carboxyl (-COOH) 
negative, hydrophilic High affinity for fibronectin and albumin. 
 
The nature of the substrate surface topography may also influence protein adsorption. In 
comparison to a smooth surface, a rough surface topography may provide greater 
surface area for protein interaction.   
 Fluid properties 
 
The protein concentration of a biological fluid is an important aspect that greatly 
influences protein adsorption. When considering a fluid that contains one single type of 
protein only, it can generally be stated that the higher the protein concentration in 
solution, the greater the protein adsorption to a substrate material. However, in complex 
biological fluids such as serum, blood, tear fluid and wound fluid, the presence of many 
competitive adsorbing proteins complicates the process. The relatively abundant plasma 
proteins, such as albumin and fibrinogen, typically adsorb first onto the substrate. The 
Vroman effect then leads to partial displacement of the primary layer of adsorbed 
proteins by proteins with a greater affinity for the substrate surface.            
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1.6.3.3 Protein Adsorption to Bandage Contact Lenses    
 
Evidence shows that SiHy lenses have a lower susceptibility to general protein 
adsorption in comparison to conventional hydrogels [94-96]. Protein adsorption to 
contact lenses worn in the non-compromised healthy eye is a common phenomenon; 
relatively few adverse effects occur when protein adsorbs on the surface. 
Complications, such as vision affected by clouding of the contact lens and contact lens 
discolouration [97], can occur when protein irreversibly denatures on the lens surface. 
When considering contact lens materials to be worn for therapeutic purposes over 
extended wear periods, minimal levels of protein deposition at the surface are therefore 
desirable. SiHy materials, which are renowned for low protein adsorption, appear to be 
ideal for this purpose.  
 
Protein adsorption is influenced greatly by material properties. Factors such as contact 
lens water content and ionicity have been linked to the levels of protein deposition; 
increasing water content and ionicity of materials increases the levels of protein 
deposits [98].  
 
 FDA Group I (<50% EWC, <0.2% ionic content) materials adsorb 
approximately 10-20 μg/lens. 
 
 FDA Group IV (>50% EWC, >0.2% ionic content) materials adsorb 
approximately 1000 μg/lens. Methacrylic acid is a principle component of 
Group IV contact lenses and provides the materials with a negative polymeric 
charge, which thereby attracts positively charged proteins.    
 
Duration of contact lens wear can also affect the levels of protein deposits. Jones et al 
[99] investigated the differences in extractable protein between Group II contact lenses 
replaced monthly over a three month period with contact lenses worn for three 
consecutive months. This work revealed a significant increase in protein for the longer 
three month replacement schedule in comparison to the shorter monthly replacements. 
BCLs are commonly worn in long replacement schedules such as these, yet little is 
known regarding protein deposits in these circumstances. Protein adsorption to contact 
lenses is an instantaneous effect of material/host site interaction and is well reported in 
the non-compromised healthy eye over shorter wear periods, but far less has been 
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investigated in the compromised healing eye, where contact lenses are worn for 
extended continuous periods. Additionally, although it is well recognised that certain 
minimum levels of oxygen permeability are required for continuous wear [100] there is 
little knowledge in relation to the interactive effects of specific contact lens materials 
with corneas diagnosed with clinical conditions, and the way in which materials can 
promote or inhibit the corneal healing process.  
 
1.7 Aims of Research  
This thesis is concerned with the interaction of biomaterials with compromised ocular 
and dermal tissue sites. Section 1.2 of the introduction highlighted the analogies that 
exist between these two tissue sites. A key aspect is that in severe cases of corneal 
impairment and tear film dysfunction, the corneal surface will keratinise to give a 
pseudo-dermal surface. Conversely, distinct parallels may be drawn between the 
healthy functional cornea and the impaired chronic dermal wound. These analogies 
require further investigation and it is the exploration of these links which underpin the 
work in this thesis.    
 
Chapter one addressed that both ocular and dermal tissue sites may suffer from acute 
and chronic injury and thus require a biomaterial to support the healing process. In the 
acute/chronic wound environment, skin adhesive materials serve as wound dressings at 
the dermal wound interface. Similarly, in the compromised ocular environment contact 
lenses designed for conventional use also serve as therapeutic bandage contact lenses. 
The material, whether it is a wound dressing or a bandage contact lens, has a substantial 
influence upon the biological interface. Because the eye is such an easily accessible 
site, and because contact lenses are particularly well-studied devices, the physical 
interaction of the contact lens with the cornea appears to be a logical platform for the 
study of material interactions with compromised tissue sites. There are three aims of 
this research which will enable these interactions to be studied. 
 
1) The first aim is to identify biomarkers which are common to both ocular and 
dermal sites. One prime candidate is vitronectin, an important cell adhesion 
glycoprotein present in both tear fluid and wound fluid. The eye is a useful body 
site to study tissue-biomaterial interactions because the cornea is an easily 
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accessible tissue site. In order to investigate the nature of biointeractions in the 
non-compromised ocular environment, the potential value of a novel cell-based on-
lens assay technique to detect the presence of vitronectin on the contact lens 
surface will be explored.  
 
2) The second aim of this work is to extend investigations of biomarkers in lens-
cornea interactions to bandage contact lenses worn in the compromised eye. The 
majority of contact lenses suitable for therapeutic use are, in fact, lenses designed 
for conventional wear. The potential adverse effects of vitronectin deposition on 
contact lenses worn by symptomatic subjects will be discussed. 
 
3) Parallel work in the compromised dermal environment requires examination of the 
physical properties of skin adhesive wound dressing materials. A third aim is to 
investigate skin adhesive material properties in relation to the biophysical 
properties of skin, and to investigate material interactions with unbreached skin. 
Furthermore, because the dermal wound environment is a far more complex 
environment to study in comparison to the easily accessible ocular surface, the 
design of a standard artificial wound fluid is appealing to further tissue-biomaterial 
interaction studies. Thus, it would be logical to explore the potential design of 
artificial wound fluid models for acute and chronic wounds, which are influenced 
by parallel studies in the ocular environment.   
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CHAPTER TWO 
Materials and Experimental Techniques 
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2.1 Materials 
 
The following section outlines the contact lens materials and skin adhesive wound 
dressing materials tested within this thesis.  
 
2.1.1 Contact Lens Materials 
 
Table 2.1 lists all daily disposable conventional hydrogel contact lenses and Table 2.2 
list all silicone hydrogel (SiHy) contact lenses used for the studies in chapters three and 
four. The monomer chemical structures of the contact lenses are provided in Table 2.3.   
 
Table 2.1 Daily disposable conventional hydrogel contact lenses and their properties. 
Material 
Vistagel 
38 
Vistagel 
42 
Vistagel 
60, 72 
Precision 
UV 
Acuvue 
USAN/ISO 
Nomenclature 
Filcon I 1 Filcon I 2 Filcon II 2 
Vasurfilcon 
A 
Etafilcon A 
Manufacturer 
Vista 
Optics 
Vista 
Optics 
Vista 
Optics 
CIBA 
Vision/ 
Alcon 
Johnson & 
Johnson 
Vision Care 
Principal 
Components 
HEMA HEMA 
HEMA/ 
NVP 
PMMA, 
NVP 
HEMA, MA 
FDA Group I I II II IV 
Water Content 
(%) 
 
38 
 
42 
 
60 
 
 
72 
 
74 58 
Modulus (MPa) 0.48 0.43 
 
0.22 
 
 
0.16 
 
0.25 0.25 
Oxygen 
Permeability 
(Barrers) 
9 10 20 43 39 28 
Surface 
Treatment 
No 
treatment 
No 
treatment 
No 
treatment 
No 
treatment 
No treatment 
HEMA, 2- hydroxyethyl methacrylate; MA, methacrylic acid; PMMA, methyl 
methacrylate; NVP, N-vinyl pyrrolidone. 
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Table 2.2 Silicone hydrogel contact lenses and their properties. 
 
Material 
Focus 
Night & 
Day 
O2 Optix 
Pure 
Vision 
Biofinity 
UltraWave 
SiH* 
USAN/ISO 
Nomenclature 
Lotrafilcon 
A 
Lotrafilcon 
B 
Balafilcon 
A 
Comfilcon A Filcon II 3 
Manufacturer 
CIBA 
Vision/ 
Alcon 
CIBA 
Vision/ 
Alcon 
Bausch & 
Lomb 
Coopervision UltraVision 
Principal 
Components 
DMA, 
TRIS, 
Siloxane 
macromer 
DMA, 
TRIS, 
Siloxane 
macromer 
NVP, 
TPVC, 
NCVE, 
PBVC 
Aquaform 
NVP, 
Siloxane 
macromer 
FDA Group I I III I IV 
Water 
Content (%) 24 33 36 48 58 
Modulus 
(MPa) 
1.5 1.0 1.1 0.75 0.5 
Oxygen 
Permeability 
(Barrers) 
140 110 91 128 86 
Surface 
Treatment 
25nm 
plasma 
coating 
25nm 
plasma 
coating 
Plasma 
oxidation 
No treatment 
No 
treatment 
DMA, N,N-dimethylacrylamide; NCVE, N-carboxyvinyl ester; NVP, N-vinyl 
pyrrolidone; PBVC, poly(dimethysiloxy) di (silylbutanol) bis(vinyl carbamate); 
TPVC, tris-(trimethylsiloxy silyl) propyl vinyl carbamate; TRIS, trimethylsiloxy 
silane. 
 
* please note that UltraWave SiH is the correct name for this contact lens and not 
UltraWave SiHy 
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Table 2.3 Monomer structures of the principle components of contact lens materials. 
 
Monomer Name Abbreviation Structure 
N,N-
dimethylacrylamide 
DMA CH
2
C
H
C
O
N
CH
3
CH
3  
2- hydroxyethyl 
methacrylate 
HEMA 
O C
H
2
CH
3
C
OH
CH
2
C
O
C
H
2
 
methacrylic acid MA 
OH
H
2
C
CH
3
C
O
C
 
poly(methyl 
methacrylate) 
PMMA 
CH
3
C
C
O
CH
3
O
CH
2 n
* *
 
N-vinyl pyrrolidone NVP 
H
2
C CH
N
H
2
C
H
2
C
CH
2
CH
2
 
trimethylsiloxy silane. TRIS 
H
3
C
H
3
C
Si
CH
3
O
Si
O
Si
H
3
C
C
H
3
Si
C
H
3
CH
3
CH
3
O
CH
3
H
 
 
3-[Tris(trimethylsiloxy) 
silyl]propyl vinyl 
carbamate 
 
TPVC 
H
3
C
Si Si
OSi
H
3
C
OH3C
H
3
C
H
3
C
H
3
C
OSiH3C
H
3
C
H
3
C
C
H
2
C
H
2
C
H
2
N
H
O
C
O
C
H
CH
2
 
 
- Chapter Two - 
 
66 
 
2.1.2 Skin Adhesive Wound Dressing Materials 
 
This section outlines all skin adhesive wound dressing materials used for testing and 
investigation in chapters five and six. 
 
2.1.2.1 Hydrocolloid Materials Supplied by Salts Healthcare 
 
Much of the work carried out in this thesis was in conjunction with Salts Healthcare, a 
leading company that manufactures ostomy and healthcare products. Four skin adhesive 
hydrocolloid materials for wound dressings were supplied by Salts Healthcare. These 
adhesives are coded as S1, S2, S3 and S4.  Table 2.4 lists each adhesive together with 
the composition, type of release liner (paper or plastic) and thickness without the 
release liner.  
 
Table 2.4 Skin adhesive wound dressing materials supplied by Salts Healthcare.  
 
 
A typical hydrocolloid adhesive consists of natural polymer particles (carboxymethyl 
cellulose, gelatin and pectin)  dispersed within an adhesive polymer matrix [51]. These 
individual components, together with their chemical structures, are presented in further 
detail.  
 
 
 
 
- Chapter Two - 
 
67 
 
 Poly(isobutylene) 
 
Poly(isobutylene) (PIB) typically forms the hydrophobic polymer matrix of a 
hydrocolloid adhesive. When exposed to fluid, the hydrophilic natural polymers absorb 
the moisture to form a gel. PIB is a hydrophobic molecule because it lacks the presence 
of any polar groups within its structure (Figure 2.1) and, therefore, PIB becomes 
dispersed in a continuous aqueous phase as the phase structure inverts.        
 
CH
3
CH
3
CCH
2 n
 
Figure 2.1 The repeat structure of poly(isobutylene). 
 
 
 Carboxymethyl cellulose (CMC) 
 
Carboxymethyl cellulose (CMC) forms the major fluid absorbing component of 
hydrocolloids. It is synthesised by reacting cellulose with alkali to form alkali cellulose, 
which is then reacted with monochloroacetic acid. CMC is an anionic, hydrophilic 
carbohydrate capable of forming viscous solutions. It is this gel-forming function that is 
ideal for its inclusion within the typical hydrocolloid composition. The repeat structure 
of CMC is shown in Figure 2.2.      
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Figure 2.2 The repeat structure of carboxymethyl cellulose. 
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 Gelatine  
 
Gelatine is a natural protein which is derived from the refinement of animal collagen. It 
is commonly used as a gel-forming agent within the food industry, but in hydrocolloid 
wound dressing materials it is dispersed within the PIB matrix for its gelling properties. 
The structure of gelatine (Figure 2.3) is based on its parent molecule, collagen.  
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Figure 2.3 The structure of gelatine.  
 
 
 Pectin 
 
Pectins are natural polysaccharides, which can be extracted from the peel of many fruits 
and vegetables. Similarly to gelatine, pectin functions as a gel-forming agent in the 
hydrocolloid structure. Commercially produced pectin may be classified as either low 
methoxyl pectins (<50% methyl esterification) or high methoxyl pectins (>50% methyl 
esterification). The repeat unit of pectin in shown in Figure 2.4.  
 
 
 
 
Figure 2.4 The repeat structure of pectin.  
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2.1.2.2 Other Skin Adhesive Materials 
 
Table 2.5 lists all other skin adhesive wound dressing materials used in chapter five, 
which were not supplied by Salts Healthcare. This includes Ostomy Hydrocolloid 
Adhesives, ConvaTec Hydrocolloid Adhesives wound dressings, Commercial Medical 
Tapes and skin adhesive hydrogels that were synthesised in the laboratory.  
 
Table 2.5 Commercial skin adhesive ostomy, hydrocolloid and medical tapes, and 
hydrogels prepared in the laboratory.  
 
Product Type Material Name 
Thickness 
without 
release liner 
(mm) 
Ostomy Hydrocolloid 
Adhesives 
Coloplast ostomy 1.64 
ConvaTec ostomy 1.63 
ConvaTec Hydrocolloid 
Adhesives 
Granuflex 1.64 
Duoderm Extra Thin 0.51 
Commercial Medical Tapes 
3M microporous tape 1.93 
Boots microporous tape 1.89 
Aston hydrogel adhesives* 
Hydrogel 1* 1.57 
Hydrogel 2* 1.52 
 
 
* The methodology for the preparation of the hydrogel adhesives is detailed fully in the 
Experimental Techniques section 2.2.3.      
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2.2 Experimental Techniques  
 
2.2.1 Cell Culture 
 
A cell-based on-lens assay technique to detect the extent and locus of vitronectin on the 
surface of contact lenses is described.    
 
2.2.1.1 Materials  
 
Table 2.6 lists all chemicals and immunochemicals used for the cell culture work.  
 
Table 2.6 Chemicals and immunochemicals used with name, abbreviation and supplier. 
 
 
 
 
 
Name Abbreviation Supplier and Code 
Dulbecco’s modified Eagle 
medium 
DMEM Sigma-D6546 
Fetal bovine serum FBS Sigma-F7524 
Gluteraldehyde - Sigma-G6257 
HEPES buffered saline HBS Sigma-H0887 
Human Fibronectin Fn Sigma-F2006 
Human Vitronectin Vn Sigma-V8379 
L-glutamine L-glu Sigma-G7513 
Magnesium chloride MgCl2 Bioline-37026 
Rabbit anti-Fibronectin antibody Anti-Fn Sigma-F3648 
Rabbit anti-Vitronectin antibody Anti-Vn Merck-681125 
Rabbit IgG IgG Sigma-I5006 
Trypsin/Ethylenediaminetetraacetic 
acid 
Trypsin/EDTA Sigma-T4049 
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2.2.1.2 Isolation and Culture  
 
An ampoule of frozen Mouse 3T3 Swiss Albino embryo fibroblasts cells was purchased 
from the European Collection of Cell Cultures (ECACC; Salisbury, UK). The ampoule 
was thawed and suspended in Dulbecco’s modified Eagle medium (DMEM), 
supplemented with 10% fetal bovine serum (FBS) and 1% 200 mM L-glutamine 
solution. Cells were incubated in a Heracell 150 incubator at 37°C in 5% CO2, and 
maintained for up to 10 passages. Cells were passaged upon reaching 80% confluency, 
as described below. All cell culture procedures were carried out in a laminar flow hood.  
 
2.2.1.3 Determination of Cell Viability 
 
Cell viability was determined by the standard trypan blue dye exclusion test. The test is 
based on the principle that dead cells with non-intact cell membranes uptake the dye to 
display a blue cytoplasm, whereas live viable cells do not. 250 μl of cell suspension was 
mixed with 100 μl of trypan blue dye in a bijou vial. The cell suspension/dye mixture 
was loaded onto a haemocytometer and ten separate counts were taken to determine cell 
viability.   
 
2.2.1.4 Passage of Cells 
 
The passage of cells involves the ‘splitting’ of a monolayer of cells and subsequent 
reseeding into a new cell flask. The Dulbecco’s modified Eagle medium (DMEM) was 
prepared by adding 50 ml fetal bovine serum (FBS) and 5 ml of 200 mM L-glutamine 
solution. The medium and trypsin/EDTA were then pre-warmed to 37°C. When the cell 
flask had reached confluency, the medium was aspirated from the flask by means of a 
25 cm
3
 pipette and discarded. Approximately 3 ml trypsin/EDTA was added to the 
monolayer of cells and the flask was gently shaken to remove any loose cells, which 
were then also discarded. A further 5 ml trypsin/EDTA was added to the flask and 
incubated at 37°C and 5% CO2 for no longer than 5 minutes. After incubation the cells 
were seen to have detached from the bottom of the flask, turning the trypsin/EDTA 
solution slightly cloudy. The cells were observed under an inverted microscope to 
ensure detachment from the flask. 10 ml medium was added to the flask in order to 
neutralise the trypsin/EDTA. Of this solution, 10 ml was transferred to a centrifuge tube 
and centrifuged at 2000 rpm for 5 minutes, after which time a pellet of cells could be 
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seen. This 10 ml volume of trypsin/media supernatent was aspirated and discarded, and 
the pellet of cells was resuspended in either 10 ml medium (for further cell culture) or 
10 ml HEPES buffered saline (HBS) (for the assay procedure). In order to reseed the 
cells at the required density, a small volume of suspended cells was placed in a 
haemocytometer slide to count the average number of cells. The density of cells to be 
reseeded was then calculated using the following calculations: 
 
a) Total no. cells in culture  
= average cell count  *  vol. size of each square  *  vol. of cell suspension  
= average cell count  *  10
4
  x  10 
 
b) Volume of cells to be reseeded 
= (concentration required  *  vol. of flask) / total no. cells in culture 
 
Medium was then added to a new cell flask together with the calculated volume of cell 
suspension and incubated at 37°C in 5% CO2.  
  
2.2.1.5 In Vitro Doping of Contact Lenses  
 
Contact lenses were removed from packing solution and rinsed in phosphate buffered 
saline (PBS). Lenses were blotted, placed aseptically in polystyrene bijou vials and 
doped with specific solutions, which varied according to the requirements of each assay 
requirement. The individual bijou vials were placed on an orbital shaker for 24 hours at 
room temperature. Lenses were assayed in triplicate.  
 
2.2.1.6 Ex Vivo Contact Lenses  
 
Contact lenses were worn by asymptomatic subjects in either a daily wear modality, 
averaging 196 hours over 2 weeks, or an extended wear modality, averaging 168 hours 
over 1 week, as specified with each assay. Upon removal contact lenses were placed in 
PBS and stored at 4°C.  
 
2.2.1.7  On-Lens Cell Attachment Assay Procedure 
 
On-Lens Cell Attachment Assay Procedure: All solutions and analytes were pre-heated 
to 37°C. A magnesium chloride stock solution (MgCl2, 50 mM), a rabbit IgG solution 
(300 µg/ml in HBS) and a 1% solution of glutaraldehyde in HBS were prepared. Each 
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assay procedure required the use of three controls; a vitronectin positive control, an 
antibody control and an anti-vitronectin control.  The contact lenses, removed from 
either doping solution (control lenses and unworn lenses) or PBS (worn lenses), were 
placed individually into the appropriate test wells of a 24-well plate. Each well was 
rinsed with 1 ml HBS (x3). 1 ml HBS was added to the vitronectin positive control 
well, 1 ml of the prepared IgG solution was added to the antibody control well, and 100 
µl anti-human vitronectin diluted with 900 µl HBS was added to the anti-vitronectin 
control well. Each 24-well plate was incubated for 60 minutes, at 37°C and 5% CO2, 
and gently agitated every 10 minutes. After incubation, the solution from each contact 
lens was aspirated by means of a pipette taking care not to touch the lens. 1 ml of serum 
free HBS cell solution and 100 µl of MgCl2 stock were added to each well. The 24-well 
plate was then incubated for a further 60 minutes at 37°C and 5% CO2. Following this 
second incubation period, the cell solution from each well was removed, and each well 
and contact lens was rinsed with 1 ml HBS three times. All contact lenses were moved 
to a new 24-well plate and rinsed once with 1 ml HBS. The cells were fixed in 1 ml of 
1% glutaraldehyde stock solution ready for counting. A schematic diagram of the on 
lens - cell attachment assay is shown in Figure 2.5. 
 
 
Figure 2.5 The on-lens cell attachment assay procedure for the location and 
quantification of surface-bound vitronectin on ex vivo or vitronectin-doped contact 
lenses. 
Cell counts: In order to count the surface-located cells, each contact lens was notionally 
divided into two areas; the edge and the centre. The field of vision in which each 
individual count was taken was defined by an internal graticule in the eye piece of the 
microscope. The eye piece graticule measures 1 cm x 1 cm, which when read under a 
x10 magnification allowed a field of vision of 1 mm
2
. Cell counts were taken at four 
areas on the edge of the lens and one area at the centre of the lens, as shown in Figure 
2.6. 
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Figure 2.6 Five defined areas on the posterior contact lens surface for recording cell 
counts (zones not to scale).  
 
2.2.2 Schirmer Test   
 
The Schirmer test is a method for the measurement of tear secretions. It is one method 
of evaluating patients with dry eye symptoms. The test was first described by Schirmer 
in 1903 as a method to measure the amount of tears wetting a filter paper strip in 5 
minutes [101]. A standardised filter paper strip is typically 35 mm by 5 mm. It is folded 
at one end to create a rounded lip, which is intended to reduce discomfort upon 
insertion in the eye.  
 
Tests were performed on subjects who required the use of a bandage contact lens to 
manage an ophthalmic or corneal condition. The tests were carried out prior to bandage 
contact lens insertion. The end of the Schirmer strip with the folded lip was inserted 
into the lower eyelid, taking care not to touch the cornea (Figure 2.7). Subjects were 
asked to blink normally or to close their eyes as appropriate for the duration of the 5 
minutes. The Schirmer strip was removed after the 5 minutes period using tweezers and 
the length of the wetted strip was measured to provide a Schirmer score. The following 
Schirmer scores are guidelines for tear secretion measurements [102]: 
 
 ≥ 15 mm/5 minutes : normal  
 14 – 6 mm/5minutes : mild to moderate 
 < 6 mm/5 minutes : severe  
1.0mm
2
 surface 
area 
Edge 
Centre 
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Figure 2.7 The Schirmer test for sampling of tear secretions. 
 
2.2.3 Preparation of Skin Adhesive Hydrogels  
 
2.2.3.1 Materials  
 
Anionic monomers:  
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Figure 2.8 The structure of sodium salt of 2-(acrylamido)-2-methyl propane 
sulfonate (NaAMPs.) 
 
 Potassium salt of 3-sulfopropyl acrylate (SPA) 
Molecular weight: 232.29 
[Supplied by Raschig] 
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Figure 2.9 The structure of potassium salt of 3-sulfopropyl acrylate (SPA). 
                                          
 Sodium salt of  2-(acrylamido)-2-methyl propane sulfonate (NaAMPs) 
Molecular weight: 229.23 
[58% solution supplied by Lubrizol] 
 
filter paper placed on the lower eyelid 
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Initiator:  
 
 1-hydroxycyclohexyl phenyl ketone (Irgacure 184) 
Molecular Weight: 204.27 
OHC
O
 
[Supplied by CIBA] 
 
Figure 2.10 The structure of Irgacure 184. 
 
Crosslinker: 
 
 Ebecryl 11 
[Supplied by U.C.B – the structure of this poly(ethylene) diacrylate photo 
crosslinker is not available from its supplier] 
 
Other Reagents:  
 
 1,2,3-propanetriol (Glycerol) 
Molecular weight: 92.09 
[Supplied by Sigma Aldrich] 
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H
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Figure 2.11 The structure of glycerol.  
 
2.2.3.2 Preparation of Skin Adhesive Hydrogels Method 
 
Skin adhesive hydrogels were prepared by photopolymerisation. This form of 
photopolymerisation has the following advantages: 
 
- spatial and temporal control over thermal polymerisation 
- fast curing rates 
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- minimal heat production 
 
Two hydrogel compositions (Hydrogel 1 and Hydrogel 2) were prepared by using 
varying amounts of distilled water, glycerol, monomers and a photoinitiator/cross linker 
mixture, as shown in Table 2.7. The photoinitiator/cross linker mixture consists of a UV 
acrylated urethane crosslinker (Ebacryl 11) and a UV initiator (Irgacure 184). The 
photoinitiator/cross linker mixture was measured into a glass vial with a ratio of 10:3 
(2.5:0.75g). The vial was placed onto an orbital shaker for 30 minutes to ensure the 
mixture had been adequately mixed. The vial was stored in darkness to prevent 
photodegradation of the initiator by stray light.   
 
Table 2.7 Compositions of skin adhesive hydrogels – Hydrogel 1 and Hydrogel 2. 
 Hydrogel 1 Hydrogel 2 
Distilled Water (g) 1.1 10.0 
Glycerol (g) 30.0 30.0 
NaAMPs 68.9 40.0 
SPA 0.0 20.0 
Photoinitiator/cross 
linker mixture (g) 
0.25 0.25 
NaAMPs, 2-acrylamido-2-methyl-1-propanesulfonic acid, sodium salt, 50% wt 
solution in water; SPA, 3-sulfopropyl acrylate, potassium salt. 
 
For each hydrogel composition, the water, glycerol and monomers were mixed in glass 
vessels and shaken gently to ensure thorough mixing. The photoinitiator/cross linker 
mixture (0.25 g) was added to the monomer mixture and the vessel was inverted three 
times. The mixture was poured immediately into a metal tray lined with release paper 
and then passed under a UV lamp (GEW Ultraviolet Lamp) at a speed of 5 m/mins, 
until the monomers had completely polymerised to form an adhesive gel. This typically 
took five passes on a moving conveyor under the UV lamp. To prevent contamination 
and dehydration, the hydrogels were covered with a paper release liner and stored in 
poly(ethylene) bags.  
 
2.2.4 Surface Energy Measurements  
 
Surface energy measurements were taken for the skin adhesive materials as listed in 
Table 2.4 and Table 2.5 using the sessile drop technique.  
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2.2.4.1 Materials  
 
Water and diiodomethane were used as two separate probe liquids. These liquids were 
chosen because of their opposing polar components; water has a high polar component 
(51.0 mNm
-1
) whereas diiodomethane in comparison has an extremely low polar 
component (2.3 mNm
-1
). The surface free energy data for each probe liquid, which 
includes the polar component [γlv (p)], dispersive component [γlv (d)], surface tension 
[γlv (T)] and contact angle is provided in Table 2.8.   
 
Table 2.8 The surface free energy data for water and diiodomethane. 
 
Liquid s(p) s(d) s(T) Contact Angle (°) 
Water 51.0 21.8 72.8 60 
Diidomethane 2.3 48.5 50.8 40 
 
 
2.2.4.2 The Sessile Drop Technique  
 
Surface and interfacial behaviour of synthetic materials govern their biocompatibility 
with aqueous environments, such as the open wound. Surface energy is a concept that 
describes the potential energy of surface molecules. The cohesive forces of attraction 
between molecules at the centre of a liquid drop are the same in every direction. At the 
surface of the drop, however, the cohesive forces of attraction are unbalanced, giving 
rise to the spherical shape of the droplet. The molecules at the surface therefore possess 
energy known as surface energy or surface tension. Weak cohesive forces between 
molecules at the surface give rise to a lower surface energy and vice versa.   
 
When a liquid comes into contact with a solid, forces of attraction between the two 
surfaces lead to the concept of interfacial tension. A lower interfacial tension will allow 
the liquid to spread over the surface. Interfacial tension is given by Equation 2: 
 
Equation 2 γ 1,2 = γ1 + γ2 – 2(γ1p. γ2p)
1/2
 – 2(γ1d . γ2d)
1/2 
 
The sessile drop technique is a means of evaluating surface free energy of a solid by 
contact angle measurements. The technique was used to calculate the surface energy of 
a range of skin adhesive wound dressing materials and ostomy devices (as listed in 
Table 2.4 and Table 2.5). A GBX Digidrop instrument was used with the Windrop 
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software program. Adhesive materials were prepared to give 1cm
2 
sized samples. The 
release liner was removed from the adhesive material and the sample was placed on the 
platform of the GBX. Two probe liquids were used: water and diiodomethane. The 
syringe component was filled with the probe liquid, taking care to ensure there were no 
air bubbles present. A separate syringe was used for each probe liquid to prevent any 
contamination. A droplet of probe liquid was then suspended from the needle of the 
syringe until an appropriate sized droplet was formed. The platform of the GBX 
instrument, with the sample in place, was raised automatically, causing the droplet to 
drop onto the sample (Figure 2.12). A contact angle is formed at the liquid-solid 
interface. The angle formed can give rise to wetting, partial wetting or non-wetting 
hysteresis owing to the adhesive and cohesive forces involved, as shown in Figure 2.13. 
A high contact angle (greater than 90°), or low/non-wetting surface, indicates a low 
surface energy. Conversely, a low contact angle (less than 90°), or high wetting surface, 
indicates a high surface energy. The integrated camera of the instrument photographed 
the droplet shape upon contact with the sample and simple on-screen integration 
allowed the contact angle to be recorded. Five contact angle measurements were taken 
for each adhesive to provide an average angle and the method was repeated for both 
probe liquids. Surface energies were determined using an Excel spreadsheet application. 
 
 
Figure 2.12 A droplet of probe liquid forming a contact angle with a solid surface.  
          
needle of  
syringe 
droplet of  
probe liquid 
surface of  
adhesive  
substrate 
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Figure 2.13 Contact angle hysteresis. 
 
2.2.5 X-ray Photoelectron Spectroscopy 
 
X-ray photoelectron spectroscopy (XPS), also referred to as electron spectroscopy for 
chemical analysis (ESCA), is a powerful surface sensitive chemical analysis technique 
to investigate the chemical composition of surfaces. The technique, which was 
developed in the mid 1960’s by Siegbahn, is based upon the photoelectric effect 
whereby an X-ray source is used to ionise electrons from the surface of a solid sample. 
In this work, XPS was used to analyse the surface of Salts Hydrocolloid Adhesives S1, 
S2, S3 and S4 (listed in Table 2.4) with their respective release liners. Samples of 2 cm
2 
were prepared and sent externally for analysis to Midlands Surface Analysis.  
 
XPS irradiates the solid surface of a sample with mono-energetic X-rays, causing the 
electrons of atoms at the surface to become excited. Each element has a characteristic 
binding energy. If the electrons of an element have a binding energy less than the X-ray 
energy, photoelectrons will be emitted from the sample surface (as shown in Figure 
2.14). Only photoelectrons at the extreme outer surface of the sample are ejected (at a 
penetration depth of 10 nm), thus XPS is sensitive surface analysis technique. The 
kinetic energies of photoelectrons relate to the speed at which they are emitted from the 
sample and can be measured from the simple Equation 3 which relates kinetic energy to 
the binding energy: 
 
Equation 3  KE = hν - BE – eΦ 
where 
KE: Kinetic Energy of ejected photoelectron 
hν: Characteristic energy of X-ray photon 
BE: Binding Energy of the atomic orbital from the electron 
eΦ: Spectrometer work function 
 
 
             θ = <90°                         θ = 90°                      θ = >90° 
      Wetting surface      Partially wetting surface     Non-wetting surface 
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The kinetic energy enables direct identification of elements in the sample from peaks in 
the photoelectron spectrum. The presence of a peak at a particular kinetic energy 
indicates the presence of a specific chemical element and the intensity under each peak 
is related to the concentration of the element.  
 
 
 
Figure 2.14 Photoelectron spectroscopy - excitation of electrons to emit photoelectrons 
by photoemission.  
2.2.6 Peel Strength 
 
The adhesive strength of a material, or the strength of an adhesive bond between two 
materials, may be measured by peel strength tests. As discussed in the main 
introduction to this work, the adhesive component of a dermal wound dressing has 
many functions. Amongst these, the adhesive must not fail cohesively during 
application and must not cause trauma upon removal from the wound site. Therefore, 
peel tests were performed for skin adhesive materials listed in Table 2.4 and Table 2.5 
to determine adhesive strength and ease of removal from skin. Tests were performed at 
90° on skin and a steel substrate and at 180° on steel using a Hounsfield Hti tensometer. 
The tests provided the average peel strength (N), the average peel strength per width 
(N/mm) and the maximum force of removal (N).  
 
Adhesive materials samples were cut into strips measuring 12 cm by 2.5 cm, with the 
release liners in place. All samples were tested in triplicate.     
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90° Peel Test – Steel Substrate  
 
The 90° peel test required a test fixture to create a 90° angle between the adhesive 
sample and the substrate. A wooden base with a sliding tray was placed directly 
underneath the tensometer grip. The steel substrate was positioned at the centre of the 
sliding tray so that the substrate was perpendicular to the grip (the substrate was held in 
place using tape). The release liner from the adhesive sample was then removed and the 
sample was applied to the steel substrate. A representation of the test set-up is shown in 
Figure 2.15A. A 1 kg weight was rolled over the length of the material to ensure 
adequate adhesion. The sample was left for 5 minutes before testing in order to keep 
adhesion times consistent between samples. A tensometer grip was attached to one end 
of the sample and the strip was peeled from the steel substrate at a peel speed of 500 
mm/min using a 10 N load cell. The sliding tray was moved at a rate steady with the 
peel speed to ensure that the 90° angle between the adhesive and substrate remained 
consistent throughout the test.  
 
90° Peel Test – Skin Substrate  
 
The 90° peel test was conducted on skin to provide a comparison against steel. Tests 
were carried out in a similar method as described above for steel, but on the unbreached 
forearm skin of a healthy volunteer. The release liner of the adhesive was removed 
before sample application to the forearm and a 1 kg weight was rolled over the sample. 
Again, the sample was left for 5 minutes before the peel test was carried out. The arm 
was then placed on the sliding tray and the test was performed. The forearm was 
cleaned with methanol before and after each test to remove any dirt, lipids, or residual 
adhesive left from samples.  
 
180° Peel Test – Steel Substrate  
 
The 90° peel test on steel was modified to increase the angle between the adhesive 
sample and steel substrate from 90° to 180°. The wooden box was turned vertically 
underneath the tensometer grip and the tests were repeated as described for the 90° tests 
on steel (Figure 2.15B). Because of the difficulty in positioning the arm at 180°, it was 
not possible to conduct tests on skin as well.  
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Figure 2.15 A representation of the peel test set-up at: A) 90° and B) 180°. 
2.2.7 Tensile Strength 
 
Tensile strength testing of adhesive materials provides an indication of the mechanical 
strength and elasticity of adhesives. Tests were conducted on skin adhesive wound 
materials listed in Table 2.4 and Table 2.5 using a Hounsfield Hti tensometer coupled 
with QMAT Testzone software. During a tensile test a load is applied to a sample until 
it stretches and breaks. Three values are provided from a typical tensile test: 
 
1) tensile strength (Ts) - the maximum stress applied before the adhesive breaks  
Equation 4 Ts = load at break / cross-sectional area 
 
2) elongation at break (Eb) - percentage increase in length of adhesive before it 
breaks under tension  
Equation 5 Eb = (extension of gauge length / original gauge length) * 100  
 
3) the elastic modulus (E.mod) – also referred to as Young’s modulus, this is a 
measure of rigidity 
Equation 6 E.mod = stress / strain 
 
where stress = load / cross-sectional area 
strain = extension of gauge length / original gauge length 
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8 mm 
3 mm 
Samples were cut from the adhesive materials using a dumbbell shaped cutter to give 
dimensions of 8 mm gauge length and 3.3 mm width. The sample size is shown in 
Figure 2.16. Where samples had a woven backing on the non-contact side of the 
adhesive, the backing was removed using acetone. A few millilitres of acetone were 
used to dampen the backing to enable it to be peeled off. This did not appear to affect 
the integrity of the adhesive material itself. The thickness of each sample was 
determined using a micrometer. 
                                      
 
 
 
Figure 2.16 Dimensions of an adhesive samples for tensile testing. 
 
The release liner was removed from the sample prior to testing and the sample was 
clamped vertically between the two grips of the tensometer. The sample was stretched 
at a test speed of 100 mm/min under a 10 N load cell and 30 mm extension range. A 
diagrammatic representation of the test set-up is shown in Figure 2.17. Each sample 
was tested in triplicate. The tensile strength at break, elongation at break and Young’s 
modulus for each sample were recorded. 
 
                                    
 
 
 
 
 
 
 
 
 
 
 
Figure 2.17 A representation of the tensile strength test set-up. 
 
Upper grip 
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Test sample 
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2.2.8 Dynamic Testing 
 
Rheology testing was performed on skin adhesive materials listed in Table 2.4 and 
Table 2.5. Rheology is the study of deformation and flow of matter under the influence 
of an applied sheared stress. Material deformation behaviour may be described by two 
parameters. Elasticity describes the property that enables a material to return to its 
original undeformed state after a deforming stress is applied and removed. The energy 
that is used to cause the deformation is stored and then released once the stress is 
removed and relaxation has occurred. This is signified by the elastic, or storage, 
modulus (G'). Viscosity describes the non-recoverable linear deformation of a material. 
It is a measure of the resistance of a material to being deformed. This is described by 
the viscous, or loss, modulus (G'') and such behaviour is characteristic of liquids.  
 
Most materials exhibit both elastic and viscous behaviour; hence these are viscoelastic 
materials. The viscoelastic behaviour of a material may be measured as a function of 
frequency by deforming the material with an applied stress to in turn cause a strain. An 
oscillation test, where an oscillating force is applied to the sample whilst the frequency 
is varied, generates a sinusoidal stress or strain. The difference between the stress and 
sine waves is the phase shift (δ). The tan δ is a ratio of the viscous modulus (G'') to the 
elastic modulus (G'). Tan δ values below a certain value indicate elastic-dominant 
‘solid-like’ behaviour, whereas values above this value indicate more viscous-dominant 
‘liquid-like’ behaviour. The tan δ values may be calculated by Equation 7: 
 
Equation 7  tan δ = G''/G' 
 
The viscoelastic behaviour of skin adhesive materials was measured using a Bohlin 
CVO Rheometer. 20 mm discs were cut from adhesive materials in their unhydrated 
form using a number 13 cork borer. All tests were performed at 37°C to represent body 
temperature conditions. The release liners were removed from the samples and the 
samples were then loaded individually onto the lower plate of the rheometer and 
subjected to an oscillating frequency of between 0.5 Hz and 25 Hz. The lower 
frequencies were chosen to represent the application of adhesive materials to skin, 
whereas the higher frequencies represent the removal of the materials from skin. All 
samples were repeated in triplicate. The elastic modulus (G') and viscous modulus (G'') 
were recorded for each sample.  
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2.2.9 Total Protein Method 
 
2.2.9.1 Materials  
 
The total protein content of biological fluids was detected and quantitated by a Micro 
BCA Protein Assay Kit purchased from Thermo Scientific (product code 23225). The 
kit consists of a Micro BCA Reagent A, Micro BCA Reagent B, Micro BCA Reagent C 
and Bovine Serum Albumin (BSA) Standard ampules.   
2.2.9.2 Preparation of Diluted Albumin Standards 
 
A set of protein standards was prepared from the BSA Standard, according to Table 2.9. 
The Albumin Standard was diluted with saline to give 7 vials (A-G) of protein 
concentrations from 1000 μg/ml to 0 μg/ml. A new set of standards was prepared for 
each test.   
Table 2.9 Preparation of bovine serum albumin (BSA) standards. 
Vial 
Final Concentration 
(μg/ml) 
A 1000 
B 750 
C 500 
D 375 
E 250 
F 125 
G 0 = Blank 
 
2.2.9.3 Preparation of the Micro BCA Working Reagent (WR)  
 
The Working Reagent (WR) was prepared from the three Micro BCA Reagents using 
the following calculation: 
 
Volume of WR = (#standards + #unknowns) * (# replicates) * (volume of WR per 
sample) 
i.e. to test 5 unknown samples in triplicate:  
Volume of WR = (7 + 5) * (3) * (1) 
    = 36 ml 
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Micro BCA Reagent A (25 parts) was mixed with Micro BCA Reagent B (24 parts) and 
Micro BCA Reagent C (1 part). The WR reagent was mixed thoroughly to give a clear-
green solution. The reagent was stored at room temperature and discarded after one day.   
 
2.2.9.4 Total Protein Determination  
 
1 ml of each BSA standard and unknown sample was pipetted into appropriately 
labelled test tubes. 1 ml of the WR was added to each tube and mixed well. The tubes 
were covered and incubated at 60° in a water bath for 1 hour. After this incubation 
period the tubes were cooled to room temperature to allow for colour development. The 
absorbance of all the standards and samples were measured on a SpectraMax M2 
spectrophotometer at 562 nm. Colour development still occurs after the cooling period 
at a low rate, therefore, all absorbance measurements were made within a 10 minute 
time period. The average absorbance reading of the blank standard (0 μg/ml) was 
subtracted from the remaining standards and unknown samples to provide blank-
corrected readings at 562 nm. A concentration curve was determined by plotting the 
blank-corrected reading for each standard versus its concentration in µg/mL. The total 
protein concentration of each unknown sample was determined by extrapolation of the 
concentration curve. An example of a curve is provided in Figure 2.18.  
  
Figure 2.18 A concentration curve for bovine serum albumin standards at 0-1000 
µg/mL. 
 
2.2.10 Osmolarity Measurements 
Osmolarity measurements were made on a micro-Digitial CamLab osmometer. The 
osmometer was calibrated with a standard solution of known osmolarity, for example 
pH 7 phosphate buffered saline (300 mOsm/kg).  
y = -5E-07x2 + 0.0016x + 0.1184 
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CHAPTER THREE 
The Nature and Consequences of Vitronectin 
Interactions in the Non-Compromised Contact Lens-
Wearing Eye  
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3.1 Aim  
 
The main introduction to this thesis highlighted vitronectin as a very adhesive 
glycoprotein with a high affinity for hydrogel biomaterials. It is likely that this affinity 
extends to hydrogel contact lenses. The important roles of vitronectin as a cell adhesion 
molecule in the wound healing process have also been discussed. It is this cell-binding 
function that forms the basis of this work. Vitronectin was selected to investigate 
interactions with hydrogel contact lenses in the healthy non-compromised eye by the 
use of a novel on-lens cell attachment assay technique.  
 
The aim of this chapter was to investigate the locus and extent of vitronectin-mediated 
cell adhesion on ex vivo contact lenses and to determine the influence of wear modality 
together with surface and bulk characteristics of the contact lens material. A cell-based 
vitronectin mapping technique was used to investigate vitronectin-mediated cell 
adhesion to a range of lens contact materials.   
 
3.2 Introduction 
 
3.2.1 Introduction  
 
A contact lens has the potential to alter normal ocular function. Specifically, material 
composition has the propensity to affect local changes in tear biochemistry, particularly 
those encountered in the post-contact lens environment [103]. There is growing interest 
in the biomarkers related to inflammation and immunoregulation of the ocular 
environment in contact lens wear. One interesting candidate biomarker is vitronectin, a 
prominent inflammatory regulatory glycoprotein and adhesion molecule, which has 
been detected in tears [104, 105]. Section 1.3.5 emphasised vitronectin as an important 
inflammatory marker and very adhesive protein with a high affinity for natural and 
synthetic compositions – a feature that is of particular relevance to studies of lens-eye 
interactions. Additionally, due to the adhesive nature of vitronectin, once adsorbed to a 
surface it is very difficult to remove. This property enables the locus of specific 
physical interaction of the contact lens and the cornea to be determined. The purpose of 
this work was to determine the locus and the extent of maximum physical interaction 
of a range of contact lenses upon the cornea in the non-compromised eye, and to 
determine the influence of this on wear modality together with surface and bulk 
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characteristics of the contact lens material.  A novel on-lens cell-based vitronectin 
mapping technique was used to quantify vitronectin-mediated cell adhesion on contact 
lenses doped in vitro and on ex vivo contact lenses, and therefore assess the potential 
upregulation of the plasmin protease which is found in the post-contact lens 
environment.  
 
3.2.2 Vitronectin in Tears  
 
The concentration of vitronectin in tears has been shown to be dependent on the tear 
state; the levels in reflex, open-eye, and closed-eye tear samples have been reported to 
be 0.08±0.3 µg/ml, 0.75±0.32 µg/ml, and 3.7±2.2 µg/ml respectively [104, 105]. 
Detection in tears can, however, be difficult because other proteins with similar 
molecular weights (e.g. albumin at 68 kDa, lactoferrin at 77 kDa) are often found in 
higher concentrations in tears and can therefore mask vitronectin. It has been proposed 
that the majority of vitronectin comes from conjunctival blood vessels [105], but more 
recently, vitronectin was found within the basement membrane of the corneal 
epithelium, which may indicate a possible endogenous source [106]. It has also been 
suggested that the overall elevation of protein levels during eye closure is due to an 
increase in vascular permeability in combination with the accumulation of leakage 
products resulting from a reduced tear turnover [104, 107]. The effect of vascular 
leakage on the ocular surface and the potential consequences of the altered overnight 
ocular environment are at present poorly understood. Although the parallel influx of 
certain components, including plasmin and complement proteins are likely to be related 
[108], the anti-inflammatory properties of vitronectin, such as the inhibition of 
complement lysis and plasmin-mediated inflammation, may be extremely important in 
controlling or co-controlling the closed eye environment.  
 
The diverse list of functions of vitronectin and its involvement in many cascades 
generally relate to its interactions with plasma associated proteins and systems, 
suggesting its relevance in the eye may be less important. However, this cannot be the 
case with growing evidence of more and more plasma proteins ‘invading’ the tear film 
as a result of inflammation, ocular dysfunction, and diurnal variation and contact lens 
wear amongst others [109-111]. Contact lens wear can induce mild or acute red eye, 
involving vascularisation of the cornea, thus increasing the permeability of the 
blood/tear barrier and creating more susceptibility to plasma/serum leakage. 
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Consequently, the contact lens has the potential to alter normal ocular function. 
Specifically, material composition has the propensity to affect local changes in tear 
biochemistry, particularly those encountered in the post-contact lens environment 
[103].  
 
3.3 Method Validation - In Vitro Demonstration of the On-Lens Cell 
Attachment Assay for the Detection of Vitronectin-Mediated 
Cell Adhesion 
 
3.3.1 Assessment of the Contributory Role of Vitronectin  
 
The cell attachment assay used in this work relies on the basis that vitronectin adheres 
to contact lens surfaces and that fibroblast cells with integrin receptors for vitronectin 
adhere to the contact lens using vitronectin as the binding ligand. An initial experiment 
was performed to prove that vitronectin adsorbed out of solution onto the contact lens 
surface and that it could be detected using the cell-based assay. Three Group I unworn 
polyHEMA contact lenses were doped for 24 hours in vitro with a 20 μg/ml solution of 
vitronectin, by the doping method described in section 2.2.1.5. A duplicate set of 
unworn, non-doped polyHEMA contact lenses (n=3) were assayed as a control. The 
choice of a Group I set of contact lenses in this assay was used to take the assay to the 
limits. Group I lenses are known to display lower levels of spoilation over various wear 
regimes compared to Groups II and IV, and thus could be classed as the lowest 
threshold for all contact lenses to be analysed. The cell assay involves the selective 
inhibition of the adhesion molecules, by the use of antibody blocking techniques, to 
validate the significance of vitronectin-mediated cell adhesion on the contact lens 
surface. An anti-vitronectin (anti-Vn) antibody control diluted to 1:100 in HBS was 
incorporated into the assay to block the action of vitronectin and used as a comparison 
against the vitronectin standard control wells in order to assess vitronectin-mediated 
cell adhesion to the lens. The use of an IgG antibody, at 300 µg/ml, as a control was to 
negate the action of an arbitrary antibody in the system.  For in vitro assays human 
vitronectin diluted in PBS to give a range of concentrations was used as the positive 
vitronectin control (Vn positive control).  
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Figure 3.1 shows that the average cell count per field to doped contact lenses was 
greatest for the vitronectin positive control contact lenses (59±3) and for the antibody 
control contact lenses (52±3), whereas the contact lenses blocked with anti-vitronectin 
demonstrated low cell counts per field (4±2), as expected. A set of four non-doped 
polyHEMA contact lenses was also assayed as a control group where an average 
background level of <5 cells was observed on all lenses; this is a similar cell count to 
the lenses treated with anti-vitronectin (also shown on Figure 3.1). The comparison of 
cell counts between the blank lenses and doped lenses shows a 20-fold increase in the 
average cell count per field.  
 
 
Figure 3.1 Cell counts on polyHEMA contact lenses doped with 20 µg/ml vitronectin in 
vitro. 
 
 
3.3.2 Assessment of the Contributory Role of Fibronectin  
 
Fibronectin is an important adhesion protein which, in addition to vitronectin, has been 
reported in tears [112]. Both of these cell attachment-promoting proteins are 
immunologically unrelated and biochemically different, but due to the fact that their 
cell adhesive properties are similar, it was inadvisable to assume that vitronectin was 
solely responsible for both adsorption onto the contact lens and the cell-mediated 
adhesion. From a doubling dilution range of standards, a concentration of 12.5 μg/ml of 
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fibronectin was selected - taking into account the requirement for a satisfactory cell 
count and cost effectiveness. This concentration, which was similar to those used for 
vitronectin doping experiments, but far greater than those found in tears, was selected to 
incorporate any extremes of fibronectin influx. Group IV etafilcon A contact lenses 
were doped in 12.5μg/ml of fibronectin for 24 hours (n=3). For all initial validation 
assays an anti-fibronectin (anti-Fn) antibody, at 1:100 in HBS, was also used as a direct 
comparison against the anti-Vn antibody and vitronectin standard controls.  Again this 
was to either eliminate or accept the role of fibronectin as a competitive adhesion 
molecule in contact lens wear and/or to further validate the dominant adhesion of 
vitronectin onto the contact lens. 
 
 
 
Figure 3.2 Cell counts on polyHEMA contact lenses doped with 20 µg/ml fibronectin in 
vitro. 
 
Figure 3.2. shows that fibronectin demonstrated poor adsorption out of doping solution 
onto the contact lens, displaying low cell counts per field (10±2) in comparison to 
vitronectin-mediated adhesion (59±3).   
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3.3.3 Discussion  
 
In terms of method validation, the assay was verified using vitronectin doped 
polyHEMA contact lenses. The use of polyclonal anti-vitronectin antibodies as a 
control in the cell-based assay demonstrated the essential role of vitronectin-mediated 
mouse 3T3 Swiss Albino embryo fibroblasts cell adhesion, and thus validated the use of 
the cells as a means of detecting vitronectin presence. The negative control antibodies 
blocked the numerous exposed sites of vitronectin, preventing cell attachment; the level 
of adhesion to the contact lenses treated with anti-vitronectin was comparable with 
those on the blank contact lenses, indicating the effective inhibitory action of anti-
vitronectin. These results verify vitronectin dependant adhesion of cell fibroblasts to 
contact lenses and demonstrate the use of a cell-based assay to detect vitronectin.  
 
Additionally, it was shown that fibronectin, which also mediates cell adhesion, did not 
adversely interfere with the vitronectin dominated cell-based assay. Therefore, 
vitronectin was established as the dominant ligand involved for cell-mediated adhesion 
to the contact lens surface.  
 
3.3.4 Key Points for Cell Assay Method Validation  
 
 Vitronectin was shown to adsorb out of doping solution and onto the contact 
lens surface. This adsorption can be detected by vitronectin-mediated fibroblast 
cell adhesion.  
 Fibronectin was demonstrated to show poor adsorption out of doping solution, 
as demonstrated by the low fibronectin-mediated cell counts. Therefore, the 
presence of fibronectin in solution does not interfere with the detection of 
vitronectin.  
3.4 The Effect of Protein Concentration on Vitronectin-Mediated 
Cell Adhesion 
 
3.4.1 In Vitro Doping Experiments – Varying Protein Concentration   
 
The effect of vitronectin doping concentration on vitronectin-mediated cell adhesion to 
the contact lens surface was evaluated. PolyHEMA contact lenses (n=4) were used in 
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order to keep the contact lens type consistent with the initial experiment performed in 
section 3.3.1 and to reduce experiment parameter variability. The four concentrations of 
vitronectin used to dope the contact lenses were: 1μg/ml, 5μg/ml, 10μg/ml and 20μg/ml. 
Control non-doped contact lenses (n=3) were also analysed. No antibody controls were 
required for these assays. The results show that the higher the vitronectin concentration 
of the doping solution the higher the vitronectin-mediated cell adhesion. Increasing the 
vitronectin concentration from 1 µg/ml to 20 µg/ml gave an increase in the average cell 
count per field from 5±0.8 to 37±1.7 (Figure 3.3). All subsequent contact lenses doped 
with vitronectin were done so at a concentration of 10 µg/ml, as this was found to be 
the optimum concentration.  
 
 
 
Figure 3.3 The relationship between vitronectin-mediated cell adhesion and 
concentration of the vitronectin doping solution.  
 
3.4.2 Discussion  
 
The in vitro doping of contact lenses with vitronectin at varying concentrations showed 
a direct correlation between an increase in vitronectin concentration and vitronectin-
mediated cell adhesion to the contact lens. Although a plateau was not reached within 
the concentration levels studied, it can be expected that a limiting plateau would 
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ultimately be achieved after a gradual increase. However, as previously stated, 
vitronectin concentrations in the eye have been reported at 0.75±0.32 µg/ml in the open 
eye [104]. It is, therefore, extremely unlikely for vitronectin concentrations to exceed 
the in vitro experimental limits of 20 µg/ml in tears. These results demonstrate that cell 
adhesion is dependent upon vitronectin concentration in solution. However, it would be 
inadvisable to produce concentration curves to calculate vitronectin concentration 
against cell counts as each assay must be treated separately. 
 
3.4.3 Key Points for the Effect of Protein Concentration on Vitronectin-Mediated 
Cell Adhesion 
 
 Vitronectin-mediated cell adhesion is directly dependent upon vitronectin 
concentration in solution; the higher the concentration the higher the vitronectin-
mediated cell adhesion to the contact lens surface.  
 The optimum doping concentration for the purpose of initial experimentation 
was found to be 10 µg/ml. 
3.5 The Influence of Contact Lens Water Content and Ionicity on 
Vitronectin-Mediated Cell Adhesion 
 
3.5.1 In Vitro Doping Experiments – Varying Contact Lens Water Content and 
Ionicity    
 
Two separate assays were designed to assess the influence of the contact lens material 
on vitronectin-mediated cell adhesion. Firstly a contact lens water content assay was 
performed; the contact lenses used were all non-ionic lenses with water contents of 
38%, 42%, 60%, and 75% (n=4). HEMA or HEMA/NVP lenses were chosen to 
evaluate the effect of contact lens water content on cell adhesion because the material is 
available in a range of water contents. The effect of contact lens water content on cell 
count showed the higher the water content of the contact lens the higher the vitronectin-
mediated cell adhesion. The average cell count per field for contact lenses with water 
contents of 38% and 75% increased from 42±0.8 to 58±0.96 respectively (Figure 3.4A).  
 
Secondly, a contact lens ionicity assay using non-ionic Group II (vasurfilcon A, n=2) 
versus ionic Group IV (etafilcon A, n=2) contact lenses (both are high water content 
- Chapter Three - 
 
97 
 
lenses) was performed. Both contact lens types were doped with vitronectin at a 
concentration of 10 μg/ml for 24 hours. Only the vitronectin standard control and anti-
vitronectin lenses were tested. Figure 3.4B reveals greater cell counts on the ionic 
Group IV contact lenses (73±6) in comparison to the non-ionic Group II contact lenses 
(53±9). 
 
  
 
Figure 3.4 The relationship between vitronectin-mediated cell adhesion and: A) contact 
lens water content, B) contact lens ionicity. 
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3.5.2 Discussion  
 
The results from Figure 3.4A illustrate the fact that the percentage water content of the 
contact lens material directly affects vitronectin-mediated cell adhesion; an increase in 
water content clearly exhibited a rise in the levels of vitronectin-mediated cell adhesion. 
Additionally, the ionicity of the contact lens also greatly influences cell adhesion, with 
greater cell counts on the ionic (Group IV) versus the non-ionic (Group II) contact 
lenses. In this work vitronectin-mediated cell adhesion to etafilcon A contact lenses 
(Group IV – 58% water content, ionic) was compared with adhesion to vasurfilcon A 
(Group II – 74% water content, non-ionic). Although vasurfilcon A has the higher water 
content of the two materials, cell adhesion was found to be greater to etafilcon A 
contact lenses. This suggests that the ionicity of the contact lens material is more 
important than the water content with regards to vitronectin-mediated cell adhesion. 
 
3.5.3 Key Points for the Influence of Contact Lens Water Content and Ionicity 
on  Vitronectin-Mediated Cell Adhesion 
 
 Vitronectin-mediated cell adhesion is influenced by contact lens water content; 
the higher the water content the higher the vitronectin-mediated cell adhesion 
onto the contact lens surface.  
 Vitronectin-mediated cell adhesion is also influenced by contact lens ionicity; in 
these investigations cell adhesion was found to be greater to an ionic lens 
material in comparison to a non-ionic material.    
 It appears that ionicity is the greater contributing factor to vitronectin-mediated 
cell adhesion, as greater cell counts were detected on high water content ionic 
contact lenses (etafilcon A 58%) than high water content non-ionic lenses 
(vasurfilcon A 74%).  
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3.6 Vitronectin-Mediated Cell Adhesion to Anterior and Posterior 
Surfaces of ex vivo Contact Lenses in Daily Wear and Extended 
Wear Modalities  
 
3.6.1 Ex vivo Contact Lenses - Anterior versus Posterior and Daily Wear versus 
Extended Wear  
 
Cell counts on the anterior and posterior surfaces of Group IV etafilcon A contact 
lenses were analysed. Lenses from 8 subjects were worn on a daily wear basis (n=8) 
and on an extended wear basis (n=8). Figure 3.5 reveal that higher cell counts per field 
on the posterior surface of the contact lenses were determined in comparison to the 
anterior surface, irrelevant of the modality of wear, as average cell counts per field 
increased by 95% from the anterior to the posterior surface in both wear modalities. All 
further test lenses therefore analysed the posterior contact lens surface only. Greater cell 
counts were also detected on extended wear lenses than daily wear lenses, with an 
average increase in cell count of 46% for both the posterior and anterior surfaces of the 
lenses, as also shown in Figure 3.5.  
 
Figure 3.5 Cell counts on the anterior and posterior surfaces of etafilcon A contact 
lenses worn on both daily wear and extended wear basis. 
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3.6.2 Discussion  
 
The analysis of vitronectin-mediated cell adhesion on both the anterior and the posterior 
surfaces of the contact lens revealed that adhesion was predominantly found to occur on 
the posterior surface of the lens. In contrast, very low levels were revealed on the 
anterior surface - resembling the levels of vitronectin in tears. The posterior surface 
presented greater accumulation of vitronectin-mediated cell adhesion, accounting for 
the majority of vitronectin detected. This accumulation at the posterior contact lens 
surface may reflect vitronectin moving out of the corneal tissue bed due to contact lens-
tissue interactions, as opposed to being simply derived from tears. The aggregation of 
vitronectin on the posterior surface is thought to create a particular micro climate, 
which due to its multifunctional nature and ability to bind to numerous ligands and 
proteins, could lead to the initiation of, or assist in, a number of effector systems.   
 
Greater vitronectin-mediated cell adhesion was also detected on extended wear contact 
lenses in comparison with daily wear lenses. Taking the total wear time and contact 
lens-tissue bed contact into consideration, the cell attachment was always greater for the 
extended wear lenses than the daily wear lenses. The cell attachment observed at the in 
vitro concentrations equivalent to those found in tears are much lower than those found 
on posterior surfaces of worn lenses. This may be explained by the interaction between 
the ocular tissue and contact lens, with the posterior microclimate favouring vitronectin 
attachment. 
 
3.6.3 Key Points for the Analysis of Anterior versus Posterior and for Daily 
Wear versus Extended Wear on Ex Vivo Contact Lenses 
 
 Greater vitronectin-mediated cell adhesion to the posterior surfaces of ex vivo 
contact lenses in comparison to the anterior surfaces strongly suggests that 
vitronectin deposits as a result of contact lens-tissue mechanical interaction as 
opposed to adsorption from tears.   
 Vitronectin-mediated cell adhesion was found to be greater on ex vivo extended 
wear contact lenses than ex vivo daily wear lenses on the lenses studied in this 
work.  
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3.7 Vitronectin-Mediated Cell Adhesion to ex vivo Daily Wear 
Contact Lenses - Centre versus Edge 
 
3.7.1 Ex Vivo Contact Lenses – Centre versus Edge  
 
It was noted that there was a difference in the locus of vitronectin-mediated cell 
adhesion to the posterior contact lens surface. Therefore, a comparison of cell adhesion 
at the centre and edge of the contact lenses was performed. The location of cell 
adhesion was analysed for Group II (vasurfilcon A, n=8) daily wear and Group IV 
(etafilcon A, n=8) daily wear lenses (n=16). Greater vitronectin-mediated cell adhesion 
was observed at the contact lens edge compared to the centre, irrespective of the contact 
lens material type. Average increases in cell counts per field from centre to edge (on the 
posterior contact lens surface) of 68% and 65% were observed for Group II contact 
lenses and Group IV contact lenses respectively (Figure 3.6). The results revealed a 
greater cell attachment on the Group IV ionic material in comparison to the Group II 
non-ionic material, both for the contact lens centre with an average cell count increase 
of 30%, and the contact lens edge with an average increase of 25%. Figure 3.7 
illustrates cells on the contact lens edge of an ex vivo etafilcon A lens under an inverted 
microscope.  
 
 
 
Figure 3.6 Cell counts on the centre and edge areas of the posterior surface of ex vivo 
Group II and Group IV contact lenses worn on a daily wear basis. 
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Figure 3.7 Cells on the posterior surface of the contact lens edge of a Group IV ex vivo 
etafilcon A material. High cell counts at the lens edge are apparent. 
 
3.7.2 Discussion  
 
Vitronectin-mediated cell adhesion was significantly greater to ex vivo contact lenses in 
comparison to lenses doped with vitronectin in vitro. Centre versus the edge of the 
contact lens analysis revealed interesting differences in vitronectin-mediated cell 
adhesion. There was a marked increase in cell adhesion at the edge of the contact lens 
in contrast to the centre of the lens. This phenomenon was evident in both the daily and 
extended wear regimes. The fact that this preferential adhesion was evident for both 
wear modalities is very significant. As the name suggests, daily wear contact lenses are 
inserted and removed on a daily basis, the effect of daily handling of the lens, varying 
insertion and removal parameters and cleaning would be expected to change the 
characteristics of the deposition of vitronectin. However, this was not the case and the 
adhesion profiles resembled that of the extended wear modality. Both wear modalities 
appeared to create a vitronectin rich micro-climate at the edge of the lens, which may be 
the site of localised inflammatory mediation. 
 
A comparison of vitronectin-mediated cell adhesion levels for the central and peripheral 
regions of Group II and Group IV contact lenses was performed. Greater cell adhesion 
to Group IV materials in contrast with Group II materials demonstrated that cell 
attachment is markedly dependent upon material type, highlighting the potential for 
materials effects in influencing vitronectin deposition on the lens surface and the nature 
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of the post-contact lens microclimate. Again, an evaluation of the centre versus the edge 
of the contact lens revealed that greater vitronectin-mediated cell adhesion resulted at 
the edge. The locus of vitronectin deposition is significant, as this may influence the 
locus of plasmin regulation. Localised plasmin at the edge has the potential to escape 
into the tear film, whereas plasmin regulated at the centre of the contact lens may 
become “trapped” in that region. 
 
3.7.3 Key Points for Vitronectin-Mediated Cell Adhesion to the Contact Lens 
Centre versus the Lens Edge 
 
 Vitronectin-mediated cell adhesion was found to be greater at the edge of lens 
than at the centre of the lens.  
3.8 Investigating Contact Lens Material Variation  
 
3.8.1 The Effect of Contact Lens Modulus on Vitronectin-Mediated Cell 
Adhesion 
 
The study was extended to include one conventional hydrogel contact lens material 
(etafilcon A) and three silicone hydrogel contact lens materials (lotrafilcon A, 
lotrafilcon B and balafilcon A). Each contact lens type (n=4) was worn by the same 
asymptomatic subject on a daily wear basis and stored in saline solution after removal. 
Four contact lenses of each material type were assayed and the average cell count per 
field calculated. Figure 3.8 reveals that the highest levels of vitronectin-mediated cell 
adhesion were determined on the etafilcon A material (117±4), with lotrafilcon B, 
balafilcon A and lotrafilcon A showing decreasing cell counts at the contact lens edge 
(115±4, 107±5, 88±6 respectively). Figure 3.9 shows the relationship between 
vitronectin-mediated cell adhesion and contact lens modulus - the lower the modulus, 
the greater the cell adhesion at the contact lens edge. It was demonstrated that a low 
water content high modulus material, such as lotrafilcon A, has a lower edge:centre 
ratio of 1.3:1, whereas a high water content low modulus material, such as etafilcon A, 
has a higher edge:centre ratio of 3.3:1. The modulus and centre:edge ratios are 
summarised in Table 3.1. 
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Figure 3.8 Vitronectin-mediated cell adhesion to ex vivo contact lenses worn on a daily 
wear basis averaging 8 hours over 1 day, where n=8. 
 
 
 
Table 3.1 The relationship between edge:centre ratio and contact lens modulus. 
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Figure 3.9 The relationship between vitronectin-mediated cell adhesion and contact 
lens modulus; the lower the material modulus the greater the cell adhesion at the lens 
edge. 
 
3.8.2 Discussion  
 
Interaction of the contact lens edge with the cornea was further demonstrated using a 
range of materials with varying moduli. The modulus of a contact lens describes its 
resistance to deformation, where modulus is equal to stress/strain. An edge:centre cell 
count ratio was calculated for each material. The edge:centre cell count ratio is clearly 
material dependent and one important aspect of this appears to be modulus – above a 
certain value a more even distribution of vitronectin-mediated cell adhesion is found, 
and overall cell adhesion levels are lower. It must be noted that it is difficult to 
decouple the effect of lens water content and the effect of lens modulus on vitronectin-
mediated cell adhesion. The effect of the contact lens material modulus on the 
edge:centre ratio was, however, further demonstrated with two similar contact lens 
materials; lotrafilcon A and lotrafilcon B. Both lens materials are FDA group I 
materials (low water content and non-ionic). However, lotrafilcon B with a lower 
modulus of 1.0 MPa revealed a much greater edge:centre ratio in comparison to 
lotrafilcon A with a higher modulus of 1.5 MPa. Lotrafilcon B, the softer material, 
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allows more drape of the contact lens over the cornea, thus contact lens-tissue 
interaction is emphasised at the edge. 
 
3.8.3 Key Points for the Influence of Contact Lens Modulus on Vitronectin-
Mediated Cell Adhesion 
 
 The locus and extent of vitronectin-mediated cell adhesion is largely influenced 
by material modulus. 
 
 Lower modulus materials exhibit greater cell adhesion at the contact lens edge, 
whereas higher modulus materials give a more even distribution of vitronectin-
mediated cell adhesion over the lens surface.      
 
3.9 Concluding Discussion 
 
3.9.1 Vitronectin-Mediated Cell Adhesion Due to Contact Lens-Tissue Interaction 
 
This study has shown that, in general, the high levels of vitronectin-mediated cell 
adhesion detected on ex vivo contact lenses cannot be reproduced with in vitro doping 
experiments at similar concentrations of vitronectin in tears. This suggests that 
vitronectin adsorption from the tear film alone cannot explain the levels detected on ex 
vivo contact lenses; deposition arising from mechanical contact of the contact lens with 
the corneal tissue bed, rather than out of solution, is highly likely. This is further 
demonstrated by the comparison of vitronectin-mediated cell adhesion between the 
anterior and posterior surface of the lens. There is a significant difference between cell 
adhesion levels on both surfaces, and the low levels of vitronectin-mediated cell 
adhesion detected on the anterior surface resemble the vitronectin levels found in tears.   
 
The sliding motion of the eyelid over the contact lens surface will bring about fricto-
mechanical stimulation. This movement might be expected to stimulate a biochemical 
response with the potential to generate an upregulation of particular components or to 
activate additional pathways in response to the physical trauma of the eyelid-contact 
lens interaction – modest though that might be. The diminished tear flow at the 
posterior surface of the lens, in addition to a reduction in the dynamic interaction with 
the tissue bed, would be expected to produce a quite different level of response with the 
potential adsorption of specific biochemical components from the more ‘closed’ 
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environment. This difference is typified by the fact that dramatically higher (greater 
than tenfold) levels of vitronectin deposition have been reported on posterior, relative to 
anterior contact lens surfaces [46].  
 
3.9.2 Vitronectin and Tear Plasmin Activity  
 
The emerging patterns are clear - the presence of a contact lens concentrates vitronectin 
in close proximity to the ocular tissue bed, and thus the preferential adsorption of 
vitronectin onto the contact lens surface highlights the fact that post-contact lens micro 
climate, particularly towards the edge, is rich in vitronectin to a degree that is capable 
of influencing localised inflammation and upregulation of plasmin. Vitronectin is 
involved in the regulation of fibrinolysis, a consequence of the fact that it binds and 
stabilises plasminogen activator inhibitor-1 (PAI-1), which thereby allows PAI-1 to 
inhibit the action of tissue plasminogen activator (tPA) and the fibrinolysis process as a 
whole. If vitronectin is localised on a surface adjacent to the cellular site, the 
somatomedin B homology region of the protein binds to the active site of PAI-1, 
thereby generating plasminogen activator and resulting in the upregulation of plasmin 
[113]. Tear plasmin activity has been observed in tear fluid of subjects with corneal 
disorders, for example an increase in tear plasmin in corneal ulcers has been 
demonstrated [114]. This leads to the implication that elevated plasmin levels are 
important in the pathogenesis of ocular infection and dysfunction. The view is that it is 
an important potential trigger of additional events, leading in extreme cases to 
pathology in an otherwise healthy tissue. Plasmin, for example, can cleave fibronectin 
(an important adhesion molecule involved in corneal re-epithelisation), which is 
significant as fibronectin degradation is associated with impaired wound healing [115, 
116].  
 
Levels of tear plasmin have been shown to increase progressively in the sequence: no 
contact lens control group, daily wear soft, extended wear soft [117], and it has been 
proposed that the proteolytic activity of plasmin may contribute to corneal epithelial 
abnormalities associated with contact lens wear [113]. Vitronectin localised on the 
contact lens surface adjacent to the corneal surface [46]  may remove PAI-1 leading to 
local upregulation of plasmin in the posterior tear film. Plasminogen is synthesised in 
the cornea and can be activated by plasminogen activator to produce plasmin, this in 
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turn activates latent collagenase which can result in collagen degradation implicated in 
corneal ulceration [118]. The physical contact between the contact lens and tissue bed 
can potentially remove vitronectin together with PAI-1, thus plasmin is found in the 
post-contact lens environment [119]. Studies also suggest a link between high 
plasminogen activator levels and the pathogenesis of persistent corneal defects [120]. 
To parallel this observation in the eye, chronic wound fluid from venous ulcers often 
shows complete degradation of vitronectin and fibronectin into smaller peptides that 
prevent local cell adhesion to the wound bed, therefore preventing closure [121]. If 
vitronectin is localised on a (synthetic) surface adjacent to the cellular site (such as a 
chronic wound) it removes PAI-1 from the reaction by fixing it, creating an imbalance 
in favour of plasminogen activator. This can result in a local upregulation of plasmin 
formation, thereby controlling an important regulatory mechanism in wound repair; an 
increase in degradative proteolysis which may then result in a state of non-healing and 
excessive inflammation.  
 
The potential for materials to affect vitronectin deposition from the corneal tissue bed 
will affect the locus of plasmin generation and thus influence lens-induced 
inflammatory processes. The clinical implications of this are yet to be determined, and 
further studies are required in order to comment on the ideal properties of a contact lens 
when considering the connection between contact lenses and the consequential 
inflammatory process. It can be said, however, that an ideal contact lens is one that 
minimises protein interaction at the surface and that allows more exchange of protein at 
the edge. The unique conformational flexibility and multidomain structure of 
vitronectin which allows it to bind to a large repertoire of ligands makes its potential 
interactions with biomaterials all the more intriguing. The versatile binding capabilities 
and receptor functions of vitronectin could, in the future, be used in the characterisation 
of structure-function properties and importantly in the design of new biomaterials. 
 
3.9.3 Potential for Further Work 
 
The significance of this body of research must lie in the area of wound healing and the 
compromised anterior eye. Bandage contact lenses (BCLs) are regularly used to protect 
the compromised cornea from further ocular insult, to enable the relief of pain and to 
improve the ability of the corneal epithelium to heal. However, the use of contact lenses 
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in therapeutics as bandage lenses is in its infancy. Lens choice appears to be influenced 
by convenience and availability rather than specific knowledge of their biochemistry of 
the healing process. Little is known about the interaction of specific materials with 
corneal conditions and the way in which materials can promote/inhibit the healing 
process. The importance of contact lens choice is therefore apparent when evaluating 
the effect of material on the inflammatory process. Ex vivo contact lenses worn in the 
non-compromised eye only were analysed in this work. The study may therefore be 
expanded to include contact lenses worn for bandage use in the compromised eye.  
 
3.10 Chapter Summary 
 
The aim of this work was to investigate vitronectin-mediated cell adhesion to the 
surface of ex vivo contact lenses worn in the healthy non-compromised eye. It is the 
exploitation of two specific properties of vitronectin which enabled its presence on 
hydrogel and silicone hydrogel contact lenses to be detected. Firstly, vitronectin has a 
high affinity for hydrogel materials and is not easily removed from the surface. 
Secondly, vitronectin possesses cell-binding properties. Therefore, the development and 
optimisation of a novel on-lens fibroblast cell-based assay has enabled the locus and 
distribution of vitronectin-mediated cell adhesion to be measured directly on the contact 
lens surface. The work presented here shows that the adhesive nature of vitronectin 
enables it to adsorb to a range of contact lens materials. Importantly, the influence of 
the contact lens on vitronectin deposition out of solution and from the corneal tissue bed 
was established. Vitronectin-mediated cell adhesion to contact lenses is influenced by 
material water content, ionicity and modulus. Cell adhesion was shown to be greater on 
the posterior surface than the anterior surface, and greater at the edge than at the centre 
of the lens.  
 
The technique used in this chapter can be extended to contact lenses worn in the 
compromised eye.  
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The Investigation of the Locus and Extent of 
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4.1 Aim 
 
The locus and extent of vitronectin-mediated cell adhesion to a range of contact lens 
materials worn in the non-compromised eye was studied in chapter three. Following 
these baseline experiments with the non-injured cornea, the aim of the research 
described in this chapter was to investigate the quantity and locus of vitronectin-
mediated cell adhesion to the posterior surfaces of ex vivo bandage contact lenses 
(BCLs) worn under hospital conditions. This was to provide a comparison against the 
healthy eye. Lenses in this study were worn by symptomatic subjects with various 
ocular disorders, and examined using the cell-based on-lens vitronectin assay.  
 
4.2 Introduction  
 
Principles regarding silicone hydrogel (SiHy) contact lenses for therapeutic bandage 
applications were discussed in the main introduction of this work (section 1.6). SiHy 
contact lenses with enhanced oxygen permeability allow for longer periods of wear, 
including nominally safe extended wear, in comparison to conventional hydrogel 
contact lenses [90]. This, together with the fact that SiHy contact lenses generally 
produce less protein deposition [94-96], enables SiHy contact lenses to offer advantages 
over conventional hydrogels for bandage contact lens (BCL) applications. The work 
presented in chapter three shows that vitronectin readily deposits onto SiHy contact 
lenses. This deposition on lenses can potentially result in the upregulation of plasmin. 
Tear plasmin activity has been observed in tear fluid of subjects with corneal disorders 
[122]; it was therefore logical to investigate vitronectin-mediated cell adhesion on SiHy 
BCLs worn in the compromised eye and thus potential plasmin upregulation. 
 
Many studies have investigated the efficacy of various SiHy contact lenses for 
therapeutic use [75, 80, 91, 123], in particular lotrafilcon A (Air OptixNight & Day) has 
been shown to be an effective BCL for improving the ocular condition and comfort in 
bullous keratopathy patients [91]
 
and photorefractive keratectomy patients [80].
 
However, no study has yet reported the specific interaction of contact lenses with the 
compromised corneal tissue bed in terms of deposition of biomarkers. Consequently, 
the work described in this chapter represents the first systematic attempt to understand 
this interaction, with a particular focus on the consequences of vitronectin deposition on 
BCLs. Subjects diagnosed with a variety of corneal and ocular surface disorders and 
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who required BCLs to manage these conditions were included in this work. BCLs were 
examined in the context of vitronectin-mediated cell adhesion as a mediator for plasmin 
generation. These contact lenses were assayed according to the novel on-lens assay 
technique described in chapters two and three. 
 
4.3 Methods   
 
4.3.1 Contact Lens Materials 
 
The two contact lens materials used within this controlled study were: Biofinity 
(comfilcon A- approved for seven days continuous wear) and UltraWave SiH (Filcon V 
3 - approved for four weeks continuous wear). A brief overview of each contact lens 
type is provided in Table 4.1. The full properties of each contact lens can be found in 
section 2.1.1.  
 
Table 4.1 Properties and characteristics of the two contact lens materials studied: 
Biofinity and UltraWave SiH. 
 
 
4.3.2 Study Population for Bandage Contact Lens Wearers 
 
Subjects with a variety of corneal and ocular surface disorders presenting at the 
Leicester Royal Infirmary UK (LRI) and Warwick Hospital UK (WK) who required the 
long term use of a BCL were included in this work. All subjects required a BCL in one 
eye only.  
 
The subject population comprised fifteen subjects (seven men and eight women) with 
an average age of 66±16 (range 32-86). Of this total subject population, eleven subjects 
were from Leicester Royal Infirmary UK and received a Biofinity contact lens in the 
affected eye. These subjects are referred to with a patient ID of LRI. The ocular/corneal 
conditions for these subjects included band keratopathy, bullous keratopathy, Sjögren’s 
 Contact Lens Material 
Commercial Name Biofinity UltraWave SiH 
USAN Nomenclature Comfilcon A Filcon II 3 
FDA Group I IV 
Water Content (%) 48 58 
Modulus (MPa) 0.75 0.5 
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syndrome and a corneal graft. The remaining four subjects of the total subject 
population were from Warwick Hospital and received an UltraWave SiH contact lens in 
the affected eye. These subjects are referred to with a patient ID of WK. Conditions for 
these subjects included trichiasis corneal scarring, corneal ulcers and epithelial 
disruption. Information for each patient in the study is provided in Table 4.2. This 
information is also shown as a flowchart in Figure 4.1.  BCL wear time ranged from 
one day to eight weeks depending upon the subject’s condition and individual 
requirement. No care solutions were used. Contact lenses were removed aseptically 
from the eye and stored in 0.9% saline solution at 4°C. 
 
Six healthy CL-wearers (non-compromised eye, n=6) were also included as controls to 
provide a comparison against BCL-wearers (compromised eye) and wore Biofinity 
contact lenses. Contact lenses from the non-compromised eye were worn for eight 
hours on a daily wear schedule. The same healthy contact lens wearers then wore 
Biofinity lenses on a daily wear schedule over five days. These lenses were removed 
overnight and stored in care solutions before reinsertion the following day. 
 
Figure 4.1 A flowchart to show contact lens material and clinical condition information 
for the study population of bandage contact lens wearers.  
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Table 4.2 Patient information for the subject population of bandage contact lens 
wearers (n=15).  
 
Patient 
ID 
Gender Age Corneal/Ocular 
Condition 
Contact 
Lens Type 
Wear 
Duration 
(weeks) 
Subjects from Leicester Royal Infirmary (LRI) 
LRI-1 F 63 Bullous keratopathy Biofinity 2 
LRI-2 F 78 Bullous keratopathy Biofinity 4 
LRI-3 M 76 Bullous keratopathy Biofinity 4 
LRI-4 M 63 Bullous keratopathy Biofinity 4 
LRI-5 F 60 Bullous keratopathy Biofinity 4 
LRI-6 F 83 Bullous keratopathy Biofinity 4 
LRI-7 F 64 Sjögren's syndrome Biofinity 3 
LRI-8 F 62 Sjögren's syndrome Biofinity 3 
LRI-9 F 77 Sjögren's syndrome Biofinity 6 
LRI-10 F 86 Band keratopathy Biofinity 4 
LRI-11 M 37 Post graft & corneal glue Biofinity 6 
Subjects from Warwick Hospital (WK) 
WK-1 M 73 
Trichiasis corneal 
scarring 
UltraWave 
SiH 
8 
WK-2 M 73 
Trichiasis corneal 
scarring 
UltraWave 
SiH 
8 
WK-3 M 30 Epithelial abrasion 
UltraWave 
SiH 
0.14 
WK-4 M 72 Corneal ulcer 
UltraWave 
SiH 
1.4 
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4.3.3 Assay Procedure  
 
All ex vivo contact lenses were assayed according to the on-lens cell-based vitronectin 
assay, as described fully in section 2.2.1, whereby cell attachment to the contact lens 
surface is indicative of the quantity and locus of vitronectin-mediated cell adhesion on 
the contact lens surface. 
 
4.4 A Comparison between Vitronectin-Mediated Cell Adhesion to 
ex vivo Contact Lenses Worn in the Healthy Contact Lens-
Wearing Eye and the Bandage Contact Lens-Wearing Eye  
 
4.4.1 Non-Compromised versus Compromised Eye  
 
The aim of this section was to draw an initial comparison between vitronectin-mediated 
cell adhesion to lenses worn in the healthy-CL wearing eye (contact lenses in the non-
compromised eye) versus lenses worn in the BCL-wearing eye (bandage contact lenses 
in the compromised eye).  
 
All contact lenses from the BCL study population (n=15, as defined in Figure 4.1) were 
assayed. Lenses from healthy CL-wearers (n=6) were also assayed for a comparison. 
Figure 4.2 presents an average of cell count data for five fields on the posterior surface 
of: 
 
 Biofinity BCL (n=11) 
 UltraWave SiH BCL (n=4)  
 Biofinity contact lenses in the normal lens-wearing eye (n=6)  
 
Greater vitronectin-mediated cell adhesion was detected to both BCL materials worn in 
the compromised eye (average cell count per field: Biofinity 90±5, UltraWave SiH 
78±5) in comparison to the non-compromised healthy CL-wearing eye (14±1). Various 
parameters that could contribute towards the large difference in cell adhesion seen here, 
such as duration of contact lens wear, lens material type and ocular condition, are 
studied in further depth in sections 4.5 - 4.7. 
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Figure 4.2 A comparison of cell counts on ex vivo Biofinity bandage contact lenses 
(BCLs) (n=11) and UltraWave SiH BCLs (n=4) worn in the compromised eye. Biofinity 
lenses (n=6) worn by a subgroup of healthy contact lens-wearers (CL wear) are also 
shown for comparison. 
 
4.4.2 Discussion  
 
As previously discussed in chapter three, vitronectin deposition on the contact lens 
surface is believed to arise from contact lens-tissue interaction as opposed to from the 
tear film. The results presented here suggest that vitronectin-mediated cell adhesion is 
greater on contact lenses worn in the compromised eye than on lenses worn in the non-
compromised eye (Figure 4.1). As stated in the methods section, the lenses studied here 
were not worn for the same wear duration. The BCLs were worn for up to eight weeks 
of continuous wear, whereas contact lenses for the healthy eye were worn for eight 
hours. It is, therefore, highly likely that varying wear durations contributed to the large 
difference in cell adhesion seen between contact lenses worn for bandage use in the 
healing eye and for contact lenses worn in the healthy eye. The following section aims 
to examine the effect of wear duration on vitronectin-mediated cell adhesion on BCLs 
worn in the compromised eye. 
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4.5 The Influence of Wear Duration on Vitronectin-Mediated Cell 
Adhesion  
 
4.5.1 The Effect of Wear Duration on Vitronectin-Mediated Cell Adhesion to ex 
vivo Contact Lenses Worn in the Healthy Contact Lens-Wearing Eye 
 
The effect of wear duration on vitronectin-mediated cell adhesion to contact lenses was 
investigated in the healthy CL-wearing eye (non-compromised). Biofinity contact 
lenses were worn by three healthy subjects in both eyes (n=6). Two wear schedules 
were employed: 
 
 1 day wear (n=6) - daily wear regime of eight hours. Contact lenses were worn 
for 8 hours and then removed to be stored in saline solution.  
 
 5 days wear (n=6) - five day daily wear regime. Contact lenses were worn for 
forty hours over five days. Care solutions were used to store the lenses 
overnight.  
 
Cell counts were taken over five fields on the posterior surface of each contact lens to 
give an average cell count per field. Figure 4.3 shows that overall cell adhesion levels 
were found to be significantly greater on contact lenses worn for the five day daily wear 
regime (25±1 average cell counts per field) in comparison to contact lenses worn for 
one day disposable wear (14±1 average cell counts per field). The average cell count 
per field increased from one day to five days by 44%.  
 
 
 
 
- Chapter Four - 
 
118 
 
 
Figure 4.3 Comparative average cell count data on the posterior surface of ex vivo 
Biofinity contact lenses (1 day wear schedule, n=6) and ex vivo Biofinity contact lenses 
(5 day daily wear schedule, n=6) in the healthy contact lens-wearing eye. 
 
4.5.1.1 Discussion 
 
The study of wear duration in the healthy CL-wearing eye revealed that as contact lens 
wear duration is increased from 1 day to 5 days, vitronectin-mediated cell adhesion to 
the contact lens surface also significantly increases (Figure 4.3). This shows that the 
cell adhesion detected on contact lenses worn in the healthy eye is a progressional effect 
over five days wear. In order to determine whether the same trend of increasing 
vitronectin-mediated cell adhesion levels with wear duration is observed on contact 
lenses worn in the compromised eye, the next logical step was to investigate 
vitronectin-mediated cell adhesion to ex vivo bandage contact lenses (BCLs).  
 
4.5.2 The Effect of Wear Duration on Vitronectin-Mediated Cell Adhesion to ex 
vivo Contact Lenses Worn in the Bandage Contact Lens-Wearing Eye 
 
The effect of wear duration on vitronectin-mediated cell adhesion on contact lenses was 
then investigated in the BCL-wearing eye. All Biofinity (n=11) and UltraWave SiH 
(n=4) lenses from the BCL study population described in section 4.3.2 were assayed. 
Cell counts were taken for five fields on the posterior surface of each contact lens to 
give an average cell count per field. Figure 4.4 shows the average cell count per field 
for each subject in relation to the contact lens wear duration. The shortest wear duration 
(1 day subject WK-1) showed the lowest cell adhesion. Conversely, the longest wear 
0
5
10
15
20
25
30
Biofinity 1 day wear Biofinity 5 days wear
A
v
er
a
g
e 
ce
ll
 c
o
u
n
t 
p
er
 f
ie
ld
 
Lens wear schedule 
- Chapter Four - 
 
119 
 
durations (8 weeks subjects WK-3 and WK-4) showed the highest cell counts. All BCLs 
worn after 10 days had average cell counts higher than 60.  
 
Figure 4.4 Comparative average cell count data from 5 fields for ex vivo UltraWave 
SiH bandage contact lenses (n=4) and Biofinity bandage contact lenses (n=11). Lenses 
were worn for durations ranging from 1 day daily wear to 8 weeks continuous wear. 
 
In order to determine a correlation between wear duration and cell counts, the cell count 
data from Figure 4.4 is presented in scatter form for both Biofinity and UltraWave SiH 
contact lenses (Figure 4.5). For the Biofinity contact lenses, there is a positive trend; as 
wear duration increases, the cell counts also increase (Figure 4.5A). For the UltraWave 
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SiH contact lenses, the results also show an increase in cell counts, with an apparent 
plateau effect after circa 1 week (Figure 4.5B).  
 
 
 
 
 
Figure 4.5 The effect of wear duration of bandage contact lenses on cell counts to:  
A) Biofinity lenses (n=11) and B) UltraWave SiH lenses (n=4). 
Bandage contact lenses were worn by subjects over differing wear durations ranging 
from 1 day to 8 weeks.   
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4.5.2.1 Discussion 
 
From the BCL-wearing study population (n=15), a range of Biofinity contact lenses 
(n=11) and UltraWave SiH contact lenses (n=4) were worn from one day daily wear to 
eight weeks continuous wear. One contact lens from this study (WK-1) was worn for a 
short duration of one day. Lens WK-1 showed the lowest average cell count per field of 
all the contact lenses assayed (36±2). In comparison, two BCLs worn for the maximum 
eight weeks continuous wear (WK-3 and WK-4) showed the highest average cell count 
per field (104±5 and 105±5 respectively). These results initially suggest that as wear 
duration is increased in the BCL-wearing eye, the extent of vitronectin-mediated cell 
adhesion to the contact lenses also increases, regardless of contact lens type.  
 
Further examination of the results presented in Figure 4.4 show that cell counts on two 
BCLs worn for the maximum eight weeks continuous wear (WK-3: 104±5 and WK-4: 
105±5) are comparable with BCLs worn for three weeks and four weeks. For example, 
contact lens LRI-8 was worn for three weeks continuous wear and showed an average 
cell count per field of 99±5, and contact lens LRI-8 was worn for four weeks and 
showed a comparable average cell count per field of 101±5). These results suggest that 
the intensity of vitronectin deposition from the corneal bed does not continually 
increase with time, more rather there is initially a rapid increase in deposition followed 
by an apparent plateau effect after approximately one week, as shown in Figure 4.5B. 
The sensitivity of the assay technique must also be accounted for - it is possible that 
beyond a certain period the technique may lose sensitivity. Assuming that vitronectin 
deposits in layers, it is unknown whether the technique sensitivity remains for several 
protein layers.  
 
It is known that the cornea has the ability to heal rapidly, thus it would be highly 
unusual for the healing process in the compromised eye to be active for eight weeks. 
These results suggest that the BCL serves to protect the eye from further insult rather 
than aid in healing during extended wear. On average, the cell counts seen on BCLs in 
the compromised eye are significantly higher than contact lenses worn in the regular 
non-compromised eye. BCLs in this work were worn on a longer continuous wear 
schedule than lenses worn on a daily basis in the healthy eye and therefore a direct 
comparison between lenses worn for the same wear duration in the compromised and 
non-compromised eye is required.  
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4.5.3 The Effect of Wear Duration on Vitronectin-Mediated Cell Adhesion: One 
Day Healthy CL-wearing Non-Compromised Eye versus One Day BCL-
wearing Compromised Eye 
 
Biofinity contact lenses worn in the healthy non-compromised eye (n=6) for one day 
are compared with one Biofinity contact lens worn in the BCL-wearing compromised 
eye (n=1, subject WK-1 treated for epithelial abrasion) also worn for one day. All 
contact lenses were worn for 8 hours. Cell counts were taken over five fields on the 
posterior surfaces to obtain an average cell count per field. (Figure 4.6) reveals 
significantly higher cell counts on the contact lens worn in the compromised eye (36±2) 
in comparison to cell counts on the lenses worn in the healthy non-compromised eye 
(14±1). 
 
 
Figure 4.6. A comparison of average cell counts on Biofinity contact lenses worn in the 
non-compromised eye (n=6) with a Biofinity bandage contact lens worn in the 
compromised eye (n=1). All contact lenses were worn for 8 hours. 
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4.5.3.1 Discussion 
 
In the BCL study population, the shortest duration of contact lens wear was a one day 
Biofinity lens for the management of a corneal abrasion (subject WK-1). The 
comparison of the average cell count per field on lens WK-1 (36±2) with the average 
for contact lenses worn for one day in the non-compromised eye (14±1) reveals 
significant differences. Because vitronectin deposition on the contact lens surface 
results from mechanical interaction between the contact lens and the cornea, the results 
presented in Figure 4.6 strongly suggest that vitronectin is more readily deposited on 
the contact lens posterior surface from the compromised cornea than from the non-
compromised cornea.   
 
The nature of the abrasion in subject WK-1 must be considered in greater depth. Due to 
the propensity of the corneal epithelium to heal rapidly for superficial injuries, it is 
feasible that the abrasion on the cornea partially healed during the time lapse between 
the damage to the cornea and the BCL application. Although the BCL would have 
provided instant pain relief, it would not have greatly influenced the healing process. If 
the BCL was applied immediately after the injury occurred, the extent of vitronectin 
deposition to this contact lens may potentially have been higher than the actual levels 
observed.  
 
4.5.4 The Effect of Wear Duration on Vitronectin-Mediated Cell Adhesion: Four 
Week Wear Duration  
 
A subset of the BCL study population includes five subjects who were prescribed with 
Biofinity contact lenses for the management of bullous keratopathy. All contact lenses 
(n=5) were worn for a period of four weeks continuous wear. An average cell count per 
field was obtained for the posterior surface of each lens. Figure 4.7 shows that despite 
the isolation of wear duration, contact lens type and clinical condition, the average cell 
count per field ranges largely from 64±3 to 86±4. In particular, the average cell count 
per field on the contact lens worn by patient LRI-5 (64±3) is significantly lower than 
the other four contact lenses in the same sub-group.  
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Figure 4.7 Cell count data for ex vivo Biofinity bandage contact lenses worn by five 
subjects for the management of bullous keratopathy (n=5). All lenses were worn for 
four weeks.   
 
4.5.4.1 Discussion 
 
Comparison of cell counts on BCLs of the same contact lens materials type (Biofinity), 
worn for the same wear duration (four weeks continuous wear) and clinical condition 
(bullous keratopathy) reveal significant differences between contact lenses. These 
results highlight that wear duration in the compromised eye is not the overriding 
influential factor on vitronectin-mediated cell adhesion and that the effect of ocular 
clinical condition and patient-to-patient variation must also be accounted for.   
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4.5.5 Key Points for the Influence of Wear Duration on Vitronectin-Mediated 
Cell Adhesion 
 
 In the healthy CL-wearing eye, overall vitronectin-mediated cell adhesion was 
found to be significantly greater on contact lenses worn for five days extended 
wear in comparison to contact lenses worn for one day disposable wear. This 
shows that as wear duration is increased in the non-compromised eye, the extent 
of vitronectin-mediated cell adhesion also increases.  
 
 In the BCL-wearing eye, cell adhesion appears to increase with wear duration, 
reaching a plateau after approximately 1 week, regardless of contact lens 
material type.  
 
 The comparison of contact lenses worn in the compromised eye and the non-
compromised eye reveals significant differences; it appears that vitronectin is 
more readily deposited from the impaired corneal tissue bed than the intact 
healthy corneal tissue bed.  
 
 Vitronectin-mediated cell adhesion to contact lenses varied significantly 
between bullous keratopathy subjects, despite contact lenses being worn for the 
same wear duration. This suggests that wear duration alone does not determine 
the extent of vitronectin deposition levels from the corneal tissue bed.     
 
4.6 The Influence of Contact Lens Material on Vitronectin-
Mediated Cell Adhesion in the Bandage Contact Lens-Wearing 
Eye  
 
4.6.1 Biofinity versus UltraWave SiH  
 
In chapter three it was demonstrated that the locus and extent of vitronectin-mediated 
cell adhesion is largely influenced by contact lens modulus. It was therefore logical to 
determine whether this effect is also seen with ex vivo BCLs. Two types of ex vivo 
BCLs were compared in order to investigate the influence of contact lens material type 
upon vitronectin-mediated cell adhesion. The contact lenses included Biofinity and 
UltraWave SiH.  
- Chapter Four - 
 
126 
 
Analysis of the contact lenses reveals that Biofinity with a higher modulus of 0.75 MPa 
gave a more even distribution of cell adhesion on the lens surface (1.9:1 edge:centre 
ratio), whereas UltraWave SiH with a lower modulus of 0.5 MPa shows greater cell 
adhesion at the edge (2.7:1 edge:centre ratio). Figure 4.8 shows that although both 
materials show greater vitronectin-mediated cell adhesion at the edge of the contact lens 
than at the centre as expected, there is a significant difference in the distribution over 
the lens surface. This difference in contact lens material behaviour is also demonstrated 
in Figure 4.9, where the relationship between wear duration and the edge:centre cell 
count ratio for each contact lens in this study is provided.  
 
 
 
Figure 4.8 The effect of contact lens material type on the locus of vitronectin mediated-
cell adhesion. The locus of cell adhesion (contact lens centre and lens edge) is shown 
for ex vivo Group II Biofinity bandage contact lenses (n=11) and for ex vivo Group IV 
UltraWave SiH bandage contact lenses (n=4).  
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Figure 4.9 The relationship between bandage contact lens (BCL) wear duration and the 
edge:centre cell count ratio. Data is provided for Biofinity contact lenses (n=11) and 
UltraWave SiH contact lenses (n=4). 
4.6.2 Discussion  
 
It was shown in chapter three that:  
 
 the higher the contact lens water content the higher the vitronectin-mediated cell 
adhesion (section 3.5). 
 
 the higher the contact lens modulus the lower the edge:centre cell count ratio 
(section 3.8). 
 
In this study two materials of similar water contents, but differing moduli were 
examined. Inspection of Figures 4.8 and 4.9 show that UltraWave SiH contact lenses 
(0.5 MPa) gave greater vitronectin-mediated cell adhesion at the edge of the contact 
lens than at the centre. Biofinity contact lenses (0.75 MPa) also showed greater cell 
adhesion at the edge of the lens, but in comparison to UltraWave SiH, this edge/centre 
effect was less pronounced. Increased cell adhesion at the contact lens edge may be due 
to a number of factors. Firstly, the contact lens is constantly rotating to give mechanical 
contact lens-tissue interaction with the cornea. As the eyelid moves over the anterior 
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contact lens surface, the lens edge will firstly be compressed followed by the centre. 
This contact lens-tissue interaction is greatly influenced by material modulus; the effect 
at the edge is more pronounced with lower modulus contact lenses which tend to drape 
over the cornea. Therefore, a comparison of the two materials studied shows that a 
material such as UltraWave SiH with a low modulus (0.5 MPa) is shown to have greater 
vitronectin-mediated cell adhesion at the contact lens edge. The radial movement of the 
contact lens means that the contact lens-tissue contact in rotation is greater at the 
contact lens edge than at the lens centre. As Biofinity has a higher modulus (0.75 MPa), 
the stiffer material produces more contact with the cornea at the centre of the lens. 
Secondly, progressive dehydration of any contact lens material in the eye during wear 
may affect the radius of curvature, allowing greater contact and interaction with the 
contact lens edge. This accounts for greater vitronectin-mediated cell adhesion at the 
edge, a trend which is seen throughout each assay performed.     
 
The locus of vitronectin-mediated cell adhesion on the posterior surface of the contact 
lens is significant because this will in turn influence the locus of plasmin upregulation. 
As discussed in section 3.9, vitronectin binds and stabilises plasminogen activator 
inhibitor-1 (PAI-1). The specific localised removal of vitronectin from the corneal 
tissue bed, together with PAI-1, leads to the specific localised upregulation of plasmin. 
In this work, assuming that the BCL is constantly rotating as usual during wear, plasmin 
generated at the contact lens edge is likely to be removed from the contact lens surface 
and escape into the tear film. Conversely, plasmin generated at the centre of the contact 
lens has a lower chance of removal, regardless of the extent of contact lens rotation.  
 
When comparing the two materials studied here, UltraWave SiH appears to be the 
favourable contact lens material for BCL wear because it shows less vitronectin-
mediated cell adhesion at the centre of the contact lens. This may potentially give less 
plasmin generation. In terms of mechanical properties, the advantage of a soft contact 
low modulus contact lens for therapeutic use is evident; such a material can offer 
minimal vitronectin build-up at the contact lens centre.        
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4.6.3 Key Points for the Influence of Contact Lens material Type on Vitronectin-
Mediated Cell Adhesion 
 
 Material modulus greatly influences the locus of vitronectin-mediated cell 
adhesion.  
 
 Biofinity with a higher modulus of 0.75 MPa gave a more even distribution of 
cell adhesion on the posterior surface of the lens, whereas UltraWave SiH with a 
lower modulus of 0.5 MPa gave greater vitronectin-mediated cell adhesion at 
the contact lens edge than at the lens centre.  
 
 The locus of vitronectin-mediated cell adhesion on the posterior surface of the 
contact lens may influence the locus of plasmin upregulation. 
 
4.7 A Comparison Between Vitronectin-Mediated Cell Adhesion to 
ex vivo Biofinity Contact Lenses Worn for the Management of 
Bullous Keratopathy or Sjögren’s Syndrome    
 
 4.7.1 Bullous Keratopathy versus Sjögren’s Syndrome  
 
Vitronectin-mediated cell adhesion was compared for BCLs worn for the two treatment 
of two different ocular conditions: bullous keratopathy and Sjögren’s syndrome. 
 
Bullous Keratopathy 
 
Bullous keratopathy is a condition of corneal oedema due to endothelial dysfunction. 
Impaired endothelial cells are unable to remove fluid entering the cornea at a sufficient 
rate, thus causing persistent oedema to the cornea. The epithelium separates from 
Bowman’s layer to result in areas of separation termed bullae, which are pushed 
towards the surface of the cornea to appear as fluid-filled blisters (figure 4.10). The 
bullae can rupture to cause extreme pain because of exposed nerve endings, and a 
reduction/loss of visual acuity is typically experienced. There are potentially many 
causes for bullous keratopthy, including Fuch’s endothelial dystrophy (a genetic 
disorder causing endothelial loss), infection and trauma. However, bullous keratopathy 
commonly occurs as a complication following cataract surgery or intraocular lens 
implantation; the onset of the condition is often due to endothelium trauma caused by 
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contact from the implanted intraocular lens or surgical instrumentation. The condition 
may be managed by: 
 
 surgical intervention. Procedures such as excimer laser phototherapeutic 
keractomy and penetrating keratoplasty offer treatment for bullous keratopathy. 
However, surgery is not suitable in many cases.  
 the use of hypertonic agents to reduce oedma. Sodium chloride (5%) eye drops 
or ointment can be effective in reducing oedema.  
 medications to reduce intraocular pressure. The intraocular pressure must be 
controlled to prevent further compromise to endothelial function. 
 contact lenses for bandage applications. 
 
A bandage contact lens may offer instant pain relief for patients suffering with bullous 
keratopathy. The BCL protects the exposed nerves of the bullae on the corneal surface, 
which can consequently reduce the level of pain experienced. Additionally, the BCL 
may increase visual acuity [124]. The symptoms of bullous keratopathy may also 
reduce with the use of long term BCL wear [125].   
 
Figure 4.10 Corneal oedema and the formation of bullae in bullous keratopathy [126].  
 
Sjögren’s Syndrome 
 
Sjögren’s Syndrome is a chronic autoimmune disease, which mainly affects the lacrimal 
and salivary glands, resulting in dry eyes (keratoconjunctivitis sicca) and dry mouth 
(xerostomia). The etiology of Sjögren’s Syndrome is currently unknown, but the 
condition may be classified as primary Sjögren’s Syndrome, when the condition 
develops by itself, or secondary Sjögren’s Syndrome, when the condition develops in 
association with another autoimmune disease such as rheumatoid arthritis. The intensity 
of ocular symptoms may vary from patient to patient, but include decreased tears, 
inability to tear, intolerance to light and foreign body sensation. Further ocular 
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complications also include persistent corneal infections due to irritation caused by dry 
eyes. Oral symptoms include inflammation of the oral mucosa and salivary glands, dry 
oral mucosal surfaces and dental decay. Figure 4.11 indicates how the disease can affect 
the body. Diagnosis is confirmed by physical examination and a variety of tests, such as 
the Schirmer test (described in chapter two) to determine tear production, saliva tests to 
determine the volume of saliva production and blood tests for the presence of certain 
antibodies indicative of Sjögren’s Syndrome. The condition is not curable, but topical 
eye drops and artificial saliva can help to lubricate the dry body sites. BCLs may be 
used to protect the corneal surface.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11 Possible symptoms of Sjögren’s Syndrome. 
 
 
Of the entire patient population in this study, six subjects wore Biofinity contact lenses 
for the management of bullous keratopathy (LRI-21 – LRI-6) and three subjects wore 
Biofinity contact lenses for the management of Sjögren’s syndrome (LRI-7 - LRI-9). A 
brief summary of each subject’s ocular history is provided in Table 4.3 for bullous 
keratopathy and Table 4.4 for Sjögren’s syndrome. All contact lenses were worn for a 
duration greater than 2 weeks, beyond the point at which a plateau of vitronectin-
mediated cell adhesion is reached. Additionally, the same contact lens material type 
(Biofinity) was worn in all cases. Therefore, by isolating wear duration and material 
effects, the influence of clinical condition (bullous keratopathy versus Sjögren’s 
syndrome) on vitronectin-mediated cell adhesion could be compared.  
Peripheral neuropathy 
Arthritis  
Difficulty swallowing, 
heartburn 
Dry mouth, ulcers, 
dental decay  
Dry nose, nose bleeds 
Dry eyes, corneal ulcerations, 
infections 
Dry skin 
Vaginal dryness  
Stomach upset/gastroparesis, 
abnormal liver function 
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Table 4.3 Patient information for subjects requiring Biofinity bandage contact lenses 
for the management of bullous keratopathy (BK).  
Patient 
ID 
Gender Age Ocular History 
Lens 
exchange 
every 4-6 
weeks? 
LRI-1 F 63 
Cataract surgery in 2008, leading to 
further ocular disruptions. Developed 
BK in 2010 - BCL fitted immediately. 
Yes 
 
 
LRI-2 
 
 
F 
 
 
78 
Retinal detachment surgery in 2005, 
leading to chronic inflammation in one 
eye. Developed band keratopathy in 
2009 leading to BK - BCL fitted in 
2012. 
 
 
Yes 
LRI-3 M 76 
Developed glaucoma in both eyes in 
1969, but treated surgically in 1980s.   
Cataract surgery in 2004. Developed 
BK in RE in 2004 - BCL fitted in 
2012. 
Yes 
LRI-4 M 63 
Surgery to treat corneal laceration of 
RE in 2009, leading to cataracts and 
surgery. Developed BK in 2009 - BCL 
fitted in 2013.  RE left with scarred 
cornea, amniotic membrane transplant 
and aphaikic. 
 
 
No, BCL 
management 
stopped 
LRI-5 F 60 
Chronic uveitis treated with steroids in 
1970s, leading to cataracts and 
secondary glaucoma in both eyes. 
Developed BK and corneal 
decomposition in 2007 - BCL fitted in 
2010. Registered blind. 
Yes 
LRI-6 F 83 
Cataract surgery in 2002, leading to 
ocular disruptions and retinal 
bleeding. BK in 2010 - BCL fitted 
immediately. 
Yes 
LRI, Leicester Royal Infirmary; BK, bullous keratopathy; BCL, bandage contact 
lens; RE, right eye. 
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Table 4.4 Patient information for subjects requiring Biofinity bandage contact lenses 
for the management of Sjögren’s syndrome (SS).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patient 
ID 
Gender Age Ocular History 
Schirmer 
Strip Data 
(mm/5 
minutes) 
Lens 
exchange 
every 4-6 
weeks? 
LRI-7 F 64 
Diagnosed with primary SS 
in 2002, unassociated with 
any other condition - BCL 
fitted in 2009. 
1 
 
Yes 
LRI-8 F 62 
Diagnosed with primary SS 
in 2008, unassociated with 
any other condition - BCL 
fitted in 2010. 
5 Yes 
LRI-9 F 77 
Diagnosed with rheumatoid 
arthritis in 1995 and then 
secondary SS. Developed 
glaucoma in RE 
(unconnected to SS). 
Recurring filimentary 
keratitis – BCL fitted in 2003. 
1 Yes 
LRI, Leicester Royal Infirmary; SS, Sjögren’s Syndrome; BCL, bandage contact lens; 
RE, right eye. 
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Figure 4.12 shows that vitronectin-mediated cell adhesion to the contact lenses studied 
is consistent with the trend seen thus far in terms of locus on the posterior surface of the 
lens, regardless of the clinical condition or wear duration involved. Greater cell 
adhesion was also found on the surface of contact lenses worn by Sjögren’s syndrome 
subjects (102±5) in comparison to contact lenses worn in bullous keratopathy cases 
(83±4). 
 
  
Figure 4.12 A comparison of the locus of cell adhesion on ex vivo Biofinity bandage 
contact lenses worn for the management of Sjögren’s Syndrome (n=3, contact lens 
wear duration: 3-6 weeks) and for the management of bullous keratopathy (n=6,contact 
lens wear duration: 2-4 weeks).  
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Bullous Keratopathy Subjects 
 
A breakdown of the subject data for the bullous keratopathy group reveals interesting 
observations and differences between subjects. Figure 4.13 shows the locus of cell 
adhesion on each BCL worn for bullous keratopathy management. It can be seen that 
subject-to-subject variability is relatively modest within this clinical sub-group. 
However, it is interesting to note that subject LRI-5 shows a noticeably reduced gross 
level of vitronectin-mediated cell adhesion in comparison to the other contact lenses 
analysed in this sub-group. The aggregated (centre + edge) value for all other bullous 
keratopathy subjects lies between 135 and 168 cell counts per field, whereas LRI-5 has 
a much lower aggregate value of 105, which is a statistically significant difference. 
Additionally, there does not appear to be a relationship between the edge:centre cell 
count ratio and overall vitronectin-mediated cell adhesion, as shown in Figure 4.14.  
 
 
(the key to Figures 4.13 and 4.14) 
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Figure 4.13 The locus of cell adhesion (contact lens centre and lens edge) on ex vivo 
Biofinity bandage contact lenses worn for the management of bullous keratopathy 
(n=6). Lenses were worn from 2-6 weeks. 
 
 
 
Figure 4.14  The relationship between vitronectin-mediated cell adhesion and the 
edge:centre cell count ratio for ex vivo Biofinity bandage contact lenses worn for the 
management of bullous keratopathy (n=6). 
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Sjögren’s Syndrome Subjects  
 
A comparison of vitronectin-mediated cell adhesion between subjects for the Sjögren’s 
syndrome group reveals little variability, as shown in Figure 4.15. All subjects had a 
poor tear flow and demonstrated higher levels of cell adhesion relative to the bullous 
keratopathy subjects shown in Figure 4.13. The edge:centre cell count ratios are fairly 
similar for Sjögren’s syndrome subjects LRI-7, LRI-8, and LRI-9 at 2.2:1, 1.9:1and 
2.0:1 respectively.    
 
 
Figure 4.15 The locus of cell adhesion (contact lens centre and lens edge) on ex vivo 
Biofinity bandage contact lenses worn for the management of Sjögren’s Syndrome 
(n=3). Lenses were worn from 3-6 weeks. 
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4.7.2 Discussion  
 
It has been shown that a significant difference in vitronectin-mediated cell adhesion 
exists between bullous keratopathy and Sjögren’s syndrome; there is a general 
observation that Sjögren’s syndrome subjects produce greater vitronectin-mediated cell 
adhesion to the BCL surface. Although vitronectin deposition on the lens surface arises 
from direct contact of the contact lens with the tissue bed, this difference may be 
described by the measure of the subject’s tear flow. In Sjögren’s syndrome, 
inflammation of the tear glands results in chronic dry eye. It is therefore expected for 
the tear flow to be considerably diminished or effectively non-existent in Sjögren’s 
syndrome patients. Artificial tears are used to replace natural tears and thus keep the 
cornea hydrated and lubricated. A Schirmer test, as described in section 2.2.2, is a 
simple measure of tear deficiency for patients presenting with dry eye symptoms. In 
patients with Sjögren’s syndrome, the Schirmer test is one type of test typically 
undertaken at the time of diagnosis, but it is not continually repeated during treatment 
because the tear flow is expected to deteriorate as the condition progresses. Therefore, 
successive tests to determine the tear flow levels would be unnecessary (Prof Martin 
Rubinstein, personal communication, 27
th
 November 2013). It is widely accepted that a 
Schirmer score of ≥15 mm/5 minutes is considered normal for the healthy eye, a score 
of 14-6 mm/5 minutes is mild to moderate and a score of less than 5 mm/5 minutes is 
considered severe [102]. The average Schirmer score for the Sjögren’s syndrome group 
studied here was 4mm/5 minutes, indicating that all subjects had a severely 
compromised tear flow. It seems highly likely that the deficient tear film enables greater 
contact lens-tissue mechanical interaction and, therefore, greater vitronectin deposition 
on the posterior surface of the lens. Tear flow measurements were not collected for any 
of the bullous keratopathy subjects because they did not present symptoms relating to 
dry eye and were assumed in clinic to have sufficient tear flow. The results presented 
for the bullous keratopathy group suggest that a more regular tear flow in these cases 
could enable less abrasive contact lens-tissue interaction, thus explaining one possible 
difference in vitronectin-mediated cell adhesion in comparison to the Sjögren’s 
syndrome subjects.  
 
When considering the bullous keratopathy clinical sub-group, although there is a degree 
of uniformity in cell counts within these subjects, it is possible that any variations that 
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do occur are tear flow dependant. Assuming that there was no unreported interruption in 
wear, and that contact lens fit is comparable in all cases, the data suggest that subject 
LRI-5 has a more coherent posterior tear film in comparison to the other subjects 
analysed. Potentially, tear flow measurements could be beneficial for all long term BCL 
wearers, to include bullous keratopathy patients, and not just for dry eye or Sjögren’s 
syndrome patients. It is apparent that the condition of the tear flow may affect 
vitronectin-mediated cell adhesion and overall vitronectin deposition, which is then 
likely to affect plasmin upregulation in a sequential process.  
 
It is evident from the subject histories detailed in Tables 4.2 and 4.3 that in several of 
these cases the first instance of BCL application occurred many years after the initial 
clinical diagnosis. For instance, subject LRI-4 was diagnosed with bullous keratopathy 
in 2007, but was fitted with a BCL four years later. This may be due to the advances of 
contact lens materials for extended wear. Due to the propensity of the cornea to heal 
rapidly, it is unlikely for any of the corneas in these cases to have been in an actively 
healing state at the time of the first BCL insertion. It appears that the BCL does not aid 
the healing process in such cases, as ascertained in experiments investigating wear 
duration in section 4.5, and the tear film plays a protective role in conjunction with the 
BCL device. An adequate tear flow is therefore imperative in order to sustain the 
healthy corneal surface. Nevertheless, the BCL serves in other roles, such as mechanical 
protection from eyelid blinking, pain relief, maintaining corneal hydration and the 
protection from other injuries. It is accepted that regular contact lens wearers with a low 
tear flow find contact lens wear to be difficult; this factor should be taken into 
consideration when selecting an appropriate contact lens material. The choice of BCL 
material is ever more vital in patients requiring the long term use of contact lenses for 
the management of conditions such as Sjögren’s syndrome and may influence the 
success and outcome of BCL wear.      
 
4.7.3 Key Points – Bullous Keratopathy versus Sjögren’s Syndrome 
 
 Greater vitronectin-mediated cell adhesion was observed to contact lenses worn 
in Sjögren’s syndrome cases in comparison to bullous keratopathy cases. All 
Sjögren’s syndrome subjects exhibited a poor tear flow.  
 
- Chapter Four - 
 
140 
 
 Vitronectin deposition on the contact lens surface arises from contact lens-tissue 
mechanical interaction. It appears that the deficient tear film enables greater 
interaction and, therefore, greater vitronectin deposition on the posterior surface 
of the lens. 
 
 The substantivity of the tear flow may affect vitronectin deposition and in turn 
affect plasmin upregulation.  
 
4.8 Concluding Discussion  
 
From the work described in this chapter it is evident that vitronectin, an extremely 
adhesive glycoprotein, adheres strongly to the BCL posterior surface. It is often argued 
that SiHy materials minimise protein adsorption, but due to the “sticky” nature of 
vitronectin, this protein has been detected on ex vivo BCLs. The development of a novel 
on-lens cell-based assay rather than an extraction technique has enabled this detection. 
The consequences of vitronectin deposition and the potential effect of plasmin 
upregulation in the compromised eye must not be overlooked.    
 
In this study comparisons were drawn between vitronectin-mediated cell adhesion on 
contact lenses worn in the non-compromised eye and compromised eye. It was 
demonstrated in chapter three that vitronectin deposition on contact lenses results from 
the mechanical interaction of the contact lens with the cornea. Evidence presented from 
the study in this chapter strongly suggests that vitronectin is more readily deposited 
from the impaired corneal surface than from the healthy intact cornea. Additionally, the 
contact lens material type has a significant influence on the locus of vitronectin-
mediated cell adhesion; lower modulus contact lenses deposit greater levels of cell 
adhesion at the edge of the lens.  
 
Furthermore, comparisons between vitronectin-mediated cell adhesion on contact lenses 
worn for bullous keratopathy and contact lenses worn for Sjögren’s syndrome were 
made by isolating material variation and wear period. A measurable overall difference 
in the levels of cell adhesion was observed and these appear to be associated with the 
nature of the tear flow. It is important to note that these levels of vitronectin-mediated 
cell adhesion are high in comparison to those of contact lens wear in the healthy eye. 
The recognised link between contact lens wear and plasmin generation means that 
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increased vitronectin may result in greater plasmin levels. The success of a BCL for the 
management of Sjögren’s syndrome in particular appears to be dependent upon the tear 
flow of the contact lens wearer. Greater success and comfort with a contact lens may be 
achieved if it is more suited to the wearer’s tear film. As a result, addressing the state of 
the tear flow first and improving the lubrication of the eye as a whole may reduce 
vitronectin build up on the contact lens surface. A contact lens material with a more 
useful ability to sustain a sufficient tear flow would be useful. It is arguable that some 
contact lenses are viewed as more favourable for dry eye patients than others. Currently 
the only contact lens available with a clinical indication for dry eye is Proclear, with a 
maximum wear time of thirty days, but it is not frequently selected as a bandage lens 
(Prof Martin Rubinstein, personal communication, 27
th
 November 2013). There is 
clearly a shortfall in appropriate contact lens materials which can potentially minimise 
vitronectin deposition during extended periods of wear.  
 
Plasmin is the key component of the plasminogen activator system, and is also involved 
in the degradation of the extracellular matrix and plasma proteins during pathological 
processes. Although plasmin activity is essential to the inflammation process, a balance 
is required to prevent the negative effects of plasmin over activity. The centre and edge 
of the lens, depending upon material mechanical properties, have different levels of 
vitronectin sorption. If plasmin generation is a progressive effect of vitronectin removal 
from the corneal tissue bed, these mechanical properties of the contact lens will 
determine the extent of active plasmin accumulation in the eye. As links between 
increased tear plasmin activity and corneal disease, due to contact lens wear or trauma, 
have been reported [122], and over activity of plasmin has been shown to inhibit wound 
healing, the upregulation of plasmin is potentially a considerable problem in the 
compromised eye. The majority of subjects studied in this chapter were non-surgical 
cases, thus the presence of active plasmin would be unlikely to adversely inhibit the 
healing process because the corneal wound would have healed by the time of the first 
BCL insertion. Nevertheless, the disturbed cornea is undoubtedly in a compromised 
state and understanding what is occurring behind the contact lens is vitally important 
for the ocular health of the subject. There is also the possibility of plasmin interaction 
with the cornea to generate more vitronectin, resulting in further corneal compromise.      
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In this study, BCLs were supplied by two hospitals. The selection of a BCL should 
ideally be dependent upon the type of corneal defect presented by a subject and the 
nature of their ocular health. It appears that the choice of Biofinity and UltraWave SiH 
contact lenses for therapeutic uses, however, was influenced by convenience and 
availability rather than specific knowledge of their healing capacity or suitability for 
each individual subject. The Biofinity or UltraWave SiH BCLs studied in this chapter 
were worn from between one day to eight weeks of continuous extended wear. Biofinity 
has a recommended wear duration of just seven days, thus it is highly abnormal that 
contact lenses harvested for this work were worn excessively beyond this period. It may 
be argued that the reasonable oxygen permeability of Biofinity (128 Dk) justifies 
exceeding the recommended wear duration of seven days. The lower oxygen 
permeability of UltraWave SiH (86 Dk), however, is comparable to that of conventional 
hydrogel materials. Hence, the risk of continuous wear for over thirty days as worn by 
some UltraWave SiH subjects appears to be irrational. The impact of this upon the 
compromised eye must be taken into account when selecting a contact lens material. In 
particular, consideration should be given to what is specifically required from the BCL 
in terms of protein interaction. From the majority of cases studied here, it is evident that 
the BCL is required as a protective corneal shield for extended wear use rather than to 
aid healing. Vitronectin deposition on the contact lens is inevitable due to its strong 
affinity for contact lens surface. The contact lens most certainly has a protective power, 
but is not biomimetic, thus it is able to remove vitronectin from the corneal tissue site. 
The “best” contact lens material choice would provide minimal interaction with the 
cornea, resulting in less vitronectin deposited central to the cornea and less vitronectin 
deposition overall. Deposition is influenced greatly by material modulus and a lower 
modulus material has been shown to minimise vitronectin deposition.  
 
This work has shown that levels of vitronectin-mediated cell adhesion to the posterior 
contact lens surface are higher in persistent BCL wear in comparison to healthy contact 
lens-wear. It appears that contact lens manufacturers are generally more concerned with 
the anterior surface of the lens, in terms of movement of the eyelid and initial comfort 
for example, rather than the posterior contact lens surface. However, understanding 
posterior surface interactions is as equally important if we are to consider the health of 
the cornea in persistent contact lens wearers. The link between plasmin and contact lens 
wear means that there is a strong argument that the design of specific BCLs with greater 
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ocular compatibility and lower levels of vitronectin deposition appears to be an 
excellent target for maintaining the ocular health of long term BCL wearers. 
 
4.9 Chapter Summary  
 
Following baseline experiments in chapter three, the aim of this chapter was to 
investigate the quantity and locus of vitronectin-mediated cell adhesion to the posterior 
surfaces of ex vivo bandage contact lenses (BCLs) worn in the compromised eye. 
Optimisation of the on-lens cell-based assay technique is undoubtedly an important 
method to investigate the interaction of a contact lens biomaterial with the 
compromised cornea. The findings presented in this work reveal that vitronectin-
mediated cell adhesion is significantly influenced by: 
 
 wear duration: in the non-compromised eye, cell adhesion increases with wear 
duration of a five day period. In the compromised eye, adhesion increases with 
wear duration until it reaches a plateau at approximately one week. 
 
 contact lens material modulus: a higher contact lens modulus will give a lower 
centre:edge cell count ratio (i.e. a more even distribution over the contact lens 
surface), whereas a lower lens modulus will give a higher centre:edge cell count 
ratio (i.e. a more vitronectin-mediated cell adhesion at the edge of the contact 
lens that at the centre).  
 
 clinical condition and nature of the patient’s tear film: where the tear film is 
severely low in volume, contact lens-corneal interaction will be increased and, 
therefore, may result in greater levels of vitronectin-mediated cell adhesion.  
 
The consequences of deposition in the BCL wearing eye in terms of potential plasmin 
upregulation must not be overlooked.            
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CHAPTER FIVE 
Surface and Mechanical Properties of Skin Adhesive 
Wound Healing Materials 
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5.1 Aim 
Chapters three and four demonstrated how mechanical interactions of the contact lens 
with the cornea can stimulate a biochemical response to potentially generate an 
upregulation of plasmin. In a similar manner, the success of a dermal wound dressing 
material lies in its surface and mechanical properties. The work presented in this 
chapter focusses on the biophysical properties of human skin and the corresponding 
properties of skin adhesive materials used in medical devices, such as wound dressings 
and ostomy devices, which are designed to function in direct contact with breached and 
unbreached skin. The important properties that directly influence behaviour of the skin 
adhesive interface, that include the mechanical properties (static and dynamic moduli) 
and surface properties of both skin and adhesive, are investigated.  
5.2 Introduction 
 
There are many studies that investigate the efficacy of skin adhesive wound healing 
materials for medical device applications in acute/chronic dermal wound and ulcer 
environments. The vast majority of these studies focus on the comparison of adhesive 
materials for the management of wounds [127-129], for the efficacy of materials on 
wound healing rates [130], and for the comparison of materials for fluid management 
and retention [131, 132]. In an industry where an extensive range of skin adhesive 
materials are available, such studies enable a platform for appropriate material 
selection. For example, Thomas and Loveless [131] compared twelve commercial 
hydrocolloid dressings in order to distinguish between performance in fluid handling, 
fluid retention, moisture vapour permeability and conformation. The authors found 
significant differences between these properties for different dressings that initially 
appear to be similar in appearance and function, and thus proposed a grading system to 
enable effective dressing selection.  
 
Although studies that critically compare adhesive materials provide an essential basis 
for material selection, a review of the literature shows that there is very little known 
regarding the biophysical properties of skin adhesive wound dressings and the direct 
impact that these properties have upon material performance. The important properties 
that will directly influence behaviour of the skin adhesive interface are the surface 
energies and mechanical properties of skin adhesive materials. This chapter recognises 
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the fact that there is a gap in information within this field and consequently addresses 
the important biophysical properties of human skin and the corresponding biomaterials 
(skin adhesive wound dressings and ostomy devices) that function with skin. These 
biomaterials have direct contact with skin and act as a physically protective barrier 
against the external environment, thus biocompatibility with skin is a primary 
requirement. As with any biomaterial, the surface and interfacial behaviour of skin 
adhesive materials governs their biocompatibility with the host body site. To promote a 
compatible skin adhesive interface, the synthetic adhesive material should ideally 
possess similar surface properties to that of the skin surface. Therefore, the first stage of 
this investigation was to study the surface properties of a range of skin adhesive 
materials.  
 
5.3 Materials  
 
5.3.1 Skin Adhesive Materials 
 
5.3.1.1 Overview of Skin Adhesive Materials   
 
The skin adhesive materials studied in this chapter are listed in section 2.1.2 and are of 
three sorts; adhesive hydrocolloids, adhesive hydrogels and medical tapes. For the 
purpose of the investigations carried out in this chapter, these materials may then be 
grouped further to give five groups, with twelve variables in total:  
 
 Salts Hydrocolloid Adhesives for wound dressings (n=4) 
 ConvaTec Hydrocolloid Adhesives wound dressings (n=2) 
 Commercial Hydrocolloid Adhesives for ostomy devices (n=2) 
 Aston hydrogels synthesised in-house (n=2) 
 Commercial Medical Tapes  (n=2) 
 
Table 5.1 provides a brief overview of the five skin adhesive material groups used 
within this chapter. A description of each adhesive material is provided in the following 
sub-sections. Compositions of adhesives are detailed where available.  
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Table 5.1 Five skin adhesive material groups used for investigations. 
 
Product Type Material Name/Code 
Salts Hydrocolloid Adhesives 
S1 
S2 
S3 
S4 
ConvaTec Hydrocolloid 
Adhesives 
Granuflex 
Duoderm Extra Thin 
Ostomy Hydrocolloid 
Adhesives 
Coloplast ostomy 
ConvaTec ostomy 
Aston Hydrogel Adhesives 
Hydrogel 1 
Hydrogel 2 
Commercial Medical Tapes 
3M microporous tape 
Boots microporous tape 
 
 
5.3.1.2 Hydrocolloids 
 
Hydrocolloids are absorptive, occlusive and generally adhesive materials. They 
typically consist of sodium carboxymethyl cellulose (NaCMC) for absorptive and fluid 
management properties, poly(isobutylene) (PIB) for the provision of an adhesive 
matrix, and gelatine and pectin which act as ‘gum-like’ gel forming agents [54]. Thus, 
hydrocolloids may be described as a continuous phase of PIB with a particulate 
dispersed phase of NaCMC, gelatine and pectin. The structure of each hydrocolloid 
component and the overall properties and functions of the material are provided in 
(section 1.4.3 – Skin Adhesive Hydrocolloids).  
 
The application of hydrocolloids in biomaterials may be classified for two purposes. 
Firstly, hydrocolloids may be fabricated for skin adhesive wound dressings. These 
materials are able to absorb low to moderate levels of wound exudate by undergoing a 
phase inversion to form a hydrophilic gel. This hydrophilic gel supports a moist wound 
environment and the occlusive nature of the material aids autolytic debridement. The 
absorptive capacity of the material is determined by its composition. Secondly, 
hydrocolloids may be used for ostomy devices. These medical devices are designed to 
collect discharged bodily waste through a surgically created ostomy. A more detailed 
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description of the function of ostomy devices can be found in section 1.4.3. Ostomy 
devices consist of two components; a pouch or bag that collects fluid discharged from 
the body and an adhesive component that adheres to the peri-ostomy area. The 
adhesive, commonly referred to as a skin barrier or wafer, is typically a hydrocolloid 
material. Devices are available as a one-piece system, in which the pouch and wafer are 
attached together to form one unit, or devices are available as two-piece system, in 
which the pouch and wafer are detachable.   
 
Table 5.2 Compositions of the Salts Hydrocolloid Adhesives group for wound 
PIB, poly(isobutylene); CMC, carboxymethyl cellulose. 
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2) ConvaTec Hydrocolloid Adhesives* - Two hydrocolloid adhesives for wound 
dressings were purchased from ConvaTec UK. ConvaTec is a competitor 
manufacturer to Salts Healthcare and one of the leaders of wound care and ostomy 
products. Granuflex and Duoderm were selected as two leading hydrocolloid 
adhesives products for comparison against the Salts Healthcare Adhesives. Both 
examples of the ConvaTec Hydrocolloid Adhesives were supplied with paper 
release liners on the adhesive surface.  
 
- Granuflex 
- Duoderm Extra Thin 
 
3) Ostomy Hydrocolloid Adhesives* – Hydrocolloid adhesives for ostomy devices 
were purchased from two leading commercial manufacturers – Coloplast ostomy 
from Coloplast and ConvaTec ostomy from ConvaTec. Both ostomy adhesives 
were supplied with paper release liners on the adhesive surface. 
 
- Coloplast ostomy 
- ConvaTec ostomy 
 
*The compositions of the ConvaTec Hydrocolloid Adhesives and Ostomy Hydrocolloid 
Adhesives were not available from the manufacturers. The compositions of commercial 
skin adhesive materials are generally not advertised with the products. The adhesives 
chosen for this work were selected as examples of leading products in the market.    
 
5.3.1.3 Hydrogels 
 
Hydrogel are networks of cross-linked water-swollen polymers [51]. Hydrogel 
adhesives are used in many biomedical applications such as bioelectrodes and 
transdermal drug-delivery patches. However, the ability of adhesive hydrogels to absorb 
fluid makes them ideal for skin adhesive wound dressing applications. Additionally, 
absorptive hydrogels are able to maintain a moist wound healing environment by 
providing moisture to the wound.  
 
The hydrogel skin adhesive materials studied in these investigations were synthesised 
in-house. Two materials of different compositions were prepared – Hydrogel 1 and 
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Hydrogel 2. The full protocol for the preparation of these two materials is provided in 
section 2.2.3. The compositions of each hydrogel material are provided in Table 5.3.  
 
Table 5.3 Compositions of skin adhesive hydrogels synthesised in-house: Hydrogel 1 
and Hydrogel 2. 
 Hydrogel 1 Hydrogel 2 
Distilled Water (g) 1.1 10.0 
Glycerol (g) 30.0 30.0 
NaAMPs (g) 68.9 40.0 
SPA (g) 0.0 20.0 
Photoinitiator/cross 
linker mixture (g) 
0.25 0.25 
NaAMPs, 2-acrylamido-2-methyl-1-propanesulfonic acid, sodium salt, 50% wt 
solution in water; SPA, 3-sulfopropyl acrylate, potassium salt. 
 
5.3.1.4 Medical Tapes   
 
Medical tapes, or surgical tapes, are designed to secure a wound dressing to the peri-
wound area. Such tapes are known as pressure sensitive adhesives because they form a 
bond with a substrate when applied with pressure. Activation by heat, solvent or water 
is not required. A typical medical tape is made of a thin sheet of polymer, such as 
poly(ethylene terephthalate), coated with an adhesive. The majority of tapes currently 
available are made from microporous materials.   
 
Two commercial brands of medical tape were purchased for the investigations in this 
chapter:  
- 3M Microporous Tape 
- Boots  Microporous Tape 
 
5.3.2 Release Liner Materials  
 
The skin adhesive hydrocolloid and hydrogel materials described in section 5.3.1 all 
require the use of release liner materials. Release liners provide effective release from 
an adhesive substrate. They are either paper or plastic based, of which one side is 
coated with a release agent. Silicon derivatives, such as poly(dimethylsiloxane), are 
commonly used as release agents. The structure of poly(dimethylsiloxane) is provided 
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in Figure 5.1. Release agents serve numerous functions, from the initial time of 
formulation of the adhesive, to up until the application of the adhesive to skin. During 
the formulation stage, temporary liners are applied to the adhesive materials in order to 
transport the adhesives from process to process. The temporary liner prevents the 
adhesive surface from adhering to other surfaces. Liners may be applied and removed 
several times during the formulation stage. The adhesive is then fabricated into a 
biomaterial device, such as a wound dressing or ostomy device. After the device 
fabrication, a permanent liner is applied to the adhesive, which protects the surface of 
the device during storage. This permanent liner is only removed from the adhesive 
immediately before the device is to be applied.  
 
Paper and plastic release liners with siliconised surfaces were supplied by Salts 
Healthcare. For the purpose of this work the paper release liner is referred to as RL1-
paper and the plastic release liner is referred to as RL2-plastic.  
          
 
Figure 5.1 The structure of poly(dimethylsiloxane). 
 
 
5.4 Surface Properties of Skin Adhesive Materials  
 
5.4.1 Surface Energy Measurements for a Range of Skin Adhesive Materials 
 
Surface energy (SE) measurements were taken for a range of skin adhesive materials, as 
listed in Table 5.1. All adhesives had different compositions, with the exception of Salts 
Adhesive Hydrocolloids S1 and S3 (refer to Table 5.2 for Salts Adhesive Hydrocolloid 
compositions).   
 
SE measurements were taken for each adhesive material using the sessile drop 
technique. This technique is commonly used to evaluate the surface free energy of a 
solid by contact angle measurements. The full protocol for the technique, which used 
GBX Digidrop instrumentation, can be found in section 2.2.4. The release liner was 
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removed from the adhesive immediately before measurements were taken. Five contact 
angle measurements were taken for each adhesive material to provide an average SE. 
An average SE for each adhesive group was then calculated.  
 
From Table 5.4 it can be observed that there are significant differences in SE between 
the groups of materials. The Ostomy Hydrocolloid Adhesives group and Salts 
Hydrocolloid Adhesives group exhibited similar average SEs (21.3 mNm
-1 
and 23.8 
mNm
-1
), whereas the ConvaTec Hydrocolloid Adhesives group in comparison gave a 
significantly higher average SE (33.6 mNm
-1
). The in-house Aston Hydrogel Adhesives 
group had an average SE of 29.5 mNm
-1
.     
 
Table 5.4 Average surface energy measurements (derived from contact angle 
measurements with water and diiodomethane probe liquids) for a range of commercial 
and non-commercial skin adhesive materials.  
Skin Adhesive 
Material 
Av. Contact 
Angle (°)  
Water 
Av. Contact 
Angle (°)  
Diiodomethane 
Av. Surface 
Energy (mNm
-1
) 
Ostomy Hydrocolloid 
Adhesives n=2 
90.6  77.9  21.3 (±0.1) 
Salts Hydrocolloid 
Adhesives n=4 
94.0  69.4  23.8 (±7.6) 
Aston Hydrogel 
adhesives n=2 
92.1  58.6  29.5 (±3.5) 
ConvaTec Hydrocolloid 
Adhesives n=2 
101.7  52.5  33.6 (±0.4) 
 
5.4.1.1  Discussion  
 
The sessile drop technique measures the contact angle formed between a probe liquid 
and substrate. Measurements enable the SE of the substrate to be determined. In order 
to evaluate the SE values of the hydrocolloid skin adhesive materials in Table 5.4, the 
structure of hydrocolloids must be considered. A typical hydrocolloid consists of a 
mixture of sodium carboxymethylcellulose (NaCMC), gelatine and pectin particles 
dispersed in a matrix of poly(isobutylene) (PIB). Figure 5.2 shows a representation of 
the particle dispersion within the polymer matrix.  
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Figure 5.2 A representation of the hydrocolloid system. 
 
The NaCMC, gelatine and pectin particles are embedded within the PIB matrix, thus the 
presence of these particles at the surface of the hydrocolloid is generally low. PIB forms 
the supporting polymer matrix and thus it is generally the most visible component at the 
surface in terms of SE. Therefore, the SE of a hydrocolloid is governed by the SE of 
PIB. The SE of PIB is approximately 33 mNm
-1 
[133].  
 
From the initial SE values of the various adhesive groups in Table 5.4, it can be 
observed that the ConvaTec Hydrocolloid Adhesives group gave on average a SE value 
of 33.6 mNm
-1
, which is comparable to the SE of PIB (33 mNm
-1
). This suggests that 
the PIB component of the ConvaTec Hydrocolloid Adhesives is unmodified at the 
adhesive surface. However, the Salts Hydrocolloid Adhesives group and the Ostomy 
Hydrocolloid Adhesives group gave on average lower SEs  (23.8 mNm
-1 
and 21.3 
mNm
-1
 respectively) in comparison to the ConvaTec Hydrocolloid Adhesives group 
(33.6 mNm
-1
). It is plausible that the surfaces of the Salts Hydrocolloid Adhesives and 
Ostomy Hydrocolloid Adhesives were contaminated with an agent that could lower the 
SE of these adhesives by such a considerable extent. One obvious candidate is 
contamination from the siliconised release liners. The SE of silicone oil is 
approximately 21 mNm
-1 
(value measured in lab). A low SE is an essential requirement 
for a release agent in order to prevent it from adhering to the substrate, which in this 
case is the hydrocolloid adhesive.  
 
It was observed that the difference between the adhesives with high SEs and the 
adhesives with low SEs was possibly due to the choice of release liner applied to the 
adhesives. The Ostomy Hydrocolloid Adhesives group and two adhesives from the 
 
 
 
Polyisobutylene 
Sodium carboxymethylcellulose 
Gelatine 
Pectin 
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Salts Hydrocolloid Adhesives group with plastic release liners had ‘low’ SEs, whereas 
the ConvaTec Hydrocolloid Adhesives group with ‘high’ SEs were supplied with paper 
release liners. Because the choice of release liner appears to have some influence on the 
SE of the adhesive surface, it was therefore rational to further investigate these liner 
materials, which were provided by Salts Healthcare. 
 
5.4.2 A Comparison Between Release Liners and Their Effect on Hydrocolloid 
Adhesive Surface Properties – Paper versus Plastic 
 
Two types of siliconised release liners (as described in section 5.3.2) form the basis of 
this investigation:  
 
 Salts paper release liner: RL1-paper 
 Salts plastic release liner: RL2-plastic 
 
Surface energy (SE) measurements of both samples, prior to application to hydrocolloid 
adhesives, were taken by the sessile drop technique (described in chapter two). 
Measurements were taken five times for each surface to obtain an average SE value. 
Both sides of the liners, to include the contact (siliconised surface) and the non-contact 
side (non-siliconised surface), were assessed to determine any differences between the 
opposing surfaces.  
 
Table 5.5 reveals that both RL1-paper and RL2-plastic showed similar SEs for the 
contact sides (15.3 mNm
-1 
and 18.2 mNm
-1 
respectively). Similarly, the SE values for 
the non-contact sides of RL1-paper and RL2-plastic were also of the same order (31.7 
mNm
-1 
and 38.4 mNm
-1 
respectively). It is important to note that the SEs for the contact 
sides of both the paper and plastic release liners are comparable. Although both release 
liner materials are of different substrates, the contact sides for both liners are coated 
with silicone to provide non-adherent surfaces. Therefore, the high (>30 mNm
-1
) SEs 
for the contact side of the release liners are lowered (<20 mNm
-1
) when the surfaces are 
coated with silicone.       
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Table 5.5 Surface energy values for the contact side and non-contact side of release 
liners RL1-paper and RL2-plastic before application to adhesives.  
  
Surface RL1-paper RL2-plastic 
Prior to liner application: 
Surface energy of  
release liner – non-contact side (mNm-1) 
31.7 (±1.6) 38.4 (±1.9) 
Prior to liner application:  
Surface energy of  
release liner – contact side (mNm-1) 
15.3 (±2.8) 18.2 (±3.9) 
 
   
In order to determine whether the release liner material type influences the surface 
properties of the adhesives that they are applied to, two Salts Hydrocolloid Adhesives 
with the same composition, but with different release liners were compared (S1 and 
S3). The compositions of S1 and S3 were detailed in Table 5.2 in section 5.3.1 of this 
chapter. Table 5.6 reveals clear differences between the two adhesives; S1 with a paper 
release liner had a SE value of 29.9 mNm
-1
, whereas adhesive S3 with a plastic release 
liner had a statistically lower SE of 16.8 mNm. These results suggest that silicone is 
transferred from the Salts plastic release liner to the adhesive, but not from the Salts 
plastic release liner to the adhesive.   
 
Table 5.6 A comparison between surface energy values of two Salts Hydrocolloid 
Adhesives with the same composition, but different release liner materials: S1 and S3. 
 
Material Av. Surface Energy (mNm
-1
) 
Adhesive S1 with release liner removed 
Paper release liner removed from S1 
29.9 (±1.8) 
19.9 (±4.8) 
Adhesive S3 with release liner removed 
Plastic release liner removed from S3 
16.8 (±5.1) 
23.7 (±4.5) 
 
 
5.4.2.1 Discussion  
 
Initial measurements for a range of hydrocolloid adhesives in section 5.4.1 suggested 
that the release liner material may influence the SE of the adhesive surface. This 
speculation was investigated further by taking measurements of the liner materials prior 
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to application to adhesives. Analysis of both sides of the paper and plastic release liner 
materials showed that both release liners had similar SEs for the contact side.  
 
In order to determine whether the liner material influences the surface properties of 
adhesives, a direct comparison was made between two adhesives of the same 
composition, but with different liners (S1 and S3). This comparison between adhesives 
S1 and S3 showed that although both adhesives were of the same composition, adhesive 
S3 with the plastic liner had a significantly lower SE adhesive S1 with the paper liner. 
These results strongly suggest that the plastic release liner transfer silicone to the 
adhesive during adhesive-liner contact and, therefore, lowers the SE of the adhesive 
closer to that of silicone oil (approximately 21 mNm
-1
). Conversely, silicone transfer 
from the paper release liner to the adhesive material appears to have a minimal effect, if 
any at all. Before fully considering the implications of any possible silicone transfer, it 
was rational to confirm the presence of silicon on the adhesive surfaces. This was 
performed by X-ray photoelectron spectroscopy, as reported in the following section.        
 
5.4.3 Quantifying Silicon on the Adhesive Surface – X-Ray Photoelectron 
Spectroscopy 
 
X-ray photoelectron spectroscopy (XPS) was adopted as a sensitive spectroscopic 
technique for the detection of silicon on specific regions of four different Salts 
Hydrocolloid Adhesives materials; S1, S2, S3 and S4. The full protocol for XPS 
methodology can be found in section 2.2.5. The release liners were removed from the 
four individual adhesives prior to analysis, and both the liners and the adhesives were 
analysed. Additionally, a Salts paper release liner (RL1-paper) and a Salts plastic 
release liner (RL2-plastic), which had not been applied to adhesives, were analysed 
separately as reference points. Table 5.7 provides the percentage of each element 
detected at the surface of materials from the spectroscopy analysis. Carbon was the 
main element detected on all materials, ranging from 45.8% to 98.4%. Oxygen was 
detected on the surface of all materials, ranging from 1% to 25.6%. Silicon was also 
detected on all material surfaces, but the value detected was dependent upon the 
material type. Nitrogen was detected on adhesives S3 and S4 at 0.2 and 0.3% 
respectively, whereas sodium was only detected on adhesive S4 at 0.2%. The 
spectroscopic analysis did not detect calcium on the surface of any material.  
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Figure 5.3 shows the lower levels of silicon detected on the surface of adhesives S1 and 
S2 after siliconised paper release liners had been removed. This is in contrast to the 
higher levels of silicon detected on the surfaces of adhesives S3 and S4 after siliconised 
plastic release liners had been removed. Figure 5.4 shows silicon detected on surface of 
the release liners removed from the corresponding adhesives.  
 
Table 5.7 Photoelectron spectroscopy results for the detection of silicon on the surface 
of Salts Hydrocolloid Adhesives (S1-S4) after the release liners are removed. Values for 
the paper (RL1) and plastic (RL2) release liners are also provided. 
 
 
 
 
 % Element Detected 
Material Carbon Oxygen Silicon Nitrogen Sodium Calcium 
Paper liner on S1 45.8 25.4 28.9 - - - 
S1 adhesive 98.4 1.0 0.7 - - - 
Paper liner on S2 46.8 25.1 28.0 - - - 
S2 adhesive 97.0 1.8 1.2 - - - 
Plastic liner on S3 48.6 25.6 25.8 - - - 
S3 adhesive 79.3 12.0 8.6 0.2 - - 
Plastic liner on S4 49.4 24.9 25.7 - - - 
S4 adhesive 78.5 13.0 8.1 0.3 0.2 - 
RL1 (paper liner) 69.1 6.6 24.3 - - - 
RL2 (plastic liner) 48.6 25.1 26.3 - - - 
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Figure 5.3 Silicon detected on the surface of adhesives S1 and S2 that had paper 
release liners and of Salts Hydrocolloid Adhesives S3 and S4 that had plastic release 
liners. 
 
 
 
Figure 5.4 Silicon detected on the surface of paper and plastic release liners removed 
from Salts Hydrocolloid Adhesives.  
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The results revealed: 
 
 similar levels of silicon were detected on the contact sides of the release liners 
RL1-paper and the RL2-plastic at 24.3% and 26.3% respectively. Comparable 
levels of silicon on both release liners were to be expected because both the 
paper and plastic liners were coated with silicone for its use as a release agent.  
 
 similar silicon levels were detected for both the paper (28.9% and 28.0%) and 
plastic (25.8% and 25.7%) release liners that were in contact with adhesives and 
then removed. 
 
 a significant difference in the silicon levels on adhesives with different release 
liners. Adhesives with paper release liners (S1 and S2) had lower levels of 
silicon on the surfaces (0.70% and 1.20% respectively) in comparison to 
adhesives with plastic release liners (S3 and S4) which had significantly higher 
levels of silicon detection in comparison (8.60% and 8.10% respectively).   
 
 the levels of silicon detected on the paper release liners after contact with 
adhesives increased from 24.30% to 28.45%. This may be due to disturbance of 
the silicon monolayer on the liner surface.  
 
The results show that silicone transfer from plastic release liners is significantly higher 
than from paper release liners.    
 
5.4.3.1 Discussion  
 
XPS was performed on Salts Hydrocolloid Adhesives (S1-S4) and Salts liner materials 
(RL1-paper and RL2-plastic) to detect silicon on the material surfaces. Table 5.7 shows 
that the technique successfully verified on average higher levels of silicon on the 
surface of two hydrocolloid adhesives with Salts plastic release liners (8.6% and 8.1%), 
in great contrast to hydrocolloid adhesives with Salts paper release liners (0.7% and 
1.2%).  
 
A large difference between transfer of silicone from the paper and plastic release liners 
to the adhesives is clearly apparent from Table 5.7; both liners have a similar silicon 
surface composition, yet the plastic release liner transfers approximately three times as 
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much silicone to the adhesive surface than the paper alternative. The transfer of silicone 
from a release liner to the hydrocolloid surface is not entirely a surprising phenomenon. 
The SE of silicone oil is approximately 21 mNm
-1
 and the SE of poly(isobutylene) 
(PIB) at the surface of the hydrocolloid adhesive is approximately 33 mNm
-1
. When a 
liquid has a lower SE than the substrate, the liquid will spread over or ‘wet’ the surface 
[51]. From the findings in this investigation, it is evident that silicon from the release 
liner surface with a lower SE than PIB spreads over the PIB surface of the hydrocolloid. 
Silicon transfer from liner to adhesive is dependent upon contact adhesion – silicon will 
only transfer at points of adhesive-liner contact. This factor is influenced by the 
properties of the release liner materials. In particular, the two liner materials studied 
here have different surfaces. For instance, the siliconised fibrous paper release liner has 
a porous surface. The silicon is bound to the fibres of the porous surface and is unlikely 
to detach easily, which results in less effective contact transfer. Conversely, the 
siliconised plastic release liner possesses a smooth regular surface, whereby contact 
with the adhesive enables high silicon transfer. Silicone is known for its spreading 
behaviour, and it is likely to spread to form a thin molecular monolayer on the plastic 
liner surface. The extent of adhesive siliconisation by either liner material may also be 
affected by storage conditions to include time, temperature and pressure.  
 
The results presented suggest that the paper liner has a significant advantage over the 
plastic liner in relation to transfer of silicon to the adhesive. In turn this could affect the 
surface properties of the adhesive and potentially affect other factors such as the peel 
strength or adhesivity of the adhesive material.   
       
5.4.4 Removal of Silicone from the Adhesive Surface 
 
Surface energy (SE) measurements for Salts Hydrocolloid Adhesives, which had not 
been in contact with release liners, would have proved valuable for this investigation. 
However, due to the nature of the manufacturing process, adhesives are only available 
with the release liners already applied. Therefore, attempts were made to remove the 
silicone detected from the surface of Salts Hydrocolloid Adhesives in order to obtain 
more accurate SE measurements for the adhesive materials. Two Salts Hydrocolloid 
Adhesives, S1 and S3, were treated with acetone immediately after the release liners 
had been removed with the purpose to eradicate any silicone from the surfaces. This 
was performed by blotting 1cm
2
 adhesive samples with acetone for 1 minute. Table 5.8 
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shows that the treatment of adhesive S3 with acetone increased the SE measurement by 
27%, whereas the treatment of adhesive S1 with acetone showed only a 0.5% increase 
in SE.  
 
Table 5.8 Surface energy values for Salts Hydrocolloid Adhesives S1 and S3, before 
and after the treatment of acetone to remove silicone from the adhesive surfaces.  
 
 
5.4.4.1 Discussion  
 
Following the detection of silicon on the surface of adhesive materials by X-ray 
photoelectron spectroscopy (XPS) in section 5.4.3, attempts were made to remove the 
silicone by the treatment of adhesive surfaces with acetone. Adhesive S3, which had 
8.60% levels of silicon detected on its surface by XPS, saw a large increase in SE of 
29% following acetone treatment. This SE after acetone treatment is more 
representative of the surface properties of the adhesive before it had been influenced by 
the siliconised plastic release liner and of PIB (with a SE of approximately 33 (mNm
-1
) 
at the hydrocolloid adhesive. In contrast, adhesive S1 saw just a 0.5% increase in SE. 
This small increase was to be expected as the adhesive had a significantly low level of 
silicon detection on the surface of 0.7% by XPS. 
 
5.4.5 Key Points for the Surface Properties of Skin Adhesive Materials  
 
 Silicon was detected by X-ray photoelectron spectroscopy on the surface of 
hydrocolloid adhesives, thus verifying that silicone is transferred from the 
release liner to the adhesive by direct contact. This ‘siliconisation’ of the 
adhesive is dependent upon the nature of the release liner material; plastic 
release liners transfer significant levels of silicone to the adhesive surface, 
whereas paper release liners in comparison transfer small quantities of silicone, 
if any at all.   
 
Adhesive 
Initial Surface 
Energy (mNm
-1
) 
Surface Energy 
After Acetone 
Treatment (mNm
-1
) 
% Increase in SE 
S1 29.9 (±1.8) 30.05 (±5.5) 0.5% 
S3 16.8 (±5.1) 21.4 (±5.3) 27% 
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 Silicone transfer by liner-adhesive contact has a direct effect upon the surface 
energy of the adhesive surface, regardless of the adhesive composition.  
 
    Paper release liner materials do not alter the surface energy of the adhesive. The 
SE of the adhesive remains unchanged and correlates to the SE of PIB 
(approximately 33 mNm
-1
).  Conversely, siliconisation by plastic release liner 
materials lowers the surface energy of the adhesive closer to that of silicone 
rubber (approximately 21 mNm
-1
).   
 
   The findings from this investigation suggest that the siliconised paper release 
liner is a favourable material liner choice in comparison to the plastic release 
liner. Although both release liner materials have silicone coated surfaces, the 
surface of the porous paper liner does not transfer silicone as effectively as the 
smooth plastic surface. Therefore, the paper release liner does not significantly 
change the SE of the skin adhesive wound care products.  
 
    The altered surface properties of the hydrocolloid adhesive materials in contact 
with plastic release liners could potentially affect material performance in terms 
of adhesivity. Materials are required to provide adherence upon application and 
for the duration of wear. Factors that could potentially affect adhesivity, such as 
silicone on the adhesive surface, could have implications for overall material 
performance. The adhesive properties of the materials studied thus far shall be 
investigated in the following sections.  
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5.5 Peel Strength Analysis of Skin Adhesive Materials 
 
5.5.1 Peel Strength Measurements of Skin Adhesive Wound Dressing and 
Medical Tape Materials  
 
Chapter two described peel strength tests as a method for adhesive strength assessment 
and an indication of the effectiveness of removal from skin. Peel tests on selected skin 
adhesives, outlined in Table 5.1, were performed. The peel test method described in 
section 2.2.6 was used to determine any correlation between the adhesive strength and 
the surface properties of materials recorded in the previous section 5.4. Measurements 
were performed for all materials at 90° and 180° on a steel substrate and at 90° on 
unbreached skin of a healthy volunteer, whereby the test site was the forearm. Each 
material was tested in triplicate.  
 
The results for each adhesive material are provided in Table 5.9. Of all materials tested 
on skin, both Hydrogel 1 and Hydrogel 2 adhesives showed the highest maximum force 
(9.77 and 9.61 N) and peel strength (0.29 and 0.25 N/25mm) required to remove from 
the test substrates. The measurements for the 180° steel test on the two hydrogel 
materials exceeded the 10N force limit. The Commercial Medical Tapes (3M and 
Boots) showed the lowest maximum force (1.89 and 0.93 N) and peel strength (0.05 
and 0.04 N/25mm). The Commercial Ostomy Hydrocolloid Adhesives, Salts 
Hydrocolloid Adhesives and ConvaTec Hydrocolloid Adhesives all showed comparable 
data.  
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Table 5.9 Peel strength measurements of skin adhesive wound dressings and medical 
tapes at 90° and 180° on steel and skin test substrates.    
 
Adhesive Material 
Angle (°) 
and Surface 
Av. Max. Force (N) 
Av. Peel 
Strength 
(N/25mm) 
Coloplast Ostomy 
90 Steel 
180 Steel 
90 Skin 
2.80  (±0.12) 
4.84  (±0.57) 
1.70  (±0.23) 
0.11  (±0.01) 
0.19  (±0.02) 
0.07  (±0.01) 
ConvaTec Ostomy 
90 Steel 
180 Steel 
90 Skin 
2.66  (±0.24) 
4.52  (±0.59) 
1.51  (±0.16) 
0.10  (±0.01) 
0.19  (±0.02) 
0.07  (±0.01) 
Salts Hydrocolloid 
S1 
90 Steel 
180 Steel 
90 Skin 
2.22  (±0.27) 
4.74  (±0.50) 
1.76  (±0.57) 
0.12  (±0.01) 
0.22  (±0.05) 
0.07 (±0.01) 
Salts Hydrocolloid 
S3 
90 Steel 
180 Steel 
90 Skin 
3.64  (±0.20) 
4.27  (±0.44) 
1.93  (±0.61) 
0.15 (±0.01) 
0.17 (±0.03) 
0.08 (±5.5) 
Granuflex 
90 Steel 
180 Steel 
90 Skin 
3.49  (±0.11) 
4.43  (±0.41) 
2.65  (±0.32) 
0.14  (±0.01) 
0.59 (±0.06) 
0.11 (±0.01) 
Duoderm Extra Thin 
90 Steel 
180 Steel 
90 Skin 
2.77  (±0.38) 
4.84  (±0.82) 
2.13 (±0.67) 
0.11 (±0.01) 
0.19 (±0.02) 
0.09  (±0.01) 
Hydrogel 1 
90 Steel 
180 Steel 
90 Skin 
9.82 (±0.15) 
>10 
9.77  (±0.24) 
0.39  (±0.03) 
>10 
0.29  (±0.1) 
Hydrogel 2 
90 Steel 
180 Steel 
90 Skin 
9.86  (±0.12) 
>10 
9.61 (±0.15) 
0.39  (±0.02) 
>10 
0.25  (±0.05) 
3M Microporous 
Tape 
90 Steel 
180 Steel 
90 Skin 
0.87  (±0.12) 
2.60 (±0.30) 
1.89  (±0.35) 
0.03  (±0.01) 
0.10  (±0.02) 
0.05  (±0.01) 
Boots Microporous 
Tape 
90 Steel 
180 Steel 
90 Skin 
1.78  (±0.19) 
3.66  (±0.44) 
0.93 (±0.30) 
0.07 (±0.01) 
0.15 (±0.02) 
0.04  (±0.01) 
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Figure 5.5 shows a typical trace generated from the peel test method. The trace was 
obtained from the peel test of Coloplast Ostomy at 90° on a skin test substrate. The 
maximum force of peel strength after an extension of 9.4 mm can be read at 1.6 N. 
Additionally, the average maximum force of peel strength data for each adhesive 
material tested at 90° and 180° on a steel substrate and at 90° on skin is shown in Figure 
5.6.       
 
 
 
Figure 5.5 The peel strength trace for Coloplast Ostomy at 90° on a skin test substrate, 
showing the maximum force of peel strength at 1.6 N.  
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Figure 5.6 Average maximum forces of peel strength (N) for various skin adhesive 
materials for three substrates - 90° skin, 90° steel and 180° steel.  
 
5.5.1.1 Discussion 
 
From Figure 5.6 it can generally be seen that a strong correlation does not exist between 
the 90° and 180° peel tests on steel - the maximum force required to peel adhesives 
from steel at 180° was always greater than the force required at 90° on the same steel 
substrate, but not always by a factor of two. There also does not appear to be a 
significant correlation between 90° tests on steel and skin. In all cases the skin 
measurements at 90° were lower than equivalent measurements on steel, but not by a 
measurable factor. The correlation must, therefore, depend upon numerous factors, such 
as nature of the adhesive, adhesive composition and adhesive thickness. Consequently, 
peel strengths for adhesive removal from skin cannot be predicted directly from 
measurements made on steel.     
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5.5.2 Pain Scores for Skin Adhesive Wound Dressing and Medical Tape 
Materials  
 
Peel tests were performed on human skin and therefore a pain scale was also devised to 
determine any possible correlation between peel strength of the adhesives and pain 
caused from removal. For each test material, the volunteer was asked to score the 
material based on three categories: pain/discomfort, redness and residue left on skin 
after removal of adhesive from the forearm. Each category was scored from one to five, 
with one being the least painful/red and five being the most painful/red. The scores for 
each material were then totalled to provide an overall pain score, as shown in Table 
5.10, together with the peel strength data. It must be noted that pain is a completely 
subjective experience and therefore the pain scores in Table 5.10 are subjective data 
The Aston Hydrogel Adhesives were scored as the most painful (scores of 11/15) with 
redness and bruising occurring immediately after the tests. The Commercial Medical 
Tapes had the next highest scores (2.5/15 and 4/15), whereas the remainder of the 
hydrocolloid materials all scored less than 2/15.  
 
Table 5.10 Pain scores for skin adhesive wound dressing and medical tape materials. 
 
Adhesive 
Pain 
/5 
Redness 
/5 
Residue 
/5 
Overall Score 
/15 
Coloplast Ostomy 0 0 0.5 0.5 
ConvaTec Ostomy 0 0 0.5 0.5 
Salts Hydrocolloid S1 1 0 0.5 1.5 
Salts Hydrocolloid S3 1 0 0.5 1.5 
Granuflex 1 0 0.5 1.5 
Duoderm Extra Thin 1 0 0 1 
Hydrogel 1 5 4 2 11 
Hydrogel 2 5 4 2 11 
3M Microporous Tape 0.5 2 0 2.5 
Boots Microporous Tape 1 3 0 4 
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5.5.3 Correlations Between Adhesive Peel Strengths, Pain Scores and Surface 
Energies 
 
Table 5.11 shows collated data for the peel tests, pain scales and surface energy tests. 
Little correlation was found between the surface energies of adhesives and their 
respective peel strengths. For example, adhesive S1 (high SE of 28.5 mNm
-1
) had a 
comparable average peel strength per width of 0.07 N with adhesive S3 (low SE 19.6 
mNm
-1
) with an average peel strength per width of 0.08 N. However, it can be seen that 
the higher the peel strength, the higher the overall pain score (Figure 5.7). Hydrogel 1, 
which was the most painful adhesive to remove from skin (pain score of 11/15), also 
showed the highest average maximum force (9.77 N) and the highest average peel 
strength per width (0.29 N). Conversely, Coloplast Ostomy device was the least painful 
to remove of all materials tested (pain score of 0.5/15) and had the lowest average 
maximum force (0.07 N) and lowest average peel strength per width (0.29 N).  
 
Table 5.11 The correlation between adhesive peel strengths on skin at 90°, 
corresponding pain scores and surface energy data. 
 Peel Tests Pain Scale 
Surface 
Tests 
Adhesive 
Av. Max. 
Force 
(N) 
Av. Peel 
Strength 
(N/25mm) 
Overall 
Pain Score 
/15 
Surface 
Energy 
(mNm
-1
) 
Coloplast Ostomy 
1.70 (±0.23) 
 
0.07 (±0.01) 0.5 21.4 (±0.1) 
ConvaTec Ostomy 1.51 (±0.16) 0.07 (±0.01) 0.5 21.2 (±0.1) 
Salts Hydrocolloid S1 1.76 (±0.57) 0.07 (±0.01) 1.5 29.9 (±1.8) 
Salts Hydrocolloid S3 1.93 (±0.61) 0.08 (±0.01) 1.5 16.8 (±5.1) 
Granuflex 
2.65 (±0.32) 
 
0.11 (±0.01) 1.5 36.3 (±0.4) 
Duoderm Extra Thin 
2.13 (±0.67) 
 
0.09 (±0.01) 1 36.8 (±0.4) 
Hydrogel 1 
9.77 (±0.24) 
 
0.29 (±0.01) 11 27.0 (±3.5) 
Hydrogel 2 
9.61 (±0.15) 
 
0.25 (±0.05) 11 32.0 (±3.5) 
3M Microporous Tape 1.93 (±0.35) 0.11 (±0.35) 2.5 22.3 (±5.2) 
Boots Microporous Tape 1.89 (±0.30) 0.09 (±0.30) 4 24.1 (±5.7) 
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Figure 5.7 The relationship between maximum force of peel strength (N) and pain 
scores. 
5.5.3.1 Discussion 
 
The Aston adhesive hydrogel materials caused the most pain upon removal from skin. 
These materials also showed the highest peel strengths. From Figure 5.7 it generally 
appears that pain is related to the average maximum force measurements – the higher 
the maximum force, the higher the pain experienced. Many adhesives with a maximum 
force of around 2 N varied in pain from scores of 1/15 to 4/15.  
 
Additionally, these peel tests were also carried out to determine whether siliconisation 
of the adhesives by adhesive-release liner contact affected the adhesive strength. This 
was not found to be the case, with little correlation between the two properties. The peel 
tests in this work were performed as part of an idealised system on the forearm skin of a 
healthy volunteer. The skin was cleaned with methanol before and after adhesive 
application. However, in real life applications, skin adhesives are required to function at 
different body sites. Adhesives are applied to the outer layer of skin – the statum 
corneum of the epidermal layer. The stratum corneun consists of corneocytes and 
extracellular lipid membranes (ceramides, cholesterol and free fatty acids), that together 
build the barrier function of skin. The surface of skin varies at different parts of the 
body and also from person-to-person. The lipid composition of skin will, therefore, also 
vary from person-to-person. Because lipids and silicone are miscible, a high lipid 
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composition has the potential to detach silicone from the surface of the adhesive 
material. The in vitro peel tests were performed under idealised conditions and no 
correlation was found with peel measurements. In real life systems, however, the lipid 
composition of skin has the potential to interact with silicone on adhesive material 
surfaces and affect material performance in terms of adhesion.  
 
5.5.4 Key Points for the Peel Strength Analysis of Skin Adhesive Materials  
 
 Peel strength measurements on a steel substrate cannot be used effectively to 
predict values on skin. Thickness and adhesive composition must also be 
considered.  
 
 The maximum force measurements during peel tests may contribute to the ‘pain 
factor’ experienced in the removal of adhesives from skin (rather than peel 
strength per width values). The results suggest that the higher the maximum 
force, the higher the pain experienced. 
 
 Although silicone was detected on the surface of hydrocolloid adhesives, this 
contaminant does not appear to affect peel strength measurements under 
laboratory conditions. The influence of silicone on the adhesive material surface 
in real life applications, however, has the potential to affect adhesion between 
the adhesive and skin host site. Skin with a high lipid composition may detach 
silicone from the adhesive surface more easily than skin with a low lipid 
composition.   
 
5.6 Tensile Strength Analysis of Skin Adhesive Materials  
 
5.6.1 Tensile Strength Measurements of Skin Adhesive Wound Dressing and  
 Medical Tape Materials  
 
The function of skin adhesive wound dressings is to provide an adhesive and absorbent 
material of sufficient tensile strength. Tensile measurements were taken for the skin 
adhesive materials listed in Table 5.1 according to the mechanical testing method as 
described in section 2.27. The Commercial Medical Tapes group and Aston Hydrogel 
Adhesives were not tested because the material widths were insufficient to provide 
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samples sizes consistent with the testing protocol. All release liners from the contact 
side of the samples were peeled off and all woven backings were removed from the 
non-contact side of the samples prior to testing. All samples were repeated in triplicate. 
Table 5.12 reveals that the Commercial Hydrocolloid Adhesives Granuflex and 
Duoderm had the highest tensile strengths of all materials tested at 0.76 and 0.90 MPa 
respectively. The tensile strengths of Coloplast ostomy and ConvaTec ostomy were 
slightly lower at 0.68 and 0.59 MPa. In comparison, the Salts Hydrocolloid Adhesives 
S1 and S3 had extremely low tensile strengths at 0.04 and 0.03 MPa respectively.  
 
Table 5.12 Tensile strength measurements for a range of skin adhesive materials. 
 
5.6.1.1  Discussion 
 
The results for the Salts Hydrocolloid Adhesives S1 and S3 from Table 5.12 may 
initially seem erroneous because these results indicate that the materials have an 
extremely low tensile strength. However, the extremely low values may be described by 
the sample treatment prior to testing. Adhesive S1 and S3 were supplied with woven 
backings on the non-contact sides of the adhesives. These were removed by blotting 
with acetone before the tensile strength tests were conducted in order to gain accurate 
measurements for the hydrocolloid adhesives without any backing support. However, 
without the woven backing, adhesives S1 and S3 were extremely difficult to handle. It 
was observed that these two adhesives broke immediately in the grips of the tensometer 
Adhesive 
Av. 
Thickness 
(mm) without 
release liner 
Av. 
Elongation 
at Breaking 
Point (%) 
Av. Initial 
Modulus 
(MPa) 
Av. Tensile 
Strength 
(MPa) 
Coloplast Ostomy 1.64 87 (±16) 0.56 (±0.06) 0.68 (±0.14) 
ConvaTec Ostomy 1.63 88 (±15) 0.54 (±0.05) 0.59 (±0.12) 
Salts  Hydrocolloid S1 0.93 15 (±5) 0.04 (±0.01) 0.04 (±0.02) 
Salts  Hydrocolloid S3 1.08 13 (±4) 0.05 (±0.01) 
0.03 (±0.02) 
 
Granuflex 1.64 100 (±24) 0.96 (±0.1) 0.76 (±0.15) 
Duoderm Extra Thin 0.51 97 (±25) 1.18 (±0.1) 0.90 (±0.18) 
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machine when a force was applied. In comparison, the commercial materials Granuflex 
and Duoderm, and ostomy materials, Coloplast and ConvaTec, were not supplied with a 
woven backing. These materials were observably easier to handle.   
 
The tensile properties of a hydrocolloid adhesive material cannot be correlated to the 
surface properties of the material. Mechanical testing studies the bulk properties of the 
material. In an isotropic hydrocolloid system, the bulk consists of a dispersed phase of 
particles within a continuous phase of poly(isobutylene). Therefore, the surface is 
different to the bulk.     
 
In these mechanical tests, materials were tested in their unhydrated form. The 
assessment of materials once partially and fully hydrated, however, would provide 
better indication for material performance at the exuding wound site. It would then be 
useful to perform wet tensile tests. A suitable wound fluid model, to mimic the moist 
wound environment, would prove useful for such testing conditions.     
      
5.6.2 Key Points for the Tensile Analysis of Skin Adhesive Materials  
 
 Accurate tensile measurements of adhesives S1 and S3 could not be carried out 
because of the woven backings applied to the materials during the 
manufacturing process. In contrast, tensile testing for commercial hydrocolloids 
for wound and ostomy applications without woven backings was successful.  
 
 Tensile measurements cannot be related to surface properties of hydrocolloid 
materials due to the nature of their formulation.  
 
 Wet tensile testing of materials may be a useful method to assess material 
tensile behaviour in their hydrated forms.   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
5.7 Dynamic Testing of Skin Adhesive Materials 
 
5.7.1 Rheology Measurements of Skin Adhesive Wound Dressing and Medical  
 Tape Materials  
 
Section 2.2.8 described the importance of rheological properties, such as elasticity and 
viscoelasticity, for the characterisation of adhesive materials. The elastic modulus (G') 
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describes the ability of a material to return to its original undeformed state after a 
deforming stress is applied and removed. The viscous modulus (G'') describes the 
resistance of a material to being deformed. 
 
Rheology measurements were taken for the range of skin adhesive materials listed in 
Table 5.1, with the exception of Salts Adhesives S2 and S4 and the Commercial 
Medical Tapes which were not tested. A Bohlin CVO Rheometer was used according to 
the method described in chapter two. For each dry adhesive sample, the viscous 
modulus, elastic modulus and tan δ (where tan δ = viscous modulus/elastic modulus) 
were recorded. Table 5.13 reveals that the tan δ values for the hydrocolloid materials 
fall in the range of between 0.65-0.80. The hydrogel adhesives, however, exhibited the 
lowest tan δ values of the adhesives studied (Hydrogel 1 – 0.38 and Hydrogel 2 - 0.25).  
 
Figure 5.8 presents the relationship between tan δ values and the maximum force of 
peel strength (N) from the peel strength data in section 5.5. It can observed that the 
hydrogel adhesives with a tan δ value below 0.6 had a high maximum force of removal 
(greater than 9 N), whereas hydrocolloid adhesives with a tan δ value greater than 0.6 
had a low maximum force of removal (less than 3 N).   
   
 
 
Figure 5.8 The relationship between tan δ and the maximum force of peel strength (N). 
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Table 5.13 Rheological measurements for skin adhesive materials tested at 0.5-25 Hz.   
 
Adhesive 
Material 
 
G' 
Elastic Modulus 
(MPa) 
G'' 
Viscous Modulus 
(MPa) 
tan δ 
(viscous/elastic) 
Coloplast Ostomy 0.75 0.49 0.65 
ConvaTec 
Ostomy 
0.74 0.48 0.65 
S1 0.34 0.24 0.71 
S3 0.31 0.20 0.65 
Granuflex 0.42 0.28 0.67 
Duoderm Extra 
Thin 
0.15 0.12 
 
0.80 
 
Hydrogel 1 1.830 0.69 0.38 
Hydrogel 2 2.644 0.66 0.25 
 
 
5.7.1.1 Discussion   
 
Table 5.13 shows the elastic modulus and viscous modulus for the range of skin 
adhesive materials. The two hydrogel materials, Hydrogel 1 and Hydrogel 2 exhibited 
the highest viscous moduli (0.694 and 0.661 MPa respectively). A relatively high 
viscous modulus equates to relatively high rigidity – a rigid adhesive material may be 
less comfortable than a lower modulus more flexible material. Such rheological tests 
may also be made on hydrogel contact lens materials. Although contact lenses are 
designed for application to one bodily site only, skin adhesive wound dressing materials 
may be applied to various skin sites. High viscosity may, therefore, restrict a material in 
performance at different host sites. Ideally a skin adhesive material should have a high 
modulus upon application and a low modulus upon removal.    
 
From the elastic modulus and viscous modulus measurements, the tangent of the phase 
shift (tan δ) values can be evaluated. The tan δ describes the ratio of viscous modulus to 
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elastic modulus, where tan δ = viscous modulus/elastic modulus. Tan δ values below a 
certain value indicate ‘solid-like’ behaviour, whereas values above this value indicate 
more viscous ‘liquid-like’ behaviour. From the above data it can be observed that the 
majority of materials tested had tan δ values of approximately 0.65. The exceptions to 
this were Hydrogel 1 and Hydrogel 2 with lower values of 0.38 and 0.25. From the peel 
strength data and pain scores in section 5.5, it was noted that these hydrogels had 
significantly higher maximum peel forces and pain scores in comparison to the 
commercial and non-commercial hydrocolloids tested. Therefore, it may be suggested 
that materials with tan δ values lower than 0.6, such as the hydrogels, have high 
maximum forces of peel removal and thus cause the most pain to detach.  
 
5.7.2 Key Points for the Dynamic Testing of Skin Adhesive Materials  
 
 All hydrocolloid skin adhesives studied gave tan δ values of ~0.65.  
 
 The hydrogel skin adhesives tested gave tan values of ~0.3. These hydrogels had 
extremely high peel strengths and were the most painful to remove from skin.  
 
  tan δ values below ~0.6 may correlate with the maximum force of peel removal.  
 
5.8 Concluding Discussion 
 
The aim of this chapter was to study the properties of skin adhesive materials used in 
wound healing applications in relation to the biophysical properties of skin. The focus 
of this work was principally on the properties of hydrogel and hydrocolloid skin 
adhesives for wound applications, and hydrocolloid adhesives for ostomy devices, 
which are applied directly to breached skin.  
 
It was shown that inadvertent modifications to the surface properties of adhesive 
hydrocolloids have the potential to affect the material performance. In particular, the 
comparison of two hydrocolloid adhesives (S1 and S3) revealed considerable 
differences in surface properties. Both adhesives, from different batches, have the same 
hydrocolloid composition and were manufactured by the same company, process and at 
similar processing times. It was shown that the choice of release liner material, has the 
ability to alter the surface energy of the material – the siliconised plastic release liner 
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transferred silicone to the S3 adhesive surface by adhesive-liner contact during storage, 
whereas the siliconised paper release liner performed as a more inert material on 
adhesive S1. The transfer of silicone by the plastic release liner was shown to 
significantly lower the surface energy of adhesive S3. In contrast the surface properties 
of adhesive S1 remained unchanged.  
 
The measure of bulk properties shows that material properties are interdependent. Best 
success of a material may be achieved if mechanical properties are above a certain 
minimum, rather than the material exceeding in one test alone. The surface and 
mechanical properties of skin adhesive wound dressing materials is not a widely studied 
area, but investigations into these properties demonstrate how they can influence 
behaviour of the skin-adhesive interface. Although in vivo work is always the final 
testing point for materials that are designed to come into contact with biological tissue, 
it is not always possible to examine in vivo all aspects of material behaviour. The gross 
functionality of the material, that includes all of the material properties, is important.  
 
The difficulty in the design of an ideal adhesive wound dressing materials most 
certainly lies in the variability of skin. The surface and mechanical properties of skin 
vary widely depending upon numerous factors which include: the location of the body, 
the treatment or washing of skin, the texture and age of skin, the lipid or moisture 
content, and general patient-to-patient variation. Table 5.14 highlights the variable 
surface properties of skin under different conditions. It can be noted that the surface 
energies vary largely from 25.3 mNm
-1 
to 57 mNm
-1
 depending upon the temperature, 
relative humidity and treatment of skin.    
 
Table 5.14 Surface properties of human skin [51].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 Surface Energy (mNm
-1
) 
Human skin 
(23°C, 34% relative humidity) 
38 
Human skin 
(36°C, 50% relative humidity) 
57 
Human skin (untreated) 38.9 
Human skin (cleaned) 25.3 
Human skin (high lipid) 42 
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Consequently, a ‘one size fits all’ dressing, such as a hydrogel, hydrocolloid or ostomy 
product, must therefore function over a range of properties and interact with complex 
biological fluids. Hydrocolloids, which consist of gelatine/pectin, 
carboxymethylcellulose and poly(isobutylene) components, are suitable for this purpose 
because the composition results in extremely responsive materials. Hydrocolloids are 
unique in that not only can they adhere to unbreached clean dry skin, they can also 
provide adequate adherence to moist surfaces, such as the wound bed environment, thus 
covering a range of substrate surface properties.  
 
Tests in this chapter were performed on various adhesive materials as received; they 
had not been in contact with breached or unbreached skin. During application, however, 
the adhesive materials come into contact with skin under different conditions. Elements 
such as skin moisture, sweat, lipid content and dirt, for example, can affect material 
performance. These materials used in contact with biological tissue do not have one 
single purpose. Accordingly, the applications considered within this thesis involve the 
material in multiple purposes – skin adhesive wound dressings must be protective, 
occlusive and provide adherence to the wound/peri-wound area. Perhaps a more 
substantial point of interest is that materials are designed to absorb and manage wound 
fluid, often in large volumes, from exuding wounds. Just as the study of surface and 
mechanical properties of materials is beneficial to further understanding of material 
behaviour, the study of material interactions with wound fluid is also a valuable field. 
Because the actual wound environment is extremely difficult or impractical to study, 
the design of an artificial wound fluid model would be ideal to investigate material 
interactions with the dermal wound.  
 
5.8 Chapter Summary 
 
There is clearly a gap within the literature for information on the surface and 
mechanical properties of skin adhesive materials for wound applications. This chapter 
used various techniques, including surface energy probes, peel testing, tensile testing 
and dynamic testing to investigate the surface and bulk properties of materials. One 
major finding of this work was that the siliconised release liner applied to adhesives 
during the fabrication process affects the surface properties of the adhesive. Greater 
silicone levels were detected on the surface of skin adhesives after contact with plastic 
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release liners than after contact with paper release liners. Although this finding did not 
correlate with peel test measurements under laboratory conditions, the implications of 
silicone on the adhesive material surface could potentially affect material and 
adhesivity performance in real life applications. The peel testing and mechanical testing 
of adhesive materials showed that materials do not perform to their maximum ability in 
every test. It appears that it is better for a material to exhibit the minimum values in a 
range of tests (peel, tensile, dynamic), rather than exceed in one particular area.    
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CHAPTER SIX 
Towards the Design of an Artificial Wound Fluid 
Model 
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6.1 Aim 
 
The eye provides an excellent site to examine specific interactions between a synthetic 
biomaterial (the contact lens) and a complex biological fluid (tear fluid). Chapters three 
and four of this thesis have shown that a cell-based technique to determine the 
interaction between the non-compromised eye/contact lens and the compromised 
eye/bandage contact lens have proved successful. Access to acute and chronic dermal 
wounds, however, is far more challenging because of ethical considerations. The 
concept for the development of synthetic biological wound fluid models is attractive in 
order to facilitate biochemical interaction studies. The aim of this chapter was to work 
towards considerations for the design of a standard chronic wound fluid model. The use 
of such a model provides a rational basis to aid material design and selection, and 
further the understanding of biomaterials-related processes that influence dermal wound 
healing. In addition, this chapter is concerned with the interaction of biological fluids 
with materials used for wound healing applications.   
 
6.2 Introduction 
 
Section 1.2 of this thesis introduced the analogy between the ocular wound healing and 
dermal wound healing environments. In summary, the human cornea shares several 
structural and biochemical similarities to the moist dermal wound bed environment. 
Specific comparisons may be drawn between: the cornea and wound bed, tear fluid and 
wound fluid, and contact lens materials and wound dressing materials.  
 
Tear fluid          Wound fluid 
   Cornea           Wound bed 
                             Bandage contact lens            Wound dressing 
    
Tear fluid/Wound fluid: The natural tear film is the liquid layer that bathes the surface 
of the cornea. It consists of three distinct layers shown in Figure 6.1; the overlying lipid 
layer prevents evaporation of the tear film; the intermediate aqueous layer forms 98% 
of the fluid and contains proteins, electrolytes, and metabolites; and the mucous layer 
anchors the tear film to the underlying epithelial cells of the cornea [67]. A more 
comprehensive description of each layer of the tear film can be found in the main 
introduction of this thesis (section 1.5.1.2). Wound fluid, or wound exudate, is produced 
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after injury in all wounds as an inflammatory response. Originating from blood plasma, 
the fluid may vary in colour, consistency and odour. Comparisons may be drawn 
between tear fluid and wound fluid. Both are complex biological fluids that contain 
proteins, electrolytes, proteases and growth factors.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1 Cross-section of the tear film. 
 
The interaction between the tear film and a contact lens results in protein and lipid 
deposition onto the contact lens surface, which in turn affects contact lens material 
performance. Likewise, the tear film is also affected as it is denuded of vital 
biochemical components which are deposited on the lens. In order to study the 
compositional changes of the tear fluid, tear sampling methods such as microcapillary, 
Schirmer strip and microsponges can be used to collect the fluid. Tear sampling 
methods are generally considered to be non-invasive and pose few ethical concerns. 
However, whereas the eye is easily accessible and the collection of tear fluid is a 
reasonably straightforward task, sampling of wound fluid from the wound bed is far 
more complicated. Accessing the wound may be difficult and aspiration of fluid from 
beneath dressings is difficult [134]. Additionally ethical considerations must be taken 
into account for in vivo human studies. Various collection techniques exist for wound 
fluid collection which include: aspiration with a syringe from under an occlusive 
dressing, blunt end glass capillaries, closed suction drains and extraction from swabs. 
However, although there are many collection techniques available, there is a lack of a 
single standardised collection procedure.  
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Cornea/Wound bed: The tear film provides optical, lubricant and protective functions to 
the underlying cornea. Should, however, the tear film fail in severe cases of dry eye, the 
cornea may keratinise to give a dry skin-like structure. The damaged keratinised cornea 
is structurally similar to intact healthy skin. This is in contrast to the healthy cornea and 
tear film, which may be likened to the moist wound bed environment 
 
Bandage contact lens/Wound dressing: A bandage contact lens over the surface of the 
injured cornea may be likened to a wound dressing protecting a dermal wound. 
Although contact lenses and wound dressings are applied at different bodily sites, the 
point of linkage which is of particular interest in this work is the crossover in material 
types: 
 
 
   
 
In this thesis, hydrogel materials for ocular bandages, and hydrogel and hydrocolloid 
materials in relation to skin adhesive wound dressings and ostomy devices have been 
examined. The development of a standard in vitro artificial chronic wound fluid model 
would prove to be of value to further these studies of biomaterial interactions in the 
compromised dermal wound environment. Additionally, because the study of the 
dermal wound is extremely difficult, a standard artificial model would provide a 
platform for such studies. This chapter considers available information and a possible 
approach to the design of wound fluid from animal serum, and records preliminary 
work on the artificial wound fluid/materials interaction for the extent to which the 
biomaterials disturb the wound fluid.  
 
6.3 Tear Fluid Models 
 
6.3.1 The Tear Film – Function and Composition  
 
The tear film is essential for sustaining the health and protection of the ocular surface 
and has five main functions: 
 
 establishes a smooth optical surface: the tear film fills irregularities of the 
corneal surface to give an optically uniform surface for light refraction.  
Corneal Wounds Dermal Wounds 
Hydrogels Hydrogels 
Hydrocolloids 
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 lubricious role: the tear film sustains a moist surface which is essential for    
providing lubricity between the corneal surface and the upper eyelid. This 
ensures comfort during the blinking mechanism.  
 
 protective barrier role: it acts as a barrier to the hostile external environment.  
 
 antibacterial role: the antibacterial activity of tear proteins, such as lysozyme, 
provide antibacterial defence. 
 
  transport role: since the cornea is an avascular tissue, the tear film acts as a 
transport medium for oxygen and nutrients. It also provides a pathway for the 
removal of metabolic waste products.     
 
The composition of tear fluid consists of serum electrolytes, protein, immunoglobulins 
and lipids. Different types of tear, such as basal, reflex and emotional, have different 
compositions. Table 6.1 lists the major tear components (electrolytes, lipids, 
immunoglobulins and sugar) and concentrations of tear fluid, with average values 
obtained from a survey of over 100 studies [135].  
 
Table 6.1 Composition of the human tear fluid [135]. 
 
 
 Tear Component 
Average Concentration 
(mg/100ml) and Range 
Electrolytes  
Chloride 470 (85-512) 
Sodium 338 (327-354) 
Calcium 3.9 (1.2-8) 
Potassium 101 (58-137) 
Lipid 
Total lipid 206 (180-240) 
Cholesterol 64 (8-190) 
 
Immunoglobulins 
 
IgA 29 (4-85) 
IgG 13 (0-79) 
IgM 1.4 (0-5) 
IgE 0.0017 (0.003-0.025) 
Sugar Glucose 11 (0-65) 
- Chapter Six - 
 
184 
 
A varying number of proteins have also been determined in tears. A recent study by 
Zhou reported 1543 individual proteins in tears from the analysis of samples taken from 
four healthy subjects [136]. Figure 6.2 shows the comparison between proteins in 
human tears and blood plasma. The protein concentrations range from mg/l to pg/ml. It 
can be observed that a number of the same proteins are found in tears and plasma, but at 
different concentrations; proteins are generally found at higher concentrations in tears 
than in healthy blood plasma. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2. A comparison between proteins concentrations of tear fluid and blood 
plasma of healthy subjects. Protein concentrations range from pg/ml to mg/l. (Adapted 
from Zhou et al [136]). 
 
6.3.2 Artificial Tear Fluid Models   
 
There are two types of tear fluid models which exist; the first is artificial tears or tear 
substitutes for clinical use and the second is artificial tear fluid models for in vitro 
experimental work. Both types of models and their purposes shall be discussed.  
 
6.3.2.1 Tear Substitutes  
 
Dry eye syndrome is a condition which may be defined as “a disorder of the tear film 
due to tear deficiency or excessive evaporation, which causes damage to the 
interpalpebral ocular surface and is associated with symptoms of ocular discomfort” 
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[137]. Symptoms may include a short tear break-up time and a sensation of irritation 
and grittiness. Artificial tears are commonly used to replace the natural tear film in 
order to lubricate the corneal surface, thus reducing discomfort and acting towards 
maintaining a healthy ocular environment. Substitute fluids also smooth the ocular 
surface, which can subsequently increase optical resolution. Artificial tears may be 
produced from different bases such as [138]:  
 
 water – the aqueous phase of tear film forms 98% of its structure.  
 
 saline solutions: sodium chloride is most commonly used to maintain the 
osmolarity of the tear film which is approximately 300 mOsm/l, but solutions 
can include potassium chloride, calcium chloride, magnesium chloride or zinc 
chloride.  
 
 glycerol: acts as a humectant to retain moisture.  
 
 polysaccharides: mucilages, such as hydroxypropyl methylcellulose 
(hypromellose) and carboxymethylcellulose (carmellose) are commonly used to 
provide adequate viscosity to tears.   
 
 synthetic polymers: poly(vinyl alcohol) and poly(ethylene glycol) derivatives 
are used for solubility and tear-stabilisation properties.      
 
Preservatives are added to artificial tears designed for multiple use to prevent bacterial 
growth in the bottled container. If artificial tears are designed for single use then the 
addition of preservatives is generally not required.    
 
The healthy ocular environment and compromised dermal wound environment share a 
similarity in that both tissue sites must be kept moist and well lubricated. In the ocular 
environment, as described in section 6.3.1, the tear film serves many functions to 
maintain the health of the cornea. The use of artificial tears when the tear film becomes 
dysfunctional, such as in the case of dry eye syndrome, is well documented within 
academic literature. This has been highlighted by Moshirfar et al, who reviewed studies 
and clinical trials for the use of commercially available artificial tears for one method of 
dry eye syndrome therapy [139]. In the compromised dermal wound, it has been shown 
that a moist wound healing environment facilitates the wound healing process [47]. 
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Although topical ointments may be applied to dermal wounds to prevent infection and 
promote a moist wound environment, the application of an artificial fluid to substitute 
wound fluid would be inappropriate. This is because wound fluid represents the 
condition of the underlying granulation tissue [140]. The colour, odour and consistency 
of wound fluid provide an indication of the state of healing. Therefore, altering the 
exudate from a wound, in any capacity, would interfere with direct observations of the 
wound health.    
 
6.3.2.2 The Need for Artificial Tear Fluid Models to Study in vitro Biomaterial  
Interactions with Biological Fluids  
 
Artificial tear fluid models may be implemented for a variety of in vitro research 
purposes. Models must reflect the composition of the tear film, whilst taking into 
account patient to patient variation. The use of real tears for in vitro tear models would 
be impractical for several reasons. Firstly, tear sampling techniques, such as 
microcapillaries, are only able to collect a few microliters at a time (approximately 1-
7μl from one sample) [141]. The stimulation of tears would increase the volume 
collected, however, the composition of reflex tears differs to that of basal tears. 
Secondly, tear compositions vary from person to person. Therefore, the need for the 
design of a standard artificial tear fluid model is appealing.    
 
There is a significant amount of work on the use of artificial tear fluids, which vary in 
complexity from single protein mixtures, to more complex mixtures that involve lipids 
and mucins. A general approach for the formulation of a multi-component tear model is 
to use saline as a base to mix various proteins, such as lysozyme and lactoferrin, at 
concentrations found in tears. The shortcoming of this approach, however, often lies in 
the solubility of the lipid components added to saline. The resulting models rarely 
mimic tear fluid to an accurate degree and, consequently, such models are limited to the 
components that may be included. Vital non-water soluble species that are found in 
tears, such as lipids and phospholipids, are often excluded. 
 
The Aston Tear Model, developed by Franklin [142], takes a different approach to the 
average saline-based artificial tear model because it is based on an animal serum (fetal 
bovine serum, FBS). The FBS base is diluted with phosphate buffered saline (PBS) for 
the tear solution (1:2 ratio of FBS:PBS), to which additional lipid and protein 
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components, as detailed in Table 6.2, are introduced. The serum-based model provides 
a composition which is more comparable to tear fluid than saline-based models. 
 
Table 6.2 The composition of the Aston Serum-based Tear Model developed by 
Franklin [142]. 
 
Aston fetal bovine serum-based tear model 
Proteins 
(all at 0.004 w/v) 
Lysozyme 
Lactoferrin 
Albumin 
Lipids 
(all at 0.004 w/v) 
Fatty acid standards 
Triglyceride mixtures 
Phospholipids 
 
Animal serum, such as FBS, as a base for artificial tear models offers greater 
advantages over water or saline bases. Firstly, the compositions of tear fluid and FBS 
are broadly similar. Secondly, in practical terms, FBS is readily available at a relatively 
low cost. Thirdly, and perhaps the most valuable property of FBS, is that it is a stable 
solution containing an array of solubilised proteins and lipids. The major limitation of 
water or saline-based artificial tear models is that the inclusion of non-water soluble 
lipid components is difficult or impossible. FBS, on the other hand, already contains 
many of the proteins and lipids found within tear film, but also provides a suitable base 
for the inclusion of other additional components. Although the total composition of 
FBS is not completely understood, FBS as a base for biological fluid models appears to 
be a more compositionally accurate alternative to water or saline.    
 
Although much work has reported the use of artificial tear fluid models, there is little 
parallel work on wound fluids. Exudate from wounds often represents different states of 
health, for example, those associated with healing acute wounds and with chronic non-
healing wounds. In order to develop an artificial model that represents chronic wound 
fluid, the approach for the use of an animal serum base, as implemented in tear models, 
was expanded.     
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6.4 Artificial Wound Fluid Models 
 
In order to work towards an artificial wound fluid model, the functions, compositions 
and requirements of wound fluid must first be understood in greater depth.  
 
6.4.1 Wound Fluid  – Function and Composition   
Traditional ideologies for successful wound healing include the notion that wounds 
must be kept dry, free from excess wound fluid and, therefore, free from infection. 
Moist wound healing was first described around 120 AD, but it was not until 1962 
when George Winter [47] demonstrated that wounds sustained in a moist state showed 
faster rates of healing, leading to an evolution of wound dressing materials. The role of 
the moist wound environment and bacterial infection was reported by Cutting [143], 
who expressed that although pathogens such as staphylococcus aureus (gram positive) 
and Pseudomonas aeruginosa (gram negative) flourish in the moist wound, neutrophils 
also thrive in these conditions. As a result, wound fluid has an important role in 
suppressing infection.  
The composition of wound fluid is patient-dependent, with numerous reasons giving 
rise to the biochemical differences found between wound fluid samples, including: 
[144]  
 
 general health of the patient 
 nutritional status of the patient  
 state/condition of the wound including wound type, wound size and phase of 
healing 
 prior wound bed management  
 
Additionally, the technique for fluid sampling may also influence the fluid composition: 
 
 method/procedure of wound fluid collection 
 time of sampling  
 assay used for sample analysis 
 
Wound fluid is a complex soup of electrolytes, proteins, lipids, growth factors and 
proteases. Very few studies have analysed wound fluid on a biochemical level [121, 
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140, 143, 145, 146]. The significance of wound fluid must not be overlooked, as it 
provides an insight into the healing condition of the wound. As mentioned above, the 
many variables occurring between patients, wounds and sampling techniques all have 
the propensity to affect the wound fluid composition and state/fate of the complex 
dermal wound healing process. Nonetheless, key differences between the compositions 
of healing wound fluid from acute wounds and non-healing wound fluid from chronic 
wounds are known. The following sections discuss these compositions in further detail.     
 
6.4.1.1 Acute Wound Fluid versus Chronic Wound Fluid 
 
The differences between acute and chronic wounds were outlined in section 1.3.4. 
Whilst acute wounds heal within a timely and well-defined healing process, chronic 
wounds fail to proceed through the orderly process and become trapped in a phase of 
inflammation and non-healing.   
It is, therefore, unsurprising that the compositions of fluids from acute healing wounds 
and non-healing chronic wounds differ, as shown in Table 6.3. The information 
presented in Table 6.3 is drawn from a study by Trengove et al [145], where wound 
fluid samples were collected from eight patients with healing or non-healing leg ulcers. 
Biochemical analysis from the two types of fluids reveals higher levels of bicarbonate, 
glucose, total protein, albumin, gamma globulin and cholesterol in the healing phase 
[145]. Both acute healing fluid and chronic non-healing fluids have similar levels of 
growth factors. It can be observed from Table 6.3 that C-reactive protein, a marker for 
inflammation, is found in greater concentrations in chronic wound fluid (13 mg/l) than 
in acute wound fluid (5 mg/l). This significant difference in C-reactive protein 
concentration highlights the measurable difference in inflammation between healing 
and non-healing wounds. Additionally, the functions of fibronectin were described in 
chapter three; as a similar protein to vitronectin, it is an adhesive glycoprotein that 
mediates cell adhesion. Wysocki et al [147] found that fibronectin is readily degraded 
into smaller molecular weight proteins in chronic wound fluid, but remains intact within 
acute wound fluid.  
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Table 6.3 The compositional comparison of healing wound fluid from acute wounds and 
non-healing wound fluid from chronic wounds [145]. 
Biochemical 
Component 
Function 
Healing Wound 
Fluid: Acute 
Wounds 
Non-healing 
Wound Fluid: 
Chronic Wounds 
Bicarbonate 
(mmol/l) 
Alkaline 
component 
19 17.5 
Glucose (mmol/l) 
Cellular energy 
source 
2 1.2 
Total protein (mg/l) 
Support tissue 
repair 
41 34 
Albumin (g/l) 
Support tissue 
repair 
23 19 
C-reactive protein 
(mg/l) 
Inflammation 
protein 
5 13 
Gamma globulin 
(g/l) 
Antibody functions 6 4.5 
Cholesterol 
(mmol/l) 
Supports cell 
renewal 
1.8 1.6 
 
Remodelling of the extracellular matrix (ECM) in the wound healing process is 
regulated by the antagonistic mechanism between matrix metalloproteinases (MMPs) 
and tissue inhibitors of metalloproteinases (TIMPs). MMPs are extracellular 
proteinases that belong to the metzincin protease family and are regulated by the 
inhibitory action of TIMPs [148]. They function to degrade components of the ECM 
such as collagen, fibronectin, laminin, proteogylycan and elastin [22] and are involved 
in various aspects of wound repair and healing. The timely action of MMPs allows not 
only for the removal of damaged matrix, but also for cellular migration and 
angiogenesis. There is, however, evidence to support the over expression of MMPs in 
chronic wound fluid [22, 147]. Trengove et al [22] reported a 30-fold increase of MMPs 
in chronic wounds compared with acute wounds. The raised level of MMPs in chronic 
wound fluid is a result of the increased production by proinflammatory cytokines, 
which also exhibit a decreased production of TIMPs. Subsequently, the crucial 
MMP/TIMP balance is disturbed and, therefore, causes the compositions of acute 
wound fluid and chronic wound fluid to be vastly different from each other [149]. As 
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the wound progresses from a non-healing to healing state, however, the levels of MMP 
activity decrease [22].  
Another important component of wound fluid is growth factors. Growth factors are 
released by inflammatory cells during the second stage of wound healing, with roles 
within the regulation of extracellular matrix degradation and synthesis, angiogenesis, 
coagulation, chemotaxis, epithelialisation and cell proliferation [150]. It has been 
suggested that growth factors, such as epidermal growth factor (EGF), platelet-derived 
growth factor (PDGF) and vascular endothelial growth factor (VEGF), amongst others, 
are deficient within chronic wound fluid as opposed to within acute wound fluid [22]. 
Accordingly, the application of exogenous growth factors to chronic wounds and ulcers 
to accelerate healing has been studied, but with varied results. This is demonstrated by 
the fact that at present, the only singly approved growth factor for topical application is 
PDGF [151]. However, it has also been argued that the exogenous application of 
growth hormones to chronic wounds may be without success. It has been suggested that 
the higher than normal levels of inflammatory proteins in chronic wounds are an 
overriding factor in unsuccessful healing, rather than due to the lower than normal 
levels of growth factors present [152]. 
Table 6.4 provides a broad overview of a comparison between the acute healing wound 
fluid and chronic non-healing wound fluid.  
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Table 6.4 A comparison of acute wound fluid and chronic wound fluid in relation to 
healthy human serum [22, 143, 145-147, 152].  
Component 
Healing Wound Fluid: 
Acute Wounds 
Non-healing Wound Fluid: 
Chronic Wounds 
Serum components  
i.e. Na
+
, K
+
, Cl
-
 
Present Present 
Bicarbonate Present Lower than AWF and serum 
Glucose Lower than serum values Lower than AWF and serum 
Total Protein 
44 g/l 
Lower than serum values of 
73g/l 
30 g/l 
Lower than AWF and serum 
Albumin 
25 g/l 
Lower than serum values of 
73g/l 
17 g/l 
Lower than AWF and serum 
C-reactive protein Same as serum values 
Raised levels - denotes 
inflammatory phase 
Cytokines Present 
At increased levels (in 
particular IL-6 and TNF-a) 
Matrix 
metalloproteinases 
Present 
Increased levels (in particualr 
MMP-2 and MMP-9) 
Tissue inhibitors of 
metalloproteinases 
Present Absent or low levels 
Growth factors Present 
Degraded or completely 
absent 
Vitronectin and 
Fibronectin 
Present in their usual forms 
Degraded into lower 
molecular weight proteins 
Urea 
8.4 mmol/l 
Similar to serum values of 
73g/l 
10.3 mmol/l 
Lower than AWF and serum 
Free radicals Low levels Raised levels 
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6.4.2 An Overview of Artificial Wound Fluid Models in Literature for  
            Biomaterial Design and Investigations  
 
A literature search was conducted to investigate the availability and compositions of 
existing artificial wound fluid models. Few models have been produced by authors for 
different purposes and no review has attempted to collate information in a bid to 
compare the different designs. This section discusses existing artificial wound fluid 
models, with a view to consider the design of a standard artificial wound fluid.  
 
Water-based fluids: A simple water-based fluid was produced by Lindsay et al [153] for 
in vitro studies to evaluate wound dressing performance. Various components were 
added to de-ionised water:  2% bovine albumin, 0.02 M calcium chloride dihydrate, 0.4 
M sodium chloride and 0.08 M tris methylamine. The overall pH of the fluid was pH 
7.5. Although this simple isotonic salt solution is more representative of wound fluid 
than unmodified water or saline, which are often used in such studies, many important 
components of wound fluid are missing. These include vital proteins and lipids.     
 
Saline-based fluids: Hobson et al have also produced what may be considered a simple 
artificial wound fluid, but from a phosphate buffered saline (PBS) base. The 
components that were dissolved in PBS at pH 7.5 included: 0.2% w/v fatty acids, 4.0% 
w/v albumin, 2.5% w/v globulins and 0.05% w/v triglycerides. This fluid was designed 
in order to test the characteristics of a novel wound dressing material pending a patent; 
the importance of such artificial fluids is therefore apparent. Although this fluid 
contains more constituents than the water-based fluid produced by Lindsay et al it is 
still not fully representative of actual wound fluid.  
 
3M Health Care has developed a more compositionally accurate artificial wound fluid 
from saline to mimic human extracellular fluid [154]. The saline-based wound fluid 
consists of proteins, electrolytes and nutrients as found in extracellular fluid. The 
composition of the fluid is shown in Table 6.5. A study by Campbell et al used the 3M 
artificial wound fluid to mimic exuding wounds in order to assess fluid absorption, fluid 
retention and wear duration of two selected wound dressings. Although the artificial 
fluid did not reproduce the composition of wound fluid, it was found to be sufficient to 
test fluid handling properties of the dressings.  
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Table 6.5 The composition of artificial wound fluid produced by 3M Health Care [154]. 
 
 
A study by Lutz et al [155] used a different approach to develop an artificial wound 
fluid from PBS for investigations in material fluid handling characteristics. PBS was 
adjusted with; whey protein isolate for a high protein concentration; vegetable oil for a 
lipid content; sodium bicarbonate; simethicone for an anti-foaming agent and 
dextrose/sucrose for  a sugar content. The authors obtained a reasonably accurate 
composition of artificial wound fluid by using the protein, lipid and sugar values of 
human extracellular fluid and chronic wound fluid determined by Trengove et al [145] 
as a guide, as shown in Table 6.6. The use of a preservative system (Germaben® II) 
was also incorporated to prevent microbial growth and reduce odour of the fluid. This 
appears to be the most developed artificial wound fluid reported, but still lacks essential 
growth factors and matrix metalloproteinases.  
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Table 6.6 The composition of artificial wound fluid produced by Lutz et al in 
comparison to extracellular fluid and chronic wound fluid [155]. 
 
Component  
Human 
Extracellular 
Fluid* 
Human Chronic 
Wound Fluid* 
Artificial Wound 
Fluid by Lutz et al 
[155] 
Sodium (g/l) 3.30 3.24 3.24 
Potassium (g/l)
 
0.20 0.17 0.56 
Calcium (g/l) 0.10 0.09 0.05 
Magnesium (g/l) 0.04 0.02 0.01 
Chloride (g/l) 3.70 3.69 3.40 
Protein (g/l) 20.30 39 40.06 
Lipids (g/l) 5.00 2.3 2.32 
Sugars (g/l) 0.90 1.30 1.05 
* The compositional values of human extracellular fluid and human chronic wound 
fluid were obtained from a study by Trengove et al [145] 
 
 
Serum based fluids: An animal serum-based model has been produced by Parsons et al 
[156] in a study investigating the antibacterial, physical and chemical characteristics of 
a silver containing wound dressing materials. The wound fluid consisted of fetal bovine 
serum (FBS) diluted with maximum recovery diluent (in a 1:1 ratio). FBS provides a 
solid basis for the design of artificial fluid as it already contains serum components, 
albumins, other proteins, immunoglobulins, lipids, minerals, vitamins and possibly 
growth factors. In this study two pathogens (Staphylococcus aureus and Pseudomonas 
aeruginosa) were also introduced to the artificial wound fluid in order to test the 
antibacterial properties of the dressing materials. Maximum recovery diluent was added 
to the fluid as it contains a low level of peptone, which reduces osmotic shock to the 
bacterial pathogens. Therefore, the artificial fluid was tailored towards the requirements 
of this particular study and thus it is not suitable as a standard wound fluid model. 
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Conclusions: As very few artificial wound fluid models have been formulated, 
substantial comparisons cannot be made to determine which model accurately 
represents wound fluid from exuding wounds, or to determine which model is reliable 
for interactions with biomaterials. Many of the models form the basic foundation of an 
artificial wound fluid, but do not include many important components found in chronic 
wound fluid. An ideal artificial chronic wound fluid model should ideally contain 
representative levels of proteins, lipids and sugars to that of chronic wound fluid, and 
additionally should contain low/absent levels of growth factors and TIMPs, and high 
levels of proteases and MMPs.       
 
6.4.3 Fetal Bovine Serum for Preliminary Considerations of an Artificial 
Chronic Wound Fluid Model 
As the functions and compositions of wound fluid have been discussed in preceding 
sections, and synthetic fluids by other authors have been identified, the preliminary 
design of an ideal artificial chronic wound fluid may now be considered. As previous 
tear fluid models have been based successfully on animal serum, the same approach has 
been taken to propose a standard wound fluid model based on animal serum. 
Animal serum provides a rational basis for the design and development of chronic 
wound fluid models. In general, animal serum is less expensive to purchase than human 
serum and poses fewer ethical considerations. Many animal sera already contain 
proteins, electrolytes, trace elements and lipids found at similar concentrations to that of 
chronic wound fluid. Therefore, using serum as a basis eradicates the need to spike 
water or saline with many biological components. Table 6.7 compares the biochemical 
compositions of seven various animal sera [fetal bovine serum (FBS), cow, horse, pig, 
sheep, goat and rabbit] with human chronic wound fluid. All animal sera data was 
obtained from Merck Manuals [157] with the exception of FBS data which was 
obtained from Sigma Aldrich (Appendix 1 – FBS Specification). It can be observed 
from Table 6.7 that the specifications of all the animal sera are comparable to human 
chronic wound fluid in terms of serum components, osmolality and pH. The total 
protein content of FBS (30-45 g/l) is most similar to chronic wound fluid (39 g/l), 
whereas the total protein contents for the remaining animal sera range from 54-83 g/l. 
Therefore, FBS was determined as the most similar in composition to chronic wound 
fluid from the range of animal sera compared. As FBS is also fairly inexpensive and 
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more easily attainable in comparison to other animal sera, it was used as a basis for an 
artificial chronic wound fluid in this work.     
Table. 6.7 The comparison of compositions of different animal sera with human chronic 
wound fluid.  
  Animal Sera 
 
Chronic 
Wound 
Fluid* 
[145] 
Fetal 
Bovine** 
(Appendix 1) 
 
Cow 
[157] 
 
Horse 
[157] 
Pig 
[157] 
Sheep 
[157] 
Goat 
[157] 
Rabbit 
[157] 
Sodium 
mMol/L 
141 138 136-
144 
128-
142 
139-
153 
142-
160 
137-
152 
131-
155 
Potassium 
mMol/L 
4.4 11.1 3.6-
4.9 
2.9- 
4.6 
4.4-
6.5 
4.3-
6.3 
3.8-
5.7 
3.6- 
6.9 
Chloride 
mMol/L 
104 100 99-
107 
98 
-109 
97-
106 
101-
113 
100-
112 92-112 
Total 
Protein 
Content 
(g/l) 
39 30-45 
67 
-75 
56- 
76 
58-
83 
59- 
78 
61- 
75 
54- 
83 
Osmolality 
(mOsm/kg) 
287 260-340 
260-
340 
260-
340 
260-
340 
260-
340 
260-
340 
260-
340 
pH 7.15–
8.9 
6.7-8 6-8 6-8 6-8 6-8 6-8 6-8 
*   The values of human chronic wound fluid were obtained from Trengove et al [145]. 
** The values of fetal bovine serum were obtained from Sigma Aldrich and may be    
     found in Appendix 1.     
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6.5 Proposals for the Design of Standard Artificial Wound Fluid 
Models    
Based upon the findings in section 6.4, a simple FBS-based artificial wound fluid model 
is proposed in this section. FBS was filtered using 13 mm cellulose acetate syringe 
filters to remove any impurities. The same batch of FBS was always used to ensure that 
the biochemical specification of the model was kept constant. The pH of the fluid model 
was determined at pH 7.4. No other components were added to the fluid.   
The model was implemented to test the performance of a hydrocolloid skin adhesive 
wound material before and after contact with the artificial fluid. For the purpose of 
these in vitro tests, materials of size 2cm
2
 were immersed in 5 ml volume of the 
artificial fluid. The composition of the hydrocolloid adhesive was: 20% sodium 
carboxylethyl cellulose (NaCMC), 20% gelatin, 20% pectin and 40% poly(isobutylene) 
(PIB). The hydrocolloid was compared with two contact lens materials (etafilcon A and 
lotrafilcon A), in order to highlight the differences between material behaviour.   
Total Protein Measurements: A sample of the hydrocolloid material (2cm
2
), one 
etafilcon A contact lens and one lotrafilcon contact A lens were immersed in 5 ml of 
FBS-based artificial fluid model for 90 minutes. Total protein measurements were taken 
for the artificial fluid model soak solution at 0, 30, 60 and 90 minutes. Measurements 
were made by the total protein method, as described in section 2.2.9. Readings were 
measured at 750 nm on a Spectramax M2. Figure 6.3 shows the total protein 
measurements of the artificial fluid model soak solution for the three different material 
types at the four time intervals. It can be seen that when the hydrocolloid adhesive was 
submerged in the FBS solution, the total protein concentration of the soak solution rose 
sharply from 0-30 minutes before levelling off. The adhesive hydrocolloid wound 
dressing is designed to absorb a large volume of fluid; the absorption rate of a 2 cm
2
 
sample of adhesive was determined as 1.3 ml over 90 minutes. This uptake of water 
from the FBS-based model excludes larger sized protein molecules. As a result the soak 
solution of the hydrocolloid material showed an increase in total protein concentration 
with time. Unlike the wound adhesive, the two contact lenses studied, etafilcon A and 
lotrafilcon A, are not designed to absorb water and differences in interaction with the 
artificial model can be seen between the two contact lens types. Etafilcon A, a Group 
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IV contact lens, shows a general decrease with time in total protein concentration of the 
soak solutions. Its anionic surface creates an electrostatic attraction with positively 
charged proteins, such as lysoyme in the tear fluid model. Lotrafilcon A, however, a 
Group I contact lens with a plasma coated surface, has a maximum protein adsoption of 
5 µg/ml per lens. This contact lens showed no significant difference in total protein 
absorbance.    
 
Figure 6.3 Changes in total protein concentration after material interaction with the 
fetal bovine serum-based artificial chronic wound fluid model. 
Osmolarity Measurements: The hydrocolloid material (2 cm
2
), one etafilcon A contact 
lens and one lotrafilcon A contact lens were immersed in 5ml of FBS-based artificial 
fluid model for up to 90 minutes. Osmolarity measurements were taken for the artificial 
fluid model soak solutions at 0, 30, 60 and 90 minutes. Measurements were made on a 
Camlab Micro-Osmometer. Figure 6.4 shows the osmolarity measurements for the 
artificial fluid model soak solutions for the three different material types over the 90 
minutes. The osmolarity of the artificial wound fluid was initially determined at 299 
mOsm/kg. It can be observed that the adhesive hydrocolloid material absorbed a small 
concentration of ions in addition to water, as demonstrated by the increase in osmolarity 
with time. The two contact lens materials, however, show little or no change in 
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osmolarity as they were stored in contact lens solution containing sodium chloride, 
which results in an extremely small ion adsorption, if any at all.   
 
Figure 6.4 Changes in osmolarity after material interaction with the fetal bovine 
serum-based artificial chronic wound fluid model. 
The premise for the use of animal serum as a base for the design of a standard artificial 
wound fluid model is appealing. The preliminary FBS-based model proposed here is a 
relatively simple, but effective suggestion; the properties and composition of the serum 
are very similar to that of acute wound fluid. However, the disturbance of the critical 
balance between TIMPs and MMPs is the difference between acute wound fluid and 
chronic wound fluid. Therefore, in order to simulate chronic wound fluid to a more 
accurate standard, the presence of MMPs is required within the model. To elaborate 
upon the FBS-based model for chronic wound fluid, it may be suggested that the 
addition of MMPs would further develop the model. In particular, MMP-2 and MMP-9 
are found at significantly higher concentrations in chronic wound fluid than acute 
wound fluid [147]. Both of these MMPs are widely available from chemical suppliers, 
in addition to MMP assay detection kits.  
The aim of this chapter was to work towards preliminary considerations for the design 
of a standard chronic wound fluid model. As the composition of wound fluid varies 
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greatly from acute wounds to chronic non-healing wounds (as discussed in section 
6.4.1.1), it is valuable to suggest a standard artificial acute wound fluid model in 
addition to a standard chronic wound fluid model: 
 
      -  Artificial acute wound fluid model: 
1) FBS with no additional components 
or 
2) FBS with TIMPs and GFs present at similar concentrations to that of serum 
 
- Artificial chronic wound fluid model:    
1) FBS with high concentrations of MMP-2 and MMP-9  
 
6.6 Overall Discussion 
 
This thesis concerns the investigation of biomaterial interactions with host tissue sites. 
Studies of material interactions with compromised sites should ultimately lead to the 
improvement of material design and selection. The ocular surface is an easily accessible 
tissue site and the study of material interactions with the compromised and non-
compromised eye is well documented within the literature. In great contrast to the eye, 
it is virtually impossible to study in vivo the way in which biomaterials, such as wound 
dressings and ostomy devices, can influence the impaired dermal environment. This is 
because of the diverse characteristics of different wounds types and wound fluids (acute 
healing fluid versus chronic non-healing fluid). Consequently, this chapter recognises 
the growing need for a standard artificial wound fluid model to facilitate material 
interaction studies.  
The work contained within this chapter demonstrated preliminary attempts to assemble 
synthetic biological fluids to study material/fluid interactions for the compromised 
wound healing environment. An approach was taken founded upon the similarities 
between the ocular and dermal environments. The comparisons between these two 
tissue sites (as described in section 6.2) and the significant amount of work 
documenting the use of artificial tear fluids within the literature enabled the ocular 
environment to be chosen as a starting basis. Literature reports the well-documented use 
of various artificial tear models for contact lens material studies on wettability, 
mechanical properties and spoilation phenomenon. However, very little parallel work 
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exists on artificial wound fluids, in particular those that would accurately represent 
different states of wound health. Primarily, the difficulties of simulating wound fluid lie 
in the marked differences between the complex compositions of acute healing wound 
fluid and chronic non-healing wound fluid. Therefore, existing knowledge from 
artificial tear fluid models was applied to the design of artificial wound fluids. 
Specifically, the use of an animal serum base for the formulation of tear fluid was 
extended to artificial wound fluid. Tear fluid and wound fluid share many similarities; 
both are complex biological fluids. It was, therefore, rational to consider animal serum 
for the design of a standard artificial wound fluid model.  
A more developed in vitro wound fluid based upon animal serum could ultimately be 
used to study one particular aspect of material-tissue interaction, and that is the extent 
to which the material disturbs active components of the wound fluid. Within this work, 
unmodified, filtered fetal bovine serum (FBS) was used as a simple wound fluid model 
to demonstrate how the fluid composition and properties change when exposed to a 
biomaterial. It was shown in Figure 6.2 that the total protein content of the FBS fluid 
increased after an adhesive material was submerged in the fluid for 90 minutes. This 
suggests that the material only absorbed water from the FBS fluid during this time 
frame and excluded the uptake of protein molecules. The concentration of protein 
within the fluid was, therefore, observed to rise. Such experiments using an animal 
serum-based wound fluid model could be extended to the study of more complex 
components of wound fluid. For instance, it is recognised that non-healing wound fluid 
from the chronic wound differs largely in its composition in comparison to healing 
wound fluid from the acute wound. Chronic wound fluid exhibits higher levels of 
matrix metalloproteinases (MMPs) than acute wound fluid, with an imbalance between 
levels of proteins, growth factors, proteases and cytokines [22, 145]. Therefore, 
incorporation of MMPs and growth factors into the FBS-based model would enable the 
study of these components with material interaction.  
This work forms the preliminary basis of an important aspect for future in vitro 
biointeraction studies. The study of active components within complex biological 
fluids, which have an essential role in wound healing, and the influence of the presence 
of the wound biomaterial on these is critical if the understanding of biomaterials-related 
processes is to progress. Although there are fewer challenges encountered in the study 
of material interactions with the ocular environment, the design of a standardised tear 
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fluid model would similarly be beneficial for biochemical interaction studies. 
Biomaterial interactions with artificial models of tear fluid reported within the literature 
show that no single tear fluid model adequately represents all modes of contact lens 
wear. Likewise, the significant differences in wound fluid composition between the 
healing and non-healing wound mean that no single wound fluid model represents all 
types of wound health. Accordingly, the concept to have an appropriate number of 
standard tear fluid models and wound fluid models, and a means of varying these is 
useful. There are many improvement that can be made for the design of biomaterials 
that are used in contact with healing tissue sites. The design of artificial fluids brings 
together in vitro measurements of material behaviour and the considerations for the 
design and selection of materials for wound applications.   
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7.1 Introduction  
 
From the outset, the purpose of this thesis was to investigate the nature of biomaterial 
interactions with non-compromised and compromised ocular and dermal tissue sites. 
The clear analogies between the two tissue sites provided a novel approach to study 
material-tissue interactions. Compelling similarities may be drawn between the 
cornea/dermal wound bed, tear fluid/wound fluid and materials for contact lens/wound 
dressings. These similarities have not previously been studied and were explored in this 
work to gain a better understanding of material-tissue interactions in the ocular and 
dermal environments.  
 
7.2 Interactions of Vitronectin with the Non-Compromised Eye   
 
The eye was chosen as an initial platform to study material-tissue interactions for two 
reasons. Firstly, unlike the dermal wound, the eye is an easily accessible tissue site, 
whether it is in a non-compromised or compromised state. Secondly, contact lenses are 
extensively studied and well-documented biomaterial devices within both academic 
literature and clinical settings.  
 
The first aim of this work was to investigate the interactions of one particular 
biomarker, vitronectin, with the non-compromised lens-wearing eye. Vitronectin was 
described in chapter one as a prominent glycoprotein present in both tear fluid and 
wound fluid. This glycoprotein has many important functions within wound healing, 
but its cell adhesion properties and role within fibrinolysis were of particular interest. It 
is also well-recognised that vitronectin has a strong affinity for hydrogel materials [46]. 
Vitronectin was, therefore, selected for investigations of contact lens-corneal 
interactions in the healthy non-compromised eye. A novel on-lens cell-based assay 
technique was used to detect vitronectin-mediated cell adhesion on a range of contact 
lenses doped in vitro, and on ex vivo contact lenses. The assay exploited two specific 
properties of vitronectin to detect its presence by vitronectin-mediated cell adhesion on 
the contact lens surface, the first being its adhesive nature and the second being its cell 
binding property. The key findings from this investigation are discussed within this 
section.   
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In vitro investigations using the cell-based assay revealed that vitronectin adsorbs out of 
doping solution and onto the contact lens surface. Fibronectin is another important cell-
adhesion glycoprotein. Although vitronectin and fibronectin are biochemically 
unrelated, fibronectin also possesses cell-binding properties which had the potential to 
interfere with vitronectin-mediated cell adhesion detection. The adsorption of 
fibronectin was, therefore, also investigated. Fibronectin demonstrated poor adsorption 
out of doping solution and thus, it was concluded that vitronectin was the dominant 
protein involved in cell adhesion.   
 
Several assays were performed to understand in greater depth the interaction of 
vitronectin with contact lenses. Vitronectin-mediated cell adhesion to contact lenses in 
vitro was found to be influenced by material properties. The effect of contact lens water 
content was firstly studied. It was found that the higher the water content of the contact 
lens material, the higher the vitronectin-mediated cell adhesion to the contact lens 
surface. Secondly, the influence of contact lens ionicity was studied. Vitronectin-
mediated cell adhesion from doping solution was greater on ionic contact lens materials 
than non-ionic materials. Additionally, cell adhesion counts were significantly higher 
on high water content ionic contact lenses (etafilcon A 58%) in comparison to high 
water content non-ionic lenses (vasurfilcon A 74%). This suggested that contact lens 
ionicity is the overriding factor for the influence on vitronectin-mediated cell adhesion 
rather than contact lens water content.   
 
The investigation was extended to the study of ex vivo contact lenses worn in the non-
compromised eye, where key findings were determined. In comparison to the contact 
lenses doped in vitro, the extent of vitronectin-mediated cell adhesion observed on ex 
vivo contact lenses was observed to be significantly higher, regardless of wear modality. 
It was shown that in vitro doping experiments at similar concentrations of vitronectin in 
tears cannot reproduce the high levels of deposition detected on ex vivo lenses. 
Furthermore, a comparison between cell adhesion levels on the anterior and posterior 
surface of the contact lens revealed significantly greater levels on the posterior surface. 
Together, these findings strongly suggest that vitronectin deposition on the contact lens 
surface arises from the mechanical interaction of the contact lens with the corneal tissue 
bed, rather than from adsorption out of tears.  The potential implications of this finding 
are immense. The antagonistic actions of plasminogen activator inhibitor-1 (PAI-1) and 
- Chapter Seven - 
 
207 
 
tissue plasminogen activator (tPA) equilibrate the conversion of plasminogen to 
plasmin. One of the functions of vitronectin is to bind plasminogen activator inhibitor-1 
(PAI-1) in the fibrinolysis process and thereby modulate the conversion of plasminogen 
to plasmin. If, however, vitronectin is removed from the corneal tissue bed by the 
contact lens-corneal interaction, it is also likely to bind and remove PAI-1. This may 
then result in the upregulation of plasmin [113]. Because tear plasmin activity has been 
observed in the tear film of patients with corneal disorders [114, 122], a post-contact 
lens microclimate abundant with vitronectin has the potential to influence 
inflammation.   
 
Analysis of the locus of vitronectin-mediated cell adhesion to ex vivo contact lenses 
showed that cell adhesion is always greater at the edge of the contact lens in 
comparison to the centre of the lens. This finding was true for all contact lenses studied, 
regardless of wear modality or contact lens material type. The material type, however, 
was found to influence the locus of cell adhesion to the posterior surface of the lens. 
Hydrogel contact lenses and silicone hydrogel (SiHy) contact lenses of varying moduli 
were analysed; lower modulus lenses (for example etafilcon A, 0.25 MPa) were shown 
to exhibit greater cell adhesion at the edge of the contact lens in comparison to higher 
modulus lenses (for example lotrafilcon A, 1.1 MPa). The material influence on the 
locus of vitronectin-mediated cell adhesion has the potential to consequently influence 
the locus of plasmin upregulation. Additionally, although protein adsorption to SiHy 
contact lenses is believed to be lower than to conventional hydrogel contact lenses [91, 
94-96], this investigation determined that the very adhesive nature of vitronectin means 
that it readily adsorbs to SiHy lenses.   
 
These investigations of vitronectin interactions in the non-compromised eye highlighted 
the potential consequences of vitronectin deposition from the corneal tissue bed on 
contact lenses and, therefore, provided an excellent basis to extend the study of the 
interactions of this particular protein to the compromised bandage lens-wearing eye.  
 
7.3 Interactions of Vitronectin with the Compromised Bandage 
Contact Lens-Wearing Eye 
 
The second aim of this thesis was to investigate vitronectin as a specific biomarker in 
lens-cornea interactions within the compromised ocular environment. Due to the 
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consequences of localised vitronectin deposition on the posterior contact lens surface 
and the potential upregulation of plasmin, it was vital to study vitronectin interactions in 
the compromised bandage contact lens-wearing (BCL) eye. A search of the literature 
showed that very little is known regarding the interaction of BCLs with the impaired 
corneal surface. In fact, the majority of contact lenses selected for therapeutic bandage 
lens use are actually designed for conventional use. BCLs are often worn for extended 
continuous wear durations, which exceed the recommended wear duration provided by 
the manufacturers. The choice of a BCL for the compromised cornea appears to be 
based upon convenience and availability; a contact lens is not often chosen because of 
its healing capacity or suitability for the impaired cornea. Therefore, vitronectin-
mediated cell adhesion to BCLs worn in the compromised eye was investigated using 
the on-lens cell-based assay. Fifteen subjects with various ocular conditions were 
included as part of the investigation. Regular contact lens wearers were also included to 
provide a comparison against the compromised eye. The influence of BCL wear 
duration, material type (Biofinity versus UltraWave SiH) and clinical condition (bullous 
keratopathy versus Sjögren’s Syndrome) on vitronectin-mediated cell adhesion to BCLs 
revealed interesting outcomes.     
 
The direct comparison of a Biofinity contact lens worn for conventional use in the non-
compromised eye and a Biofinity contact lens worn as a BCL in the compromised eye 
detected significantly higher vitronectin-mediated cell adhesion to the BCL. Both 
contact lenses were worn for the same duration (one day). The comparison of these two 
contact lenses suggested that vitronectin is more readily deposited from the injured 
corneal tissue bed than from the healthy intact corneal tissue. Importantly, vitronectin 
deposition to BCLs and the effect of plasmin upregulation in the compromised eye 
could potentially interfere with the ocular wound healing process and result in further 
corneal compromise.   
 
The influence of material modulus on the locus of vitronectin-mediated cell adhesion to 
contact lenses studied in the non-compromised showed that lower modulus contact 
lenses exhibited higher levels of cell adhesion at the edge of the contact lens in 
comparison to the centre of the lens. This modulus effect was also apparent for the two 
BCL material types studied. Both materials, Biofinity and Ultarwave SiH, gave greater 
cell adhesion at the edge of the contact lens than at the centre, but this effect was found 
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to be to a greater extent with lower modulus UltraWave SiH contact lenses (0.5 MPa) 
than higher modulus Biofinity contact lenses (0.75 MPa). The locus of vitronectin 
deposition from the corneal tissue bed could lead to localised plasminogen activator 
inhibitor and, therefore, localised plasmin upregulation. 
 
The nature of the corneal condition, more specifically the nature of the tear film as a 
result of the condition, was also found to influence the extent of vitronectin-mediated 
cell adhesion. BCLs worn by Sjögren’s syndrome subjects with a severely low tear flow 
(Schirmer scores <5 mm/5minutes) exhibited high cell adhesion levels. This was in 
comparison to contact lenses worn by bullous keratopathy subjects with a sufficient tear 
flow. The results suggested that a deficient tear flow may enable greater interaction of 
the BCL with the already compromised corneal tissue bed and, therefore, greater 
vitronectin-mediated cell adhesion and greater vitronectin deposition from the tissue 
bed. Conversely, the presence of a more substantial tear flow may assist to reduce this 
effect and the levels of vitronectin deposition on the BCL.        
 
It is apparent that the choice of BCL material for the management of an ocular 
condition is highly likely to have an impact on the health of the cornea. However, BCLs 
are not generally selected with the knowledge of their healing capacity in mind. 
Understanding the interactions of the posterior contact lens surface with the impaired 
cornea is vitally important to aid material design and selection. The link between 
plasmin and contact lens wear, and the link between plasmin levels in tears of patients 
with corneal disorders, mean that the design of specific BCLs with greater compatibility 
would be desirable. Such contact lenses should ultimately lower the levels of 
vitronectin deposition to accordingly reduce levels of plasmin upregulation.  
 
7.4 Investigation of the Surface and Mechanical Properties of Skin 
Adhesive Materials 
 
In order to consider biomaterial interactions with non-compromised and compromised 
dermal tissue sites, an examination of the physical properties of skin adhesive materials 
for wound care was required. A scan of the literature showed that many studies had 
reported the use and efficacy of skin adhesives for wound healing devices. These 
studies commonly included the comparison of material performance in terms of fluid 
handling and retention, and the effect on the rate of wound healing. However, it was 
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determined that very little is known regarding the properties of adhesive materials and 
how this relates to the corresponding properties of skin. The characterisation of skin 
adhesives based upon their properties is in its infancy. A third aim of this thesis was 
then to investigate the properties of skin adhesive materials in relation to the 
biophysical properties of skin, and to investigate material interactions with unbreached, 
healthy skin. 
 
Biocompatibility of materials with the host tissue site is influenced by the surface and 
interfacial behaviour of the materials. Skin adhesive materials come into direct contact 
with both breached (wound area) and unbreached (peri-wound) skin, yet knowledge 
regarding of the surface properties of materials is sparse. In contrast, the surface 
properties of contact lenses are well-reported. Therefore, the first stage of material 
investigations in the dermal environment was to study the surface properties of a range 
of skin adhesive materials. These adhesives included; examples of hydrocolloid 
adhesives for both wound and ostomy devices obtained from leading wound care 
product manufacturers (Salts Healthcare, ConvaTec UK and Coloplast); hydrogels 
synthesised in-house by photopolymerisation; and examples of medical tapes by leading 
manufacturers used to secure wound dressings in place. Materials were supplied with 
either a siliconised paper or plastic release liner attached to the adhesive surface.  
 
It was convenient to organise the adhesive materials into five groups in order to enable 
comparisons to be made:  
 
1) Salts Healthcare Hydrocolloid Adhesives (paper and plastic release liners) 
2) ConvaTec Hydrocolloid Adhesives (paper release liners) 
3) Commercial Hydrocolloid Ostomy adhesives (plastic release liners) 
4) Aston Hydrogel Adhesives (paper release liners) 
5) Commercial Medical Tapes (no release liner) 
Initial surface energy measurements of the adhesive material groups revealed 
significant differences between the hydrocolloid adhesives groups. It was observed that 
the Commercial Hydrocolloid Adhesives group and specific materials from the Salts 
Hydrocolloid Adhesives group with siliconised plastic release liners exhibited a lower 
surface energy in contrast to other materials from the Salts Hydrocolloid Adhesives 
group and ConvaTec Hydrocolloid Adhesives with siliconised paper release liners. It 
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was hypothesised that silicone was being transferred from the plastic release liners to 
the hydrocolloid adhesives. This assumption was verified by the detection of silicon on 
the adhesive surfaces by X-ray photoelectron spectroscopy (XPS). Silicon was detected 
at significantly higher levels on the adhesives with plastic release liners (on average 
8.35% silicon at the surface) in comparison to lower levels detected on the adhesive 
with paper release liners (on average 0.95%). 
Hydrocolloids may be described as a continuous phase of poly(isobutylene) (PIB) with 
a particulate dispersed phase of sodium carboxymethyl cellulose, gelatine and pectin. 
Thus, PIB with a surface energy of 33 mNm
-1
 is at the surface of the hydrocolloid, 
rather than the particles of the dispersed phase. Silicone oil, with a fairly low surface 
energy of approximately 21 mNm
-1
 will effectively spread over PIB at the surface of the 
hydrocolloid adhesive after liner-adhesive contact. This is because particles with a 
lower surface energy than the substrate will spread or wet the surface. Silicone transfer 
from release liner to adhesive surface is dependent upon liner-adhesive contact; silicone 
will only transfer at points of contact. The ‘rough’ porous surface of the siliconised 
paper liner transfers less silicone to the adhesive, whereas the smooth surface of the 
siliconised plastic release liner transfers higher levels due to greater contact with the 
adhesive. These findings suggest that siliconised paper is the favourable material choice 
in comparison to siliconised plastic. Altering the surface properties of the hydrocolloid 
could potentially affect the adhesivity of the materials.      
 
The adhesive properties of materials were investigated by peel test measurements on 
skin and on a steel substrate. The average maximum force of removal appeared to 
correlate to the pain caused by adhesive removal from skin; the higher the maximum 
force, the greater the pain experienced. Furthermore, dynamic testing revealed that 
materials with a tan δ value below approximately 0.60 were the most painful to remove. 
The presence of silicone on the adhesive surface did not appear to affect adhesion of the 
material to skin or to a steel substrate. However, this is not to say that silicone on the 
hydrocolloid adhesive surface will not affect adhesion properties in real life 
applications. Peel tests performed within this idealised adhesion system were carried 
out on the forearm of a healthy volunteer. The forearm was cleaned with methanol prior 
to adhesive application. In real life systems, the lipoidal composition of skin will vary 
greatly from person-to-person. A high lipid composition has the potential to dissolve 
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silicone from the hydrocolloid surface and, therefore, affect the overall adhesion 
performance of the hydrocolloid.  
Additionally, comparative data for the tensile behaviour of adhesives revealed that the 
Commercial Hydrocolloid Ostomy group had the highest tensile strength (average of 
0.64 MPa) of the adhesive materials tested. A high tensile strength is a desirable 
property for a wound care product, whether it is a dressing or an ostomy device. These 
adhesive products are applied to different parts of the body and should be able to bear 
stresses of bodily contours at different body sites. 
 
The ideal skin adhesive material for successful wound applications should have a good 
hydrophobic interaction with skin, a high tensile strength, but a low modulus on 
application and a high modulus on removal. The benefits of investigating material 
properties are conducive for the design and selection of materials. From these 
investigations it was determined that no adhesive material performs well in every test; 
the best success is achieved when material properties are above a minimum level for 
each test, rather than performing exceptionally well in one particular area.   
 
7.5 Considerations for the Design of an Artificial Wound Fluid 
Model 
 
Investigations of material interactions with the non-compromised and compromised 
ocular environment are feasible because the cornea is a readily accessible tissue site. 
Interactions between the contact lens and cornea bathed in tear fluid were successfully 
studied in this thesis by investigating the deposition activity of vitronectin in both the 
regular contact lens-wearing eye and the bandage contact lens-wearing eye. The study 
of the dermal environment, however, is far more complex. In order to further in vitro 
studies of material-tissue interactions, suggestions for artificial wound fluid models 
were proposed.  
 
Parallels between the ocular and dermal environments were considered in order to work 
towards an ideal wound fluid model. Studies of artificial tear fluid models are well-
established within the literature and it was apparent that lessons could be learnt from the 
ocular environment and applied to the dermal environment. In particular, the use of 
animal sera as a base for synthetic tear fluids appeared to be an excellent starting point 
for the development of an artificial wound fluid model. Animal sera (such as fetal 
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bovine serum, FBS) offer substantial advantages over water or saline bases that are 
modified with additional components. FBS contains many proteins at similar 
concentrations to that of chronic wound fluid. Furthermore, the problem of the inherent 
lack of solubility of non-polar lipids is overcome by the use of a biological fluid such as 
FBS.  
 
The compositional differences between wound fluid from acute healing wounds and 
wound fluid from chronic non-healing wounds were highlighted. Acute wound fluid 
contains all the components of healthy serum at normal or lower concentrations to that 
of serum [145]. These include: serum components, total protein, C-reactive proteins, 
cytokines, matrix metalloproteinases (MMPs) and tissue inhibitors of 
metalloproteinases (TIMPs) [145]. In contrast, chronic wound fluid contains 
significantly increased levels of MMPs and low or absent levels of TIMPs [22, 147]. 
Consequently, it was logical to propose artificial models for both acute wound fluid and 
chronic wound fluid: 
 
Artificial acute wound fluid model: 
3) FBS base with no additional components 
4) FBS with TIMPs and growth factors present at similar concentrations to 
that of serum.  
 
Artificial chronic wound fluid model:    
2) FBS with high concentrations of MMP-2 and MMP-9.   
 
These preliminary designs for artificial wound fluid models would very importantly 
provide a platform for the study of in vitro material interactions with fluid.   
 
7.6 Suggestions for Further Work 
 
The area of bandage contact lens (BCL) interactions with the impaired cornea is ripe for 
further investigations. Within this thesis, the contact lenses worn for therapeutic use by 
subjects with corneal conditions were supplied by two large hospitals in the UK. The 
contact lenses were silicone hydrogel materials that are designed for conventional 
contact lens use rather than for therapeutic use. There are very few purposely designed 
BCLs and it appears that although these do exist, their lack of availability makes them 
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less desirable as a material choice within the hospital setting. Nonetheless, it would be 
extremely interesting to compare vitronectin-mediated cell adhesion to contact lenses 
designed for conventional use that are worn in the compromised eye against vitronectin-
mediated cell adhesion to contact lenses purposely designed for bandage use in the 
compromised eye. For example, in this study UltraWave SiH monthly contact lenses 
produced by UltraVision were analysed by a cell-based assay technique for the 
detection of vitronectin on the contact lens surface. However, UltraVision also produce 
a bandage lens named UltraWave Bandage, which is suitable for three months extended 
wear. Because UltraWave SiH can be used for both conventional and bandage lens use, 
it is a practical choice for hospitals when selecting contact lens materials in comparison 
to UltraWave Bandage. However, the comparison of these two contact lens types could 
prove very useful. If it appears that overall vitronectin deposition is lower on 
UltraWave Bandage, there could be a strong argument for this contact lens as a better 
choice for wear in the compromised eye. This is just one example of comparisons 
between contact lenses for therapeutic use that could be studied further.  
 
Additionally, it would be interesting to study vitronectin-mediated cell adhesion to 
BCLs worn over a period in the compromised eye, from the time of initial injury to the 
end of the corneal wound healing process. It was suggested from this work that 
vitronectin is more readily deposited from the impaired corneal tissue bed than from the 
healthy intact cornea. Therefore, are vitronectin deposition levels on BCLs higher 
immediately after injury? Do these deposition levels on BCLs decrease as the cornea 
heals? These questions may be difficult to answer in the eye which has been injured by 
accident; due to the propensity of the cornea to heal rapidly following injury, the 
corneal tissue bed may reach a certain degree of healing by the time a contact lens is 
inserted into the eye. However, this type of study could be feasible in the eye following 
surgery. In elective surgery procedures, such as laser-assisted in situ keratomileusis 
(LASIK), a contact lens is normally inserted in the eye immediately after the surgical 
process. Harvesting such contact lenses immediately after surgery and then replacing 
them after appropriate time intervals could further determine the link between 
vitronectin deposition on contact lenses and corneal healing. This could potentially 
provide a further insight into the negative consequences of vitronectin deposition in 
terms of plasmin upregulation in the ocular environment.      
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With respect to material-tissue interactions in the dermal environment, further work is 
required for the development of a standard artificial wound fluid model. Preliminary 
suggestions were made for compositions of acute and chronic wound fluids using 
animal serum as a base. The development and optimisation of such artificial fluids is 
not without difficulty; the composition of wound fluid varies tremendously from 
wound-to-wound and from patient-to-patient. However, an artificial wound model, 
which can be modified accordingly to represent different states of healing, would 
provide a premise to study wound dressing material interactions with a biological fluid. 
In this work the surface and mechanical properties of skin adhesive materials were 
studied in their undisturbed unhydrated form. Material properties, such as the surface 
energies, peel strengths, tensile strength and dynamic moduli, will inevitably change 
once a material is subjected to fluid and becomes hydrated.  The investigation of 
material properties after contact with artificial wound fluid would logically be the next 
step for understanding material-tissue interactions.    
 
In the ocular environment, a great deal is known about how the contact lens can 
influence the composition of the tear film in the lens-wearing eye. However, the way in 
which materials influence and disturb the composition of wound fluid is not an area that 
is widely studied. Further work in this area could importantly aid in material design and 
selection for wound care products. 
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